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ABSTRACT
This thesis presents the results o f the synthesis of metal complexes o f sulfa drugs 
(sulfadiazine, sulfamerazine, sulfamethazine, sulfathiazole and sulfadimethoxine) with 
secondary ligands, which were subjected to X-ray crystallographic studies. The aim o f this 
work was to synthesise metal complexes of sulfa drugs with secondary nitrogen donor 
ligands e.g. ammonia, pyridine (py), ethylenediamine (en), diethylenetriamine (dien), 2,2'- 
bipyridine, 1,10-phenanthroline, 4,4'-dimethyl-2,2'-bipyridine, A(A^(3-aminopropyl)-bis- 
(ethylenediamine) (apen) and oxygen donor ligands such as, water and dimethylformamide 
(DMF) and to investigate the different modes of coordination of the sulfa drugs molecules 
to the metal ions in the presence o f nitrogen/oxygen donor ligands.
Chapter 1, details an introduction into the fundamental concepts, procedures and equipment 
involved in data collection, solution and refinement of single crystal structures.
In Chapter 2, a review o f the literature on the metal complexes of sulfa drugs along with 
the main aims of this work is presented.
In Chapter 3, the general experimental procedure and synthetic methods have been 
described for the metal complexes o f sulfa drugs whose results and discussion are 
described in chapter 4.
In chapter 4, the crystal structure o f sulfadiazine, a new polymorph of sulfamerazine and 
the syntheses of the metal complexes o f sulfadiazine, sulfamerazine and sulfamethazine, 
their analytical and spectral data along with the X-ray structure determination o f the 
complexes are presented. The complexes studied in this chapter are: A) Cobalt complex 
{[Co(smz)2(H20)].DMF}„ (3); B) Nickel complexes [Ni(en)3(sdz)2].H20 (4) and
[Ni(smr)2(py)2].4py (5); C) copper complexes [Cu(en)2 (sdz)2 ] (6), [Cu(dien)2 (sdz)2 ] (7), 
[Cu(en)2(H20 ) 2][smr)2] (8), [Cu(en)2(H20)2][smr)2].H20 (9), [Cu2(smr)4].2DMF (10),
[Cu2(smr)4] .2DMSO (11), [Cu(smz)2(apen)].3H2O.CH3OH (12) and
{[Cu(smz)2.NH3].2H20}„ (13); D) Zinc complexes [Zn(smz)2 (NH3 )2 ] (14) and
[Zn(smz)2(py)2].2py (15), E) Cadmium complexes [Cd(dien)2 (sdz)2 ].DMF (16),
V
[Cd(dien)(smr)2].H20  (17), [Cd(sdz)2(bpy)] (18), [Cd(sdz)2(phen)] (19), 
[Cd(sdz)2(dmbpy)].2DMF (20), [Cd(smr)2(phen)] (21), {[Cd(smz)2(H20)].DMF}„ (22), 
{[Cd(smz)2(H20)].2H 20}„ (23) and [Cd(smz)2(en)].2DMF (24); and F) Mercury 
complexes [Hg(sdz)2(DMF)2] (25), [Hg(smr)2] (26) [Hg(smr)2(bpy)] (27) and 
[Hg(smz)2(DMF)2] (28).
The structural results for the complexes are discussed and compared with other related 
complexes. In this context, the different types o f coordination geometries, important 
parameters within the coordination sphere, the various modes o f coordination o f the sulfa 
drugs in the anionic form, dimeric polymeric complexes, the role o f hydrogen bonds in the 
formation of the “cation-anion pair” and the packing diagram have been discussed.
In Chapter 5, we have described the syntheses and characterisation of the complexes of 
sulfathiazole, their analytical and spectral data along with the X-ray structure determination 
o f these complexes are presented. The complexes studied are: [(H2 stz)2 ][N 0 3 ].H 2 0  (29), 
[C0 CI4 ][(H2 stz)2 ].CH 3 COOH (30) and [Cu(en)2(H20 )2][stz)2].2H20  (31). In all the 
complexes the sulfathiazole molecules act as ionic species. The structural results for the 
complexes are discussed and compared with other related complexes. In this context, the 
role of hydrogen bonds in the formation of the “cation-anion pair” and the packing diagram 
has been discussed.
Chapter 6 describes the structure o f sulfadimethoxine and synthesis and characterisation o f 
a zinc complex o f sulfadimethoxine [Zn(sdm)2(NH3)2].2H20  (33) by analytical and spectral 
data along with the X-ray structure determination. The structural results of the complex are 
discussed and compared with other related complexes. The packing diagram of the 
complex with the hydrogen bonds is discussed in this chapter.
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ABBREVIATIONS
A angstrom (1A = 10"10 cm)
X wavelength
V cell volume
a, b, c cell axes
a, J3, y cell angles
d interplanar spacing
Fhki structure factor
fj scattering factor
hkl general indices
(°) degree centigrade (Celcius)
cm centimeter
cm-1 wave number
g grams
ml milliliter
mmol millimolar
tsd triple sulfa drugs
Hsdz sulfadiazine
Hsmr sulfamerazine
Hsmz sulfamethazine
Hstz sulfathiazole
Hsdm sulfadimethoxine
py pyridine
DMF dimethylformamide
DMSO dimethylsulfoxide
en ethylenediamine
bpy 2,2'-bipyridine
phen 1,10-phenanthroline
dmbpy 4,4'-dimethyl-2,2'-bipyridine
dien diethylenetriamine
apen NJSF (3 -aminopropy l)-bi s(ethy lenediamine)
IR infrared
EPR Electron Paramagnetic Resonance
c. w. continuous wave
NMR nuclear magnetic resonance
s singlet
d doublet
t triplet
PABA p-aminobenzoic acid
UTI urinary tract infection
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Chapter 1
X-RAY CRYSTALLOGRAPHY
1.1 HISTORICAL BACKGROUND
X-ray crystallography1-5 is an experimental technique that exploits the fact that X-rays are
• * 2   odiffracted by crystals. X-rays have the appropriate wavelength (in the A range, ~10 cm) to 
be scattered by the electron cloud of an atom of comparable size. Based on the diffraction 
pattern obtained from X-ray scattering off the periodic assembly of molecules or atoms in 
the crystal, the electron density can be reconstructed. Additional phase information must be 
extracted either from the diffraction data or from supplementing diffraction experiments to 
complete the reconstruction (the phase problem in crystallography). A model is then 
progressively built into the experimental electron density, refined against the data and the 
result is a quite accurate molecular structure.
The knowledge of accurate molecular structures is a prerequisite for rational drug design 
and for structure based functional studies to aid the development of effective therapeutic 
agents and drugs. Crystallography can reliably provide the answer to many structure related 
questions, from global folds to atomic details of bonding.
The region of the electromagnetic spectrum for X-rays is between ultra-violet and gamma 
radiation, with wavelengths 0.1-100 A. X-rays with these wavelengths are produced when 
fast moving electrons are suddenly decelerated and their kinetic energy of motion is 
converted directly or indirectly into a quantum of radiation. To generate X-rays, electrons 
are accelerated by an electric field and directed against metal target, which slows them 
rapidly by multiple collisions. The minimum wavelength o f this white radiation is 
determined by the accelerating voltage. X-rays are produced when the cathode is a hot 
filament that releases electrons which are accelerated by a high voltage applied between 
cathode and anode toward the anode, called the target and the electron beam strikes its 
surface. The energy o f some electrons striking the target is used to eject electrons from the 
inner shells o f target atoms, if the energy is sufficient. Subsequently electrons from higher 
energy shells fall into these vacancies and X-ray photons are emitted. This leads to an
1
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atomic line spectrum called the characteristic spectrum. When the electrons bombard the 
target reach certain critical energies (threshold potentials) which are capable o f knocking 
electrons out of their atomic orbitals, in particular, at energies o f about 10,000 eV (for 
elements with atomic number ca. 30).
The crystal is a repeating array of closely packed atoms, molecules or ions in three 
dimensions. Some solids can be crystals, usually have flat surfaces or faces that make 
definite angles with one another. The orderly stacks of particles that produce these faces 
also cause the solids to have highly regular shapes. Quartz and diamond are the examples 
of crystalline solids.
The shapes of crystal depend on its growing, and these may be sheet like, needle like, plate 
like or twin like. In general the growth should be very slow so that a regular arrangement of 
molecules or ions, leading to a well-formed crystal, may be obtained.
To choosing a crystal for collecting X-ray data, two main requirements must be met:
a) It must possess uniform internal structure and
b) It must be of proper size and shape.
To fulfil the first requirement, a crystal must be pure at the molecular, ionic, or atomic 
level and a single in the usual sense, it should not be twinned or composed of microscopic 
subcrystals. It should not be grossly fractured, bent, or otherwise physically distorted. For 
X-ray work, specimens with dimensions 0.2-0.4mm on an edge are usually appropriate.
In 1895, X-rays were discovered by Wilhelm Rontgen. It was still unknown upto 1912 
whether X-rays consisted o f particles or they were electromagnetic waves. In order for the 
wave hypothesis to be correct, the wavelength would have had to be of the order of lA
_ o
(10 cm). It was not believed possible to use a grating to measure such short wavelengths, 
due to the fact that all previous experiments had involved wavelengths o f the same order of 
magnitude as the grating spacing.
There was still no direct evidence for the structure of crystals and in 1912 came the great 
turning point in crystallography and the German Physicist Max Laue suggested that crystals
2
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might serve as diffraction gratings for X-rays. Friedrick and Knipping carried out an 
experiment to test Laue’s suggestion and irradiated a crystal o f CUSO4 .5 H2 O with X-rays. 
The detection o f diffraction confirmed Laue’s suggestions and launched the science of X- 
ray crystallography.
1.2 BRAGG’S EQUATION
Following the discovery by Friedrick, Knipping and Laue, W. H. Bragg and his son, W. L. 
Bragg developed and used X-ray diffraction techniques to determine crystal structures. The 
first crystal structure for sodium chloride was published in 1913 by W. L. Bragg. The 
excited electrons become themselves “secondary” scatterers of the same kind of X- 
radiation. This is called coherent scattering.
Bragg showed that the coherent scattering of X-rays by crystals is mathematically 
equivalent to the reflection of light from parallel planes. If an incident X-ray beam makes 
an angle 6 with such a set of planes, the reflected beam makes an angle 6 with the planes. 
The planes are known as the hkl set o f planes where h, k  and / are the number o f parts into 
which a, b and c axes o f the unit cell are divided respectively.
Angle of 
incidence 
.90° - 0
26
Figure 1.1
X-rays of wavelength X impinge on the crystal at an angle o f incidence Ohki• The path length 
of an X-ray which strikes the top layer of atoms (A) in a crystal is shorter than that o f an X- 
ray which strikes the second layer (B). This is shown in Figure 1.1.
If two emitted waves are to be in phase and reinforce each other, their path lengths must 
differ by a number of wavelengths. This difference is nX where n is a whole number and X
3
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is the wavelength o f the radiation used. Bragg showed that the angle (#/,*/) of reflection of 
X-rays could be related to the distance (dhki-the perpendicular spacing o f the hkl set of 
planes) between the two layers o f atoms and is as follows;
2dhk! sinOhki = n l  (1)
If equation (1) is rearranged, the spacing between the planes can be calculated as shown in 
equation (2);
dhki = Z /2sm 6hki (2)
1.3 RECIPROCAL LATTICE
The concept of the reciprocal lattice was used by P. P. Ewald and extended by Laue (1913) 
to describe the relationship between crystal structure and diffraction spectrum. For every 
real lattice it is possible to construct a reciprocal lattice.
The advantages o f using reciprocal distances may be appreciated by considering Bragg’s 
Law in the form
sin Ohki = nZJ2dhki (3)
From equation (3), it can be seen that sin# is inversely proportional to d.
Figure 1.2
To construct a reciprocal lattice, any point of the real lattice is taken as an origin, from 
which lines are drawn perpendicular to all sets of real lattice planes. Reciprocal lattice 
points arise on these lines at distances {dhki) inversely proportional to the spacing of the real 
planes, and also fall on sets of parallel planes. The indices o f the reciprocal lattice point, 
hkl, are the same as the indices of the planes in the real lattice that the point represents.
The interplanar spacing in the real lattice, and not the distance between lattice points, is the 
parameter which gives the distance between lattice points in the reciprocal space. The axes
4
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and angles of the unit cell in the real lattice are labelled a, b, c and a , J3, y  respectively. 
However in the reciprocal lattice they are labelled a , b*, c and a , /?*, y . A two 
dimensional reciprocal lattice can be seen in Figure 1.2.
The most important property o f the reciprocal lattice is that it allows a simple visualisation 
of Bragg’s Law. If a crystal is positioned in a beam of X-rays of wavelength X and a c 
section of the reciprocal lattice is considered, it can be assumed that the crystal is oriented 
so that the X-ray beam is parallel to a c plane. A line XO can be drawn, as shown in 
Figure 1.3, in the direction of the beam which passes through the reciprocal lattice origin
O. A circle of radius MX with its centre C on XO can be considered, so that 0  falls on its 
circumference. If we now consider a point (P) on the circle, the angle OPB is inscribed in a 
semicircle and is at a right angle (Equation 4).
sin OBP = sin 6  = OP OP OP
OB 2 /X
(4)
P is a reciprocal lattice point and therefore the length of OP is equal to Mdhkb Equation (4) 
can be rewritten to give equation (5).
s in#  =
l.X
2d hkl
Therefore, — = 2dhkl sin 6 
X
(5)
This can be regarded as Bragg’s Law with n = 1
X
X-ray
Figure 1.3
Bragg’s Law is satisfied when a reciprocal lattice point coincides with the circle and 
reflection occurs.
5
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1.4 Crystal Lattice
A crystal contains atoms arranged in a repetitive three dimensional pattern. If each repeat 
unit of this pattern is taken as a point then a three dimensional point lattice is created. Each 
crystal consists o f a basic building block that repeats over and over again in all directions. 
The building block which repeats in a perfectly regular array is known as the Unit Cell.
Primitive (P) Centred (C)
Figure 1.4: Primitive and centred cells
There are infinite numbers of possibilities for unit cells. It is possible to have lattice points 
inside a unit cell. When this occurs there is more than one lattice point per unit cell and the 
cell is centred. On the other hand, a unit cell with lattice points only on the comers is called 
primitive. This is explained in Figure 1.4.
There are seven crystal systems used to classify crystal structure depending on the 
symmetry present. In addition there are thirty-two type crystal classes or point group, so 
that there are differing degrees of symmetry of crystal belonging to the same system, and in 
three dimensions there are fourteen distinctive space lattices known as Bravais lattices, 
consisting of 7 primitive and 7 non-primitive lattices.
Table 1.1 shows the seven crystal systems, their respective parameters and the Laue 
symmetry (i.e. diffraction symmetry). In general, the unit cell is characterized by six 
parameters, three axial lengths and three interaxial angles. The lengths of the unit cell 
edges are designated by a, b, c and the interaxial angles by a , p , y. The a  is between b and 
c, p  is between a and c, while /  is between a and b. The crystal classes may be divided into 
seven main systems, each characterized by the possesion o f a certain minimum of 
symmetry elements, and referable to certain characteristic axis.
6
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x
Figure 1.5
It is conventional to label the edges of the unit cell a, b, c and the angles between them a, 
P, /w ith  the angle a  between b and c, P  that between a and c and /th a t between a and b. It 
is conventional to choose a unit cell that is the simplest, with the axial (repeat) lengths as 
short as possible and interaxial angles as near to 90° as possible. Lattice planes are defined 
as sheets of lattice points and are expressed by indices h, k, 1 where a/h, b/k and c/1 are 
proportional to the intercepts made on the a , b and c unit cell axes respectively, and are 
synonymous with Miller indices used by morphological crystallographers. Since the crystal 
(and therefore lattice) structure is infinite, for a given lattice plan definition, hkl, there will 
be an infinite stack of parallel planes with a constant interplanar spacing dhki.
Table 1.1: Crystal systems with parameters, Laue symmetry and Lattice type
Crystal Systems Symmetry Restrictions Parameters Laue
Symmetry
Lattice
Type
Triclinic Rotational Symmetry is absent a * b * c \  a *  p * y I P
Monoclinic 2-Fold Rotation axis and a 
mirror plane perpendicular to it
a * b * c ,  a  = /  = 90°; 
/?*  90°
21m P, C*
Orthorhombic 3, 2-Fold rotation axes parallel 
to the three axes and 3 mirror 
planes perpendicular to them
a *  b * c ;  a  = p  = /  = 90° mmm P, C*, I, F
Tetragonal 4-Fold Rotation axis parallel to 
the c axis
a = b * c \  a  = P  = /  = 90° 4/m, 41 mmm P,I
Trigonal 3-Fold Rotation axis parallel to 
the c axis
a - b * c \  a  -  P  -  90°; 
/  = 120°
3 , 3m tP,R
Hexagonal 6-Fold Rotation axis parallel to 
the c axis
a = b * c; a - P -  90°; 
/  = 120°
61m, 6/mmm +P
Cubic 4, 3-Fold rotation axes a = b = c; 
a  -  p  -  y  -  90°
m3 , m3m m P, F, I
*C => in monoclinic can alternatively be A or I.
=> in orthorhombic it can be replaced by A or B.
+ ^  Trigonal P and Hexagonal P have the same shape, but different symmetry
7
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1.4.1 CRYSTAL SYSTEMS
There are seven crystal systems depending on the unit cells. Table 1.1 shows that each 
crystal system has associated with its specific minimum symmetry restrictions. There are 
seven three-dimensional coordinate systems that are useful in describing crystals and are 
the basis for their classification. The systems are:
(1) Triclinic: Possessing no symmetry at all, or at the most, an inversion centre. In the 
first case opposite faces will have different properties, in the second, the same 
properties. Referable to 3 unequal axes, not at right angles.
(2) Monoclinic: Possessing a single 2-fold axes, or a single reflection plane. Referable to 
3 unequal axes, not at right angles to the other two.
(3) Orthorhombic: Having two symmetry planes at right angles, or three 2-fold axes at 
right angles to one another. The existence of two such axes demands the existence o f 
a third. Referable to 3 unequal axes at right angles.
(4) Trigonal: Having a single 3-fold axes. Referable to 3 unequal axes equally inclined to 
the 3-fold axes.
(5) Tetragonal: Having a single 4-fold axes, simple or alternating. Referable to 3 axes at 
right angles, two of them are equal.
(6) Hexagonal: Having a single 6-fold axes, simple or alternating. Referable to 2 equal 
axes inclined at 120° and a third unequal axis at right angles to them.
(7) Cubic or regular: Having four 3-fold axes, corresponding in direction to the diagonals 
of a cube. Referable to 3 equal axes at right angles to one another.
1.4.2 Unit Cell
It is usual to select out from a regular array of molecules or ions in a crystal, one small unit, 
called the unit cell. This unit cell repeats in a regular manner in each direction. The lengths 
o f the sides o f this unit cell and the angles between these sides are all that is needed 
definite. There are four different types of three-dimensional unit cell
1. The primitive unit cell (symbol P) contains one lattice point.
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2. The body-centred unit cell (symbol I) has a lattice point at each comer and also one at 
the centre of the cell.
3. The face-centred unit cell (symbol F) has a lattice point at each comer and one in the 
centre of each face.
4. The face-centred unit cell (symbol A, B or C) has a lattice point at each comer, and one 
in the centres of one pair of opposite faces.
There are seven primitive lattices and seven centred lattices and when combined they 
constitute the fourteen Bravais Lattices which are represented by lattice symbols and are 
shown in Table 1.2.
Table 1.2: Relation between the Lattice Symbol and the Lattice Points.
Lattice Symbol No. of lattice points per 
unit cell
Lattice Points
P (Primitive) 1 All comers
I (Inner) 2 At comers and at centre o f cell
A (Centred on two faces) 2 At comers and at centre o f A face
B (centred on two faces) 2 At comers and at centre o f B face
C (Centred on two faces) 2 At comers and at centre o f C face
F (Centred on all faces) 4 At comers and all face centres
R (Rhombohedral) 3 At comers
1.4.3 Miller Indices
If any crystal plane is taken which has intercepts on the three crystal axes a , b, c, then any 
other plane in the crystal is then described by alh, b/k and c/l. Here h, k  and / are small 
whole numbers or zero and are known as the indices of the plane.
If a plane intercepts all three axes a, b and c, then the unit cell will have three indices hkl 
and if only two axes are cut parallel to the third, then depending on which axis a, b or c is 
cut dictates the indices 0kl, hOl or hkO respectively. The indices 007, OkO and h00 occur if 
only one axis is cut and is parallel to the axes a and b, a and c or b and c respectively.
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1.5 SYSTEMATIC ABSENCES
Preliminary stages of a crystal structure analysis is carried out with an inspection of the 
systematic absences. An absence is observed when the reflections are too weak to be 
measured. The presence of systematic absences can be used to help determine the space 
group of the crystal.
Two examples are given here and others are given later on in the chapter.
(1) If hOO is absent for h odd, then this indicates a 2\ axis parallel to the a axis.
(2) If OkO is absent for k  odd, then this indicates a 2\ axis parallel to the b axis.
1.6 Symmetry Elements
The symmetry element is a geometrical property, such as a point, a line or a plane with 
respect to which the symmetry operation is performed. There are two types o f symmetry 
elements, point symmetry and translational symmetry.
1.6.1 Point Symmetry
It i s . an operation which when repeated returns the object to its original position. 
Reflections, rotations and inversions are the three main types o f point group symmetry.
Firstly a rotational axis can occur at an angle of 360°/n and this corresponds to n-fold 
rotations. Only 2, 3, 4 and 6 fold rotational axes are possible in crystals. Secondly an 
inversion centre is a point through which an object can be moved in a straight line, so that 
it finishes up at an equal distance from the inversion centre as it did originally. Thirdly a 
reflection operation is the reflection of an object through a plane.
1.6.2 Translational Symmetry
Two such elements used are the screw axis and the glide plane. A screw axis combines 
rotation about an axis with translation in the direction o f the axis. A three fold screw axis 
would be represented as 3i, meaning a rotation about a 3-fold axis and a translation by 1/3 
o f the unit cell. A glide plane combines reflections across a plane with translations parallel 
to the plane. If a glide plane is parallel to the a-axis, the symbol for the glide plane is 
simply “a” and for the operation is reflection in the plane and translation by a/2.
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Table 1.3 indicates three important features. The disappearance o f reflections along an 
axial line in the reciprocal lattice can be explained by the presence o f screw axes. Glide 
planes affect reflections in the corresponding reciprocal lattice planes and centring causes 
systematic absences throughout reciprocal space.
Table 1.3
Symmetry Element Affected
reflections
Conditions for 
Systematic Absences
2-fold screw axis (2i) parallel to the a-axis 600 6 = 2n + 1 = odd
2-fold screw axis (2i) parallel to the 6-axis m 6 = 2/? + 1
2-fold screw axis (2j) parallel to the c-axis 00/ / = 2n + 1
/7-glide plane perpendicular to the n-axis 06/ 6 + 1 = 2n + 1
/7-glide plane perpendicular to the 6-axis m i 6 + 1 = 2n + 1
/7-glide plane perpendicular to the c-axis 660 6 + k = 2n + 1
a-glide plane perpendicular to the 6-axis mi 6 = 2 « +  1
a-glide plane perpendicular to the c-axis 660 6 = 2/7 + 1
6-glide plane perpendicular to the tf-axis 06/ 6 = 2/7+  1
6-glide plane perpendicular to the c-axis 660 6 = 2/7+  1
c-glide plane perpendicular to the a-axis 06/ / =  2/7 + 1
c-glide plane perpendicular to the 6-axis mi / = 2/7 +  1
The atomic scattering factor, is a measure o f the amplitude o f the wavelet caused by the 
scattering of the j th atom.
1.6.3 SPACE GROUPS
A space group can be thought of as a group of symmetry operations consistent with an 
infinitely extended, regularly repeating pattern. In 1890 Federov and Schoenflies 
independently derived the 2306 possible space groups that correspond to the 32 point 
groups combined with the 14 Bravais lattices. A group whose elements include both point 
symmetry elements and the translations of a crystal is called a “space group”
The space group symbol will always consist of a capital letter donating the centring 
followed by a generalisation of the Hermann-Mauguin point group symbol to allow for
glide planes and screw axes. An example of some space groups are P2\/c, PI and P2j2i2i.
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1.7 STRUCTURE DETERMINATION
It has already been shown that if  a beam of X-rays is directed at a crystal consisting of a 
regular array o f atoms, a pattern of reflections can be recorded.
1.7.1 Atomic Scattering Factor
Every electron in an atom is responsible for scattering and each wavelet has an amplitude. 
The amplitude caused therefore by a cell o f the crystal, can be written as the sum of the unit 
amplitudes o f the wavelets. Each atom has a specific number of electrons associated with it 
in space and it is useful to know the general distribution of the electrons with respect to the 
centre o f the atom.
The scattering power of an atom ,/, is expressed in terms of the scattering power of a single 
electron. The maximum scattering by an atom is equal to its atomic number (Z). This is 
observed at sin OIX = 0. If all the electrons in an atom were concentrated at one point, there 
would be no destructive interference between the wavelets and also there wouldn’t be any 
variation in/ with sin6!X. When the electrons are distributed, as in actual atoms, destructive 
interference occurs and the larger the volume of the atom then the greater the fall-off in /  
with sin 6! X.
1.7.2 Structure Factor
The diffraction from one atom cannot be considered alone. The whole of the crystal causes 
diffraction and therefore all the atomic scatterings have to be accounted. This is represented 
as the Structure Factor Fhki which describes the amplitude and the phase of the X-rays 
scattered by a unit cell for a particular reflection, hkl.
The Structure Factor depends upon;
(1) The atomic scattering factors
(2) Arrangements of the scattering materials (including thermal motion)
(3) The direction of scattering
The intensity o f the scattered radiation from the plane, hkl, is proportional to the square of 
the amplitude.
(6)
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The structure factor, F^kt), can be represented by the following equation:
N
F(hki) =Y,fJexP27d(hxj+l<y j+!zj ) (?)
j=i
Here F^kt) -  Structure factor for hkl reflection
f j  = Scattering factor for the j th atom
x ,y ,z  = Positions of the j ih atom in the unit cell
i = V -l
(8)
(9)
Figure 1. 6  shows the phase difference between two waves.
'20 810
-3 -
a  = Phase Difference
Figure 1.6
Also it can be described as
P  _  \ p  \Ja{hkl)
r (hkl) \r (hkl ) r
F(hki) -  \hki) + iB(hki)
With \F(hki) I = the amplitude of the scattered wave
a  or cc(hki) = its phase relative to the origin of the unit cell
The components o f the wave A and B , in its vector representation, is related to the 
amplitude o f the wave through equation (10) and also can be represented using an Argand 
diagram (Figurel.7).
(10)
and a  = tan - 1  ( B / A)  (11)
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90°
(hkt)
0 (
A
Figure 1.7 Argand Diagram
A and B are products o f the individual atomic scattering factor amplitudes, Jj, and the 
cosines and sines of the phase angles of the waves scattered from the individual atoms. 
This is shown in equations (12) and (13).
N
A(hki) = Y j f j  cos2m (hXj+kyj + /z ,) ( 1 2 )
j=l
N
B(hki) = Z / y  cos2;n' ( ^  + ty j  + Izj) (13)
j=i
1.7.3 Thermal motion
The description of atomic scattering factors has yet not taken into account o f the thermal 
vibrations of an atom. When the temperature is raised the atomic vibrations are larger and 
as a result the size o f the atom appears to have increased.
The volume occupied by the electrons producing the scattering of the X-rays has increased. 
The result is a more rapid fall-off of the scattering power than would be obtained for an 
atom at rest.
As a result, a reduction in the scattering factor would be observed as governed by equation 
(14).
e ~ B ( s i n 2 0 ) U 2
Where B is the temperature coefficient which is related to the mean square displacement of 
the atoms from their mean position by expression B = %7?U2.
I(hki) 0 0  Ftfkt) excludes geometric factors, absorption corrections and other minor effects. If 
these factors were considered then equation (15) would be true.
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V )  = 4 > )  (Lp)(Abs) (15)
Here (Lp) = an abbreviation for the geometric factors 
(Abs) = an abbreviation for the absorption factors 
and K = A Scale Factor .
For an explanation of Lp and 
Abs see 1.7.7 (page 20)
If an intensity, (I(COrr)), was corrected taking into account (Lp) and (Abs) it would equal
I ic„r )= I/(A b S).(Lp) (16)
I(corr) ~ I 0  ^ )
12
hcorr) = * 1 ^ ) 1 '  exP( - 2B.so sin 2 e/X2) (18)
F(novib) is the value of F  for a structure composed of no vibrating atoms.
The value of F may be reduced as a result o f thermal vibrations so that if  F(n0 Vib) is the value 
for the structure containing stationary atoms, the experimental values will correspond to 
F^ hki) = F{novib) exp(-2 Blso sin2 0 / A2) (19)
and B(1S0) is the temperature factor.
1.7.4 THE LORENTZ FACTOR (L), POLARISATION FACTOR (p) 
AND ABSORPTION CORRECTIONS (Abs)
When X-rays are reflected by a plane in a crystal, a reduction in the intensity of the 
reflected beam occurs as a result of polarisation, scattering and absorption. The polarisation 
factor (p) is a measure of this polarisation. Equation (15) shows how the intensity is 
affected by L, p and Abs.
The Lorentz factor is an expression for the time a plane of a rotating crystal spends in the 
reflecting position. In terms of the reciprocal lattice or reflecting sphere concept, this is the 
length of time the lattice point is in contact with the sphere of reflection. This is obviously 
dependent on the distance of the reciprocal lattice point from the origin.
As stated previously, the intensity o f the reflected rays decreases and if  this is not corrected 
for then this results in systematic errors. The effect of this which can be attributed to 
absorption can be measured and corrected for using a program called SORTAV .
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1.7.5 THERMAL ELLIPSOID
We have considered the vibrations as being isotropic, however, it would be more accurate 
if they were considered as anisotropic. The location of an atom in a molecule is determined 
by considering the average time which the atom spends in all the positions it occupies 
while the structure was being determined. The resultant structure is then often represented 
in terms of thermal ellipsoids, which are probability indicators of where the atoms are most 
likely to be found.
Six parameters can be used to describe an ellipsoid compared to a single parameter for a 
sphere. Three are used to define the lengths of the three mutually perpendicular axes and 
three to define the orientations of the ellipsoidal axes.
The ellipsoidal motion is accounted for in the structure factor equation by an anisotropic 
exponential factor with six anisotropic vibration parameters by  and shown in equation (2 0 ).
^ - ( b u h 2+b22^2+b-3iI 2 +bn hk+b2jkl+biihl) (20)
The mean square vibrational amplitude in any direction, specified by the cosines, 1, o f the 
angles between the direction and the reciprocal axes, is given as;
U ‘ Uul* + U 21l\  + L^ 2 + 2  U nllll + 2U23l2\h + 2Ui\h l \ (21)
If the ellipsoid takes the shape of a rugby ball, then the motion of the atom is mostly back 
and forth along the bond axis. If however it takes the shape o f a curling-stone, then the 
motion is mostly wobbling about the bond axis. The less the thermal ellipsoid of the 
molecule, the smaller o f its thermal motion.
The computer program used during this project to represent the thermal ellipsoids was 
SNOOPI6.
1.7.6 Electron Density
X-rays are scattered by the electrons o f the atom and therefore it is important to know 
something o f the electron density at different positions w ithin the unit cell. If a point in the
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unit cell has co-ordinates x , y, z  then the electron density, p(x y  z), per unit volume near the 
point is given by
p (x + p ,y  + q ,z  + r) = p (x y z )  (2 2 )
In this equation p , q and r are any integers.
It is convenient to be able to express a function by means of a Fourier Series. This is the 
sum of the sine and cosine terms with appropriate coefficients. Fourier expansions are 
advantageous when the function is periodic and the electron density is one such function. 
Fractional co-ordinates x„, y n, z„, are often used to give the precise location of an atom in a 
unit cell. A crystal is a periodic structure and can therefore be described by the periodic 
function, the Fourier Series (or Synthesis).
In three dimension the electron density at the point xn, y n, zn is
P(x„y„z„) = \ F j l . i Z ( |cos 2n(hxn + kyn + lz „ - a ( m ) (23)
Where p(xn, y n, zn) = the electron density at the points xn, y n, z„.
1 ^
= the volume o f the unit cell
H h Z* £ /  = the mean sum over h, k, I and F(hki)
|F(W/)| = the structure amplitude
a (Md) = phase angle of each Bragg reflection
1.7.7 PHASE PROBLEM
1 12 I 12
As stated previously in 1.7.2, . However sets of values of E(M/) do not lead
to the determination of a crystal’s structure. values are needed in equation (23)
whereas, the intensities only give |e
(hk!)\
12
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If we know F(Wk/) and a  (of each hkl) we could calculate the electron densities at all values
of x, y, z and plot the p(x y  z) values to give a three dimensional electron density map. 
However, structure factor amplitudes, | , and not phase angles, a , are obtainable from
the experimental measurements.
The problem of getting estimates of the phase angles so that an image o f the scattering 
matter can be calculated is called the Phase Problem and is the central one in X-ray 
crystallography.
The phase angle can be derived from values of A and B from statistical methods (trial 
structures) or by analytical methods. Once the phase angle has been determined, the 
structure factor amplitude can also be determined. The calculated, F c, can then be 
compared with the observed amplitudes F0. F0 has to be as close to Fc as possible in order 
to give a structure that best fits the calculated values.
1.7.8 SOLUTIONS TO THE PHASE PROBLEM
There are many methods which are commonly used to determine the relative phase angles 
of the Bragg reflections, hkl. The two main methods of solving the Phase Problem are:
(1) by Direct Methods and
(2) by Patterson Methods.
1.7.8.1 Direct Methods
Direct methods o f structure determination, are based on two fundamental physical 
principles.
Firstly, the electron density in the unit cell cannot be negative at any point, and so the large 
majority of possible sets of values for the phases of various structure factors are not 
allowed. A random set of phases would give positive and negative regions in the electron 
density map with equal probability.
Secondly, the electron density in the cell is not randomly distributed, but is mainly 
concentrated in small areas which we identify as atoms.
18
Chapter 1
A consequence of these two principles is that for certain sets o f reflections having 
particular combinations of miller indices, there are theoretical probability relationships 
among their phases. The phases can be assigned to some reflections usually the most 
intense and then the positions of some or all of the heaviest atoms can be located.
When direct methods are used for phases determination, “normalised structure fa c to rs” 
are used. The structure factor |F| is modified by the removal o f the fall-off in the scattering
fac to rs ,/ with increasing scattering angle, 20. In the normalisation factor, E, (equation 24) 
the sum is taken over all atoms in the unit cell at the value of sin 6!L
where,
s=  an integer for improving the space group symmetry. The values o f e can be obtained 
from International Tables5.
F  = Structure Factor magnitude.
Fj = Atomic scattering factor of the j th atom.
Thus showing that E is independent of sin OIL
The E  values give us information about the structure of the crystal. If the mean value o f E 
is 0.798 then the structure is centrosymmetric. However, if E  were 0.886 then this would 
indicate a noncentrosymmetric structure.
A noncentrosymmetric crystal structure has phase angles anywhere between 0° and 360°. A 
centrosymmetric structure on the other hand has phase angles o f 0 ° or 180° which means 
cosa=  ± 1 , sinO= 0 .
1.7.8.2 Patterson Synthesis
This is the “heavy atom” method of solving structures and is very useful for transition 
metal complexes, which often have one atom much heavier than the rest.
I I2In 1934, A. L. Patterson discovered that a Fourier series using values of \E{hkl)\ as 
coefficients instead of Fq^ I) could produce useful information about the structure. If the
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electron density at point x, y, z is taken and multiplied by the electron density at the point x 
+ u ,y  + v ,z  + w a product
p (x ,y ,z )p (x  + u ,y  + v ,z  + w) (25)
is now formed. This is then multiplied by dxdydz and integrated over the volume of the unit 
cell.
When the equation for the Fourier expansion is substituted for each electron density 
function we arrive at equation (26).
1 _ I 12
p(»,v.»') = 77Z(m/)|-F(mo| c o s2 x(.hu + kv + lw) (26)
Where, P(U,v,w)= the electron density at u, v, w in the unit cell. 
u, v, w -  the vectors between the two atoms. 
u = jq -  x 2 v = y x -  y 2
w = z x - z 2 V= volume of the unit cell
F(hki)= is the structure factor of the hkl set of planes
i i2Here Patterson used the squares of the structure amplitudes, LF(M/) , as Fourier coefficients 
and these values were directly derivable from the primary experimental quantities. No
i i2phase information is required for this map because is independent of phase.
The peaks in the Patterson map occur at points whose distances from the origin correspond 
in magnitude and direction with distances between atoms in the crystal. This results from
= v  IfM *>  y> + u>y+ v ’z + w)dxdydz (27)
The height [P(U,v,w)] of each peak is also proportional to the product o f the atomic numbers 
of the atom giving rise to it. The very high peaks correspond to the heavy atoms and 
therefore the peaks corresponding to the hydrogens are the ones appearing last in the map 
and are of low intensity.
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One difficulty with the Patterson function is that there are so many interatomic vectors. If a 
unit cell contains N  atoms there are N  vectors. There are N  origin vectors and therefore 
there are (N2-N) peaks other than the origin peak. Of these half are related to the other half 
by a centre of symmetry so there are (N  - N)/2 independent peaks. If N  is 20, there are 190 
independent Patterson peaks and the vector map will be very crowded. A further 
complication is that the atoms are not points, but they occupy a considerable volume.
1.7.9 STRUCTURE REFINEMENT
The aim of refinement is to obtain the best agreement between the observed (F0) and the 
calculated structure factors (Fc). There is sufficient information for every atom within the 
unit cell to be located once the phase problem has been overcome. The most suitable sets of 
parameters are those which will produce the most accurate values of interatomic distances 
and bond angles. It is anticipated that the most suitable set will also give the best agreement 
between the calculated and observed structure factors.
The correctness of the structure is measured in terms of a discrepancy index, R, where
N"* 1/r _ /r I
R  = V i P I <28)z J ^ I
Generally, if  R has a value of 0.30 then this indicates that the correct structure is near. 
However, if  R is 0.1 or less then F0 is close to Fc and the results are probably very reliable.
Once all the phases have been determined, a Fourier map can be calculated and the atomic 
positions are taken as the locations of the maxima of the electron density function (or 
Fourier Synthesis).
Alternatively, the least-squares process could be carried out. In 1806, Legendre introduced 
the idea of least-squares which is a statistical method of obtaining the best fit. This is done 
by minimising the sum of the square of the deviations between the exponential and the 
calculated parameters.
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If the difference in the amplitudes of the observed and calculated structure factors
The sum in this equation is taken over independent observations that is the unique 
diffraction maxima.
In equation (15) the scale factor (K) was introduced and this brings the observed structure 
factor, F0, on to the same scale as the calculated structure factor, Fc. The relationship 
between K , F0 and Fc is given in equation (30).
1.8 Experimental Section
This section presents very briefly the most important aspects of the hardware, software and 
procedures used for X-ray data collection. CCD area detector diffractometer were used to 
collect the crystallographic data for the compounds presented in this work.
X-ray diffractometers basically comprise three principal parts. These are:
♦> The X-ray source: This consists o f the target material, usually molybdenum or copper, 
housed to that it is at the focus of an ‘electron gun’. Only about 0.1% of the power 
supplied to the source is converted to X-rays, thus there is a considerable amount o f heat 
produced. There are generally two types of X-ray source in laboratory use, a ‘sealed 
tube’ source, where the target metal is fixed within a vacuum tube; and a rotating anode 
generator, where the anode is constantly allowing heat to dissipate more effectively thus 
more intense radiation can be generated. This requires constant pumping of the vacuum.
♦> A goniometer: This is a device to orientate the crystal into the desired positions for 
diffraction. The goniometer head has adjustments in the vertical and horizontal
\F0\- \F C\, be simply called A|F| and the standard deviations o f the experimental values of 
|F0 (M/)| be [w(hkl)]~112, then the best parameters for a structure are those corresponding to 
the minimum value o f the quantity
(29)
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directions to allow alignment of the crystal within the X-ray beam. There are two main 
types of goniometer in general use. The four-circle, where there are four arcs Of, fc 0 and 
a>), which may be used to bring the crystal into the diffractometer position, and Kappa 
goniometer consisting of a Kappa block mounted at 50° to the Omega block, orienting 
the x  axis at 50° to the co axis. This geometry allows the crystal to be oriented in all 
available in the four-circle goniometer, without the steric restriction of the x  circle.
❖ A detector. Detectors fall into two categories, single point counters and area detectors. 
Single point counters such as scintillation counters can measure only one diffraction at a 
time, thus giving long data collection times. Area detectors have the advantage of 
measuring several diffractions concurrently, thus speeding up data collection. There are 
several types of area detectors available, such as image plates, CCD and the FAST 
system.
1.8.1 Data collection using a CCD area detector
Data are collected using a Bruker-Nonius KappaCCD area detector diffractometer at the 
window of a Nonius FR590 X-ray generator (Mo). The assembly, as it stands in our 
laboratory, is shown below.
Figure 1.8: Bruker-Nonius Kappa CCD area detector diffractometer
The diffractometer has Kappa geometry, where the goniometer consists of three parts, each 
with its own rotation axis, intersecting with each other at a central point. The head is 
mounted on the phi (cp) axis, which sits on the Kappa block, which rotates around the
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Kappa axis. The Kappa block is mounted on the omega block, this rotates about the omega 
(co) axis. The Kappa axis forms an angle of approximately 50 degrees, the alpha angle, with 
the omega axis. The assembly is positioned on the theta axis, to which the detector is 
linked. The detector may be positioned a distance, dx, away from the crystal (where dx may 
be variable between 25 mm and 165 mm). The distance is selected so as to give optimum 
resolvability of reflections, coupled with efficient recording of the desired portions of the 
Ewald sphere.
The CCD detector consists of a phosphor faceplate behind a Beryllium window. When X- 
rays hit the faceplate the phosphor ‘glows’ and the light is transmitted down a tapered 
bundle of glass fibres, which are bonded to the CCD chip. The CCD chip is cooled to -60° 
by a step down Peltier cooling system. The chip is then read and a digital image produced. 
Images may now be stacked together in order to extract intensities from individual 
reflections.
Figure 1.9:
Oxford Cryosystems cryostream low temperature device was used for data collection at 150 
K7. The process of data collection and reduction are automated by the Nonius program 
COLLECT8, which incorporates the following programs; DENZO9, SCALEPACK9, 
DirAx10, maXus11 and SORTAV12.
After an initial “pre-scan” to check the crystal quality, an attempt is made to index the unit 
cell. This is usually done using a phi/chi experiment , which is combined with the 
program DirAx11 but may also be performed using DENZO9  in combination with a 10 
degree (/) scan.
CCD microscope
Detector cooling 
'and electronics
CCD Detector mounted 
on the 2-theta aids
Position o f  Oxford cryostream in relation to the X-ray source and detector
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Once the unit cell and orientation matrix have been obtained COLLECT8 will calculate a 
data collection strategy to access all the reflections in the asymmetric unit. This is achieved 
via (f> and co scans and incorporates a Kappa offset to avoid excessive cooling o f the head 
and icing of the crystal. In situations where the true crystal is not clear a ‘triclinic’ data set 
will be collected.
Once the data have been collected they are integrated using DENZO and passed through 
SCALEPACK. No scaling is actually carried out at this point but the cell is refined using 
all reflections. An empirical correction for absorption is applied using SORTAV from 
within the maXus suite o f programs.
An alternative data reduction procedure may be used in the case of twins or other difficult 
non-standard crystals. This revolves around the phi/chi experiment, which enables the 
identification o f twin lattices. The program evalCCD is then used to resolve the overlaps 
and integrate the reflections writing either an ‘HKLF 4 ’ file for the major component or an 
‘HKLF 5’ for both components.
1.8.2 The programs used for structure solution, refinement and drawing
14 15SHELXS-91 was used for structure solution: SHELXL-91 for structure refinement and 
ORTEP-3 1 6  for Windows for drawing of crystal structural diagrams. Absorption correction 
programs are cited when relevant with each individual compound in Chapters 4 - 6 .
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INTRODUCTION
A sulphonamide is any member o f a class o f chemical compounds, which contain the group 
— SO2 N— . The class includes several groups o f drugs used in the treatment o f bacterial 
infections, diabetes mellitus, oedema, hypertension and gout . 1
Sulfonamides are analogues o f /?-aminobenzoic acid (PABA). The first sulphonamide of 
clinical importance was prontosil, an azo dye, which is metabolized in vivo to 
sulfanilamide. Many sulfonamides have been synthesised but they differ only slightly in 
their antimicrobial activity, but vary in their pharmacokinetic properties. The sulfonamides 
have been classified according to their rate o f excretion as short-, medium- or intermediate- 
, long and ultra-long activity. The short-acting sulfonamides are excreted in the urine in 
high concentrations and have therefore been o f particular use in the treatment of urinary- 
tract infections. O f the short-acting sulfonamides most commonly used sulfadiazine has 
low solubility in urine whereas sulfamerazine and sulfamethazine and their acetyl 
conjugates are very soluble.
The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most 
gram-positive and many gram-negative organisms. However, many strains o f an individual 
species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as 
competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial 
sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide 
indicates resistance to all.
These drugs are extensively used in medicine and they were the first agents to be used for 
the treatment o f bacterial infection for both human and animal disease. Use of 
sulfonamides today is limited to specific disease treatment in human medicine such as 
urinary tract infections. However, sulfonamides are more often encountered in animal 
medicine. The presence o f certain residues in animal products presents a potential health 
hazard due to their allergic properties. Also, some people exhibit hypersensivity to drug 
residues and/or low levels of drug residue may produce genetically altered bacteria that are 
resistant to existing drug therapy . 3 In addition, a study by the National centre for 
Toxicological Research indicated that sulfamethazine may be a thyroid carcinogen . 4
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2.1 History
Sulfonamides were first synthesised by Gelmo et a l 5 in 1908 while doing research into azo 
dyes. Directly following this work, Hoerlien et al.6 discovered dyes containing the sulfanyl 
group that had affinity for proteins of silk and wool. This led to the discovery by Eisenberg 
in 1913, that chrysolidine, one of the azo dyes studied, had pronounced bactericidal action 
in vitro.
However, until 1932 the therapeutic properties o f sulfonamides were not recognised. The 
German scientists Domagk et al.1 found that prontosil had pronounced in vivo antibacterial 
activity. They observed that mice with streptococcal septicaemia could be cured with 
prontosil. Domagk also discovered that prontosil was rapidly reduced in the cell to 
sulphanilamide and that it was in fact the sulphanilamide and not the prontosil, which was
O
the actual antibiotic.
NH
Reduction
■N=N- S—NH
in the cell
Prontosil
S—NH
Sulfanilamide
Figure 2.1: Sulfanilamide from  prontosil
Many different sulfonamides were synthesised during the late 1930’s. A great number o f 
those were discovered to possess considerable antibacterial activity for a variety o f 
streptococci and pneumonococci bacteria. Several sulfapyrimidines which were introduced 
in 19419 were found to possess considerable antibacterial activity as well as lower toxicity 
than previous sulfonamides. This advancement led to many new sulfonamides being 
synthesised. Today there are over 5000 sulfa drugs in existence but only 33 of those have 
been introduced for general medical use.
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The use of sulphonamides as drugs dates back to the beginning o f the twentieth century, 
when the discovery of the medicinal use o f sulphonamides and their derivatives was a 
milestone in the history o f chemotherapy. It represented the first investigation o f synthetic 
organic molecules as potential drugs to fight infection carried in the bloodstream.
This new class o f sulpha drugs was the only effective antibacterial drugs until penicillin 
became available in the early 1940’s. Despite the benefits o f the sulpha drugs, they proved 
ineffective against infections such as salmonella (the organism responsible for typhoid). 
Problems have resulted from the way in which they are metabolised in the human body, 
since toxic products are frequently obtained. This has ultimately led to the sulphonamides 
being superseded in many instances by penicillin. These drugs act by inhibiting the growth 
of the bacteria, rather than killing the organisms. The sulphonamides act as competitive 
enzyme inhibitors and block the biosynthesis o f the vitamin folic acid in bacterial cells. 
The enzyme responsible for linking together the component parts o f folic acid is inhibited 
and the consequences to the cell are disastrous.
The importance o f sulphonamides within the pharmaceutical industry could even be seen 
from the database search when the compound 5-Acetamido-l, 3, 4-thiadiazole-2- 
sulphonamide was located. Acetazolamide, or Diamox as it is commonly known, is used in 
the treatment of many types o f glaucoma (elevated pressure in the anterior chamber o f the 
eye; the anterior chamber is the most forward section of the eye, behind the cornea). It is 
also used as a diuretic in some problems such as heart failure, or where fluid is retained in 
the body. This medication impedes the action of an enzyme, carbonic anhydrase 
throughout the body. In the eye, this leads to a decrease in production o f fluid secreted in 
the anterior chamber o f the eye, leading to a reduction in pressure. It acts in the kidney to 
increase the amount o f bicarbonate excreted in the urine and thus increases salt and water 
elimination from the body. The way it works on the central nervous system is as yet not 
well understood.
2.2 Pharmacology
Most sulfonamides are readily absorbed orally. However, parenteral administration is 
difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. 
The sulfonamides are widely distributed throughout all tissues. High levels are achieved in 
pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to
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treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is 
inhibited by pus.
The sulfonamides are metabolized mainly by the liver to acetylated forms and 
glucuronides, both o f which are therapeutically inactive. Excretion is primarily renal by 
glomerular filtration with minimal tubular secretion or reabsorption. When these drugs are 
given in pregnancy, high levels are achieved in the fetus. Sulfonamides are loosely and 
reversibly bound in varying degrees to serum albumin. Since the bound sulfonamide is 
inactive and nondiffusible, the degree o f binding can affect antibacterial effectiveness, 
distribution, and excretion.
The relative insolubility o f most sulfonamides, especially their acetylated metabolites, may 
cause precipitation in the renal tubules. The more soluble analogues, such as sulfisoxazole 
and sulfamethoxazole, should generally be chosen, and the patient must be well hydrated. 
To avoid crystalluria and renal damage, fluid intake should be sufficient to produce a 
urinary output o f 1200 to 1500 mL/day. Sulfonamides should not be used in renal 
insufficiency.
2.3 Mechanism of Action10
Certain microbes require p-aminobenzoic acid in order to synthesize dihydrofolic acid 
which is required to produce purines and ultimately nucleic acids. Sulfonamides, chemical 
analogues o f PABA, are competitive inhibitors o f dihydropteroate synthetase. 
Sulfonamides are therefore reversible inhibitors of folic acid synthesis and are bacterostatic 
not bacteriocidal
Spectrum of antibacterial activity and Resistance
Sulfonamides inhibit (bacteriostatic) gram-positive and gram-negative bacteria, Nocardia, 
Chlamydia trachomatis and some protozoa. Enteric bacteria such as E. coli, Klebsiella, 
Salmonella, Shigella and Enterobacter are also inhibited. Resistance to sulfonamides may 
develop when bacterial mutations result: (i) in PABA overproduction, (ii) in a folic acid 
synthesizing enzyme protein that has low affinity for sulfonamides and (iii) from a loss of 
cell permeability to sulfonamides.
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2.4 Pharmacokinetics10
Sulfonamides can be classified in three groups: oral, absorbable oral, nonabsorbable topical 
and oral and absorbable oral agents may be further classified as short-, medium, or long 
acting sulfonamides. Sulfonamides are absorbed from the stomach and small intestine and 
widely distributed to tissues, including the CNS. Sulfonamides and inactivated metabolites 
are excreted by the kidney mainly through glomerular filtration.
2.5 Clinical Uses10
Sulfonamides are useful in treating urinary tract infections (UTI), but in general are rarely 
used as single agents. The fixed drug combination of trimethoprim-sulfamethoxazole 
(Bactrim) has supplanted many previous sulfonamide clinical uses. Examples are, 
sulfisoxazole (Gantrisin) and sulfamethoxazole (Gantanol) are used almost exclusive to 
treat UTI. In combination with phenazopyridine, a urinary tract anesthetic, sulfonamides 
are available as Azo Gantrisin and Azo Gantanol. Sulfadiazine in combination with 
pyrimethamine (Daraprim) (antiprotozoal agent, dihydrofolate reductase inhibitor) is first- 
line treatment for acute toxoplasmosis. Cefpodoxime (Vantin), a long-acting sulfonamide, 
is used in combination with pyrimethamine as a second-line option for treating malaria. 
Oral, non-absorbable drugs: Sulfasalazine (Azulfidine, salicylazosulfapyridine) is used in 
treating ulcerative colitis, enteritis and other inflammatory bowel disorders. The 
antiinflammatory action is due to the release o f salicylate following splitting of 
sulfasalazine by intestinal bacteria. Topical Agents such as Bacterial conjunctivitis may be 
treated with sodium sulfacetamide opthalmic solution/ointment. Sodium sulfacetamide is 
an adjunctive drug in treating trachoma. Mafenide acetate is used in preventing infection in 
bum wounds.
2.6 Adverse reactions10
The most common such as fever, rash, exoliative dermatitis, photosensitivity, urticaria, 
nausea, vomiting, diarrhea, urinary tract problems may occur due to the precipitation of 
drug in urine. Sulfonamides may cause Stevens-Johnson syndrome (<1% frequency) and 
hemopoietic disturbances, including hemolytic or aplastic anemia, granulcytopenia, 
thrombocytopenia may also be caused by sufonamides.
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2.7 Previous work on triple sulfa drugs (TSD)
Sulfadiazine, sulfamerazine and sulfamethazine are called together as triple sulfa drugs 
(TSD). The general formula is:
The presence o f several potential donor sites, e.g. the sulfonamidic nitrogen, one amino 
nitrogen, two pyrimido nitrogen and two sulfonyl oxygen atoms make them versatile 
complexing agent with metal ions. The sulfonamide derivatives and their metal complexes 
possess antibacterial activity. A few metal complexes o f the sulfonamides are still used in 
topical medicine as antiseptics, although it is known that interactions o f heavy metal ions 
with biomolecules can yield potentially toxic effects.
Metal complexes of the triple sulfa drugs have gained a significant role in co-ordination 
chemistry. Yet the studies o f metal complexes that have been reported are neither 
systematic nor exhaustive.
Replacement o f the acidic hydrogen from the triple sulfa drug molecules produces a 
negative centre on the sulfonamidic nitrogen atom, which could then co-ordinate with a 
suitable metal(II) ion (Figure 2.2).
r2
Sulfadiazine when Rj and R 2  are hydrogen (H) 
Sulfamerazine when Rj is H and R 2  is methyl group (CH 3 ) 
Sulfamethazine when Rj and R2  are methyl group (CH 3 )
Figure 2.2
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Some authors reported the preparation of several transition metal complexes o f triple sulfa 
drugs in different mediums such as methanol, alcohol, acetone, DMSO etc. Cu(II), Zn(II), 
Cd(II) and Hg(II) complexes were prepared by mixing the methanolic solution o f metal 
chloride or metal acetate and triple sulfa drugs in the molar ratio o f 1:2. A precipitate was 
formed, stirred for six hours and the precipitate collected. Based on spectrophotometric 
investigations those workers suggested that Cu(II), Zn(II), Cd(II) and Hg(II) form 1:2 
complexes, while Ag(I) form 1:1 complexes. The molecular compositions o f the complexes 
were proposed on the basis o f chemical analyses and spectrophotometric evidences.
It is to be noted that apart from the stereochemical interest o f metal complexes o f TSD, 
there are also interesting for their clinical use. For example, the silver and zinc complexes 
have already found application as topical drugs for bum healing . 1 1 ' 17
2.7.1 Sulfadiazine
The X-ray crystal structure of sulfadiazine (Figure 2.3) was initially reported for the first 
time by Shin et al . 11 in 1974.
Figure 2.3: Sulfadiazine molecule
The crystal was grown by slow evaporation o f sulfadiazine dissolved in a mixture of 
acetone and ethanol. It was found to be monoclinic space group P2\/c with a = 13.71(4), b 
= 5.84(3), c =  15.1 l(5 )A ,/?  = 115.0(3)°, Z = 4 and/? = 0.15 for 1517 reflections.
1 7Sandmann et al. prepared a series of silver complexes o f sulfa drugs and characterised 
them by spectroscopic methods. It was concluded that in the silver sulfadiazine complex, 
the silver is ionically bound to the sulfonamidic nitrogen and the sulfonyl oxygen atoms are 
not coordinated to the silver ion and he suggested that the copper complex o f sulfadiazine
1 7is coordinated through the sulfonyl oxygen atom. Fox reported that the structure o f silver 
sulfadiazine was analogous to the silver ammines. The metal complexes o f sulfadiazine 
have gained a significant role in coordination chemistry.
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The first crystal structure of stoichiometry Ag(sdz) was determined by Cook et a l.14  in 
1975 and in 1976, the same crystal structure was also reported by Baenziger et a l}5 The 
crystal was found to have the monoclinic space group P2\/c with a = 6.173(2), b = 
9.600(5), c = 20.30(2)A, f i  = 96.22(8)°, Z = 4 and R = 0.102 for 1865 reflections. The 
structure o f the silver sulfadiazinato complex reported by Baenziger et a l}5 is shown in 
Figure 2.4.
Figure 2.4: Polymeric silver complex o f  sulfadiazine
In the complex the nitrogen atoms of the pyrimidine ring coordinate to two different silver 
atoms to form a polymeric chain extending through the crystal. Each silver atom in the 
chain is also coordinated to one oxygen atom of sulfonyl group of the sulfadiazine 
molecule. A second identical chain (related by the centre of symmetry) is joined to the first 
chain by coordination o f the silver atom from each chain to the sulfonamidic nitrogen atom 
of the sulfadiazine molecule in the opposite chain. In fact the silver atom in the complex is 
five coordinated, one is a metal-metal bond with one silver atom 2.916(1 )A away from the 
other silver atom in the complex. The Ag-N(im ido), Ag-N(pyrimido), and 
Ag-O(sulfonyl) distances1 5 are 2.277(6), 2.205(6), 2.459(6) and 2.571(6) A respectively.
The crystal structure o f the zinc complex [Zn(sdz)2 ] was determined by Yuan et a l} 6 in 
1983. It crystallises in the monoclinic space group P2\/n with a = 13.9463(3), b = 
10.2008(2) and c = 17.5299(4)A, f i  =113.252(1)°, Z = 4 and R = 0.0488 for 3453 
reflections. The crystal structure o f the complex is polymeric, with local environment of 
the zinc atom as shown in Figure 2.5.
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Figure 2.5
Part o f  the polymeric structure ofZn(sdz ) 2  showing the coordination around Zn atom
In this complex the zinc atoms binds three sulfadiazine molecules in which one 
sulfadiazine acts as a monodentate ligand using imido nitrogen as the donor atom and the 
other two act as the tridentate bridging ligand. The zinc atom is four coordinated, one 
sulfonamidic nitrogen from one sulfadiazine and two pyrimido nitrogen atoms from two 
different sulfadiazine and one sulfonyl oxygen atom from sulfadiazine molecules.
Baenziger et a l , 1 7  reported the crystal structure o f the ammonia derivative o f the zinc 
complex of sulfadiazine [Zn(sdz)2 (NH 3 )2 ]. It crystallises in the orthorhombic space group 
Pn2xa, a = 13.894(1), b = 14.221(1), c = 12.608(1)A, Z = 4 and R = 0.040 for 3485 
independent reflections. The structure o f the complex is as follows:
-NH| N— S-
f n^NH3 0
■S—N.
Figure 2.6
Zinc complex o f  sulfadiazine with two molecules o f  ammonia [Zn(sdz)2 (N 1^3) 2]
It was suggested that the complex has a distorted tetrahedral arrangement with four Zn-N 
bonds, two from ammonia molecules with distances o f 2.036(4) and 2.050(4)A and two
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from the sulfadiazine molecules. The sulfadiazine molecules are coordinated at different
sites, one molecule uses its imido nitrogen atom [2.166(4)A] and the other uses its
pyrimido nitrogen atom [2.078(4)A]. In addition, there are two Zn-N interactions at
distances o f 2.406 and 2.729A with pyrimido nitrogen and sulfonamidic nitrogen atoms
respectively. From this evidence it is concluded that the complex [Zn(sdz)2 (NH 3 )2 ] may be
described as five or six coordinate. The crystal structure o f the same complex was also
1 8determined by Brown et al. and confirms the earlier study.
The crystal structure of the analogous copper complex of sulfadiazine [Cu(sdz)2 (NHs)2 ] 
was reported by Brown et a l}9 It crystallises in the orthorhombic with space group Pn2\a 
with a = 13.915(5), b = 14.356(5), c = 12.659(5)A, Z = 4 and R = 0.045 for 1417 
reflections. The structure o f the complex is shown in Figure 2.7.
NH-
Cu
•S— N.
Figure 2.7
Copper complex o f  sulfadiazine with two molecules o f  ammonia [Cu(sdz)2 (NHi) 2]
It was found that the complex the copper atom coordinates five nitrogen atoms in a 
distorted square pyramidal arrangement. The basal plane contains two nitrogen atoms from 
ammonia molecules and two nitrogen atoms from one sulfadiazine molecule. The other 
nitrogen from the second sulfadiazine molecule occupies the apex position. The Cu-N  
bond distances o f 2.071(13), 2.479(18), 2.083(11) and 1.894(10)A are in an irregular 
square with a mean N -C u -N  angles of 87.6(4)°. The C u-N  bond distance of 2.377(10)A 
is at the apex position with an angle o f 100.0(4)°. This compound is isostructural with the
17 18corresponding zinc complexes. ’
90In 1993 Menabue et al. reported the cadmium complex o f sulfadiazine [Cd(sdz)2].2H20. 
The crystals are monoclinic, space group C2/c, a = 19.879(3), b = 8.730(3) and c = 
16.538(3)A, /?= 122.15(2)°, Z = 4 and R = 0.034 for 2019 reflections. The structure of the 
complex is as follows:
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Figure 2.8: Cadmium complex o f  sulfadiazine
The cadmium atom in the complex lies on the two-fold axis and is four coordinated to two 
sulfonamidic nitrogen and two amino nitrogen from the symmetry related sulfadiazinato 
anions giving rise to the polymeric chain along the 6-direction. In the complex the 
cadmium ion has a distorted tetrahedral geometry.
* 01In 1997, Garcia-Raso et al. reported the mercury complex o f sulfadiazine with DMSO as 
a secondary ligand [Hg(sdz)2 (DMSO)2 ]. The compound crystallises in the monoclinic 
space group C2/c with a = 20.537(7), b = 8.653(3), c = 18.846(6)A, f =  106.68(2)°, Z = 4 
and R = 0.418 for 3551 reflections. The structure is shown in Figure 2.9.
Figure 2.9: Mercury complex o f  sulfadiazine with two molecules o f  DMSO
The coordination geometry about the mercury atom is approximately linear with H g-N  
distance 2.087(4)A and N -H g-N  angle 175.0(2)°. Two DMSO molecules bound to the 
mercury atom with H g -0  distance 2.769(2)° result in a four fold coordination.
37
Chapter 2
The metal complexes o f sulfadiazine show different coordination geometries, e.g., copper 
and zinc atoms in the complexes [M(sdz)2 (NH 3 )2 ] are five coordinated but zinc atom in the 
complex [Zn(sdz)2 ] is four coordinate. The silver, cadmium and mercury atoms in the 
complexes of sulfadiazine have four coordination spheres
2.7.2 Sulfamerazine
In an early stage thermomicroscopic studies indicated the existence o f two polymorphs of 
sulfamerazine.22,23 This was subsequently confirmed by the crystal structure determination. 
In 1982, Acharya et al.24 reported the crystal structure o f one form of sulfamerazine. The 
crystal was orthorhombic with space group Pbca, a = 9.145(1), b = 11.704(1), and c = 
22.884(2)A, Z = 4 and R = 0.078 for 2082 reflections. The structure of the sulfamerazine 
molecule is as follows:
S— N
O H
Figure 2.10: Sulfamerazine molecule
In 1992, Caira et al.25 reported the polymorph of sulfamerazine which was orthorhombic 
with space group Pna2 \, a = 14.474(2), b = 21.953(2), c = 8.203(1)A, Z = 8 and R = 0.047 
for 1886 reflections. The structure was dimeric form where hydrogen atom of sulfonamidic 
nitrogen o f one sulfamerazine molecule is hydrogen bonded with the pyrimido nitrogen 
atom o f the second sulfamerazine molecule which is shown in Figure 2.11.
CH3
Figure 2.11: Structure o f  sulfamerazine as dimer
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Caira et a l? 5 suggested that the two polymorphs are dimer where pseudocentro-symmetric 
exists in their structure and centrosymmetric exists in the structure, reported by Acharya et 
al.?A formed via two N(imide)-H-"N(pyrimido) hydrogen bonds.
This ligand has also capability o f forming complexes with metal ions but there is no report
o f metal complexes of sulfamerazine in the literature.
2.7.3 Sulfamethazine
Basak et a l? 6  reported the X-ray crystal structure o f sulfamethazine in 1983. It was found 
that the molecule exists as dimer, which linked together in an infinite chain. The crystal of 
sulfamethazine was monoclinic with space group P2\/a, a = 7.427(2), b = 18.986(11), c =
9.323(4)A, p =  99.09(2)°, Z = 4 and R = 0.045 for 1766 reflections.
H,N S— N
Figure 2.12: Sulfamethazine molecule
In 1984 Tiwari et a l? 1 reported the same crystal structure o f sulfamethazine with the same 
unit cell dimensions. The crystal structure is stabilised by network hydrogen bonds and van 
der W aal’s forces. The amino nitrogen atom of one sulfamethazine participates in two 
unequal hydrogen bonds with pyrimido nitrogen atoms of other sulfamethazine molecule.
Recently some metal complexes of the sulfamethazine have been published. In 2000, 
Garcia-Raso et a l? % reported the crystal structure of polymeric cadmium complex 
[Cd(smz)2 (H2 0 )].2 H2 0  in the monoclinic space group P2\/c  with a = 13.357(2), b = 
15.046(2), c = 15.369(1 )A, = 97.60°, Z =  4 and R = 0.1125 for 9258 reflections.
The cadmium ion in the complex exhibits a highly distorted octahedral geometry, being 
coordinated to two sulfonamidic nitrogen and two pyrimido nitrogen atoms of two 
bidentate chelating sulfamethazine ligands generating four membered rings. The terminal 
amino nitrogen atom o f a third sulfamethazine, which is bonded to the adjacent cadmium
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ion and oxygen atom of a water molecule complete the coordination sphere. In the complex 
one of the sulfamethazine molecules presents two equivalent C d-N  bond distances.
h 3c  h 3c  h 3c
Figure 2.13: Polymeric cadmium complex o f  sulfamethazine
• 7QIn 2001, Gutierrez et al. reported another polymeric crystal structure o f copper complex 
{[Cu(smz)2 ].2 H 2 0 }„. The crystals are monoclinic, space group P2\/c, a = 13.810(2), b = 
14.577(2), c = 13.785(1 )A, /?= 96.03(3)°, Z =  4 and R = 0.526 for 5772 reflections.
The copper ion is five coordinated and bound to five nitrogen atoms from three 
sulfamethazine molecules and two pyrimido nitrogen atoms o f two sulfamethazine 
molecules one o f which belongs to the adjacent copper atom. The copper ion exhibits a 
distorted square pyramidal geometry. The structure is shown in Figure 2.14
h 3c  h 3c  h 3c
Figure 2.14: Polymeric copper complex o f  sulfamethazine
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They also reported the dimeric copper complex o f sulfamethazine with two molecules of 
dimethylformamide [Cu(CH3 COO)2 (smz)2 ].2 dmf. The crystals are monoclinic space group 
with a = 8.9486(9), b = 15.0956(2) and c = 16.542(3)A, p  = 105.584°, Z = 2  and R =
0.0409 for 6508 reflections. The structure o f the complex is shown in Figure 2.15.
X T U
n h 2
Figure 2.15: Dimeric copper complex o f  sulfamethazine with two acetate ions
The crystal consists o f dinuclear units and two solvent molecules o f dimethylformamide. In 
the complex the Cu-Cu distance is 2.5412(6)A. The copper atom presents a nearly square 
planar geometry.
2.8 Aim of the work
The development o f sulfonamides is one o f the most fascinating and informative chapters 
in medicinal chemistry, highlighting the roles o f skillful planning and providence in drug 
research. About 30 sulfonamides are now used in clinical practice. O f them three 
sulfonamides, sulfadiazine, sulfamerazine and sulfamethazine, also known as “triple sulfa 
drugs”, were used as antibacterial agents since the 1940’s.
Sulfonamides are one of the few groups o f drugs whose mechanism of antimicrobial action 
is now known at the enzyme level. Their action is characterized by a competitive 
antagonism of certain essential factors vital to the metabolism of microorganism. Evidence 
o f this antagonism started coming soon after the discovery of sulfonamides.
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Many studies on the sulfonamide have been carried out in the past. Most o f these focused 
on its antibacterial activity, but studies on the complexes o f transition metals, particularly 
those playing important roles in the biological systems were very few and far between.
Interactions of sulfa drugs with different metal ions normally present in the body system 
are therefore quite important. Since transition metals, particularly Cu and Zn, play vital 
roles in life processes, some synthetic and structural studies o f the sulfa drug complexes of 
these metals have been carried out. A general series o f complexes with general formula 
[M(tsd)2 (L )J [M = Co, Ni, Cu, Zn, Cd and Hg; where tsd = triple sulfa drugs and L = any 
secondary ligands containing two nitrogen donor atoms when x = \ and one nitrogen atom 
when x  = 2 ] have been prepared and structurally characterised.
Triple sulfa drugs have also been shown to react with heavy metals such as Ag, Cd and Hg, 
which may lead to the potential use o f sulfa drugs as topical medicine for bum treatment. 
In all these cases, a maximum of two drug ions are directly bonded with the metal centre, 
other positions in the coordination sphere being filled up by the secondary ligands such as 
water, ammonia or other nitrogen containing donor species.
In some of these complexes, triple sulfa drug molecules are directly bonded with the metal 
ions. Previous work on this type o f complexes has been rather fragmentary and without 
systematic approach. We have therefore endeavoured in the present work to examine the 
synthesis of such complexes in a systematic way and examine in details the important 
structural features to be discussed later.
The secondary ligands that have been used in this study, most o f which contain nitrogen 
donor atoms, namely ammonia, pyridine (py), ethylenediamine (en), 2 ,2 '-bipyridine (bpy), 
1,10-phenanthroline (phen), 4,4'-dimethyl-2,2'-bipyridyl (dmbpy) and diethylenetriamine 
(dien), [(ACV'-bis(3-aminopropyl)-l,2-ethylenediamine (apen) and in some cases, water and 
dimethylformamide (DMF) are the secondary ligands which contains oxygen as donor 
atom. These species utilise their nitrogen atoms to bind with metals and can be 
monodentate (ammonia, water, py, DMF), bidentate (en, bpy, phen, dmbpy), tridentate 
(dien) or tetradentate (apen) depending on the number of nitrogen atoms available. The 
purpose of this study has been primarily to examine the behaviour o f the secondary ligands 
in the presence of sulfonamides, the relative ease with which the compounds would be
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formed and also to correlate their properties to gain greater insight into the bonding 
characteristics and structural chemistry.
The chemistry of metal complexes of sulfa drugs is important not only from the point of 
view of synthetic routes and structural varieties associated with such complexes, but also 
due to the fact that the coordination modes of sulfa drugs under different conditions and in 
different environments are particularly important. One o f our aims in this work has been to 
explore the different coordination modes o f sulfa drugs in different metal complexes.
It is well known that the neutral sulfa drug molecules contain hydrogen atom on its 
sulfonamidic nitrogen atom and act as weak acid. In solution, this acidic hydrogen can be 
easily removed from the triple sulfa drug molecules to produce a negative centre on the 
sulfonamidic nitrogen atom. Most o f the resultant negative charge is located on the 
nitrogen atom, which could then act as a Lewis base (donor) and coordinate with a suitable 
Lewis acid (metal ion).
In many cases the sulfa drug molecules act as a bidentate ligand involving the formation of 
a chelate or even a bridge between two metal centres and in some cases act as a tridentate 
ligand. The later mode of coordination is rather rare, but there is at least one example 
where the sulfa drug ion acts as a chelating as well as a bridging ligand. This happens with 
the compound Zn(sdz ) 2  as shown in Figure 2.8. The coordination chemistry of sulfa drug is 
thus quite versatile and definitely very interesting from a structural point o f view. This has 
prompted us to undertake research in this field. Different possible coordination modes of 
the sulfa drug ion are illustrated later in this chapter.
These studies reveal that sulfonamides form metal complexes rather easily under ambient 
or nearly ambient conditions most of which are biologically essential and some are toxic. 
Whether these aspects could have any bearing with the living systems need to be fully 
explored. The structural studies carried out so far clearly establish sulfonamides as 
coordinating agents o f considerable interest in that it can use any or all o f its potential sites 
(N and O) for coordination with metals producing complexes. There are a few metal 
complexes o f sulfonamides in the literatures, and we decided to carry out an in depth study 
on the topic. The sulfonyl oxygen atoms are particularly polar which enable them to 
interact with metal ions under suitable conditions. Owing to these properties the
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sulfonamides would react with different metal ions in different ways, the course o f which 
cannot be predicted during synthetic reactions. In view of the presence o f multi-center 
coordinating positions in the sulfonamide molecules, the possibilities o f coordination with 
metal ions or the formation of ionic species may follow several modes o f reactions.
i) It can act as a monodentate ligand by forming bond either through sulfonamidic or 
pyrimidine nitrogen or sulfonyl oxygen atoms:
M
ii) It can behave as a bidentate ligand in the chelating mode:
H-
o
■s N-
O ^  /I
N N
R,
2
r 2
iii) It can involve more than two donor atoms in the formation o f polymeric compounds:
R i
S— N
H,N-
or,
M
O
■s N-
O
N=
M
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The presence of secondary ligand such as ammonia could produce a variety o f metal 
complexes with interesting stereochemistry and properties.
It has been mentioned earlier that the deprotonation o f neutral sulfa drug molecules leave 
the negative charge (-)  on the sulfonamidic nitrogen atom and this is the main reason why 
the nitrogen site is preferred when bonding with metal ions. However, since the pyrimidine 
nitrogen and sulfonyl oxygen atoms are also found to be involved in bonding with the 
metal ions, it is very likely that the negative charge or a fraction o f it is shifted away from 
the nitrogen atom along the ring bonds to the oxygen atoms. In addition to the synthetic 
and structural work, we carried out theoretical calculations to investigate the charge 
distribution in the sulfa drug ions and in the neutral sulfa drug, to find out if  the above 
assumption is true.
Finally, the roles o f weak intermolecular forces particularly the hydrogen bonds in the 
formation of packing diagram and determining the properties o f materials are now well 
recognised, especially in organic chemistry. One o f our particular aims in this work has 
been to investigate the nature o f these interactions both within and between different 
complex “molecules” that we have studied by X-ray crystallography.
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EXPERIMENTAL-PREPARA TION 
OF METAL COMPLEXES OF 
TRIPLE SULFA DRUGS WITH 
SECONDAR Y LIGANDS
Chapter 3
EXPERIMENTAL
3.1 Chemicals and their purifications
The Analar grade chemicals (SIGMA and BDH) were purchased and used as received and 
the solvents acetone, methanol, dimethylformamide and dimethylsulfoxide were also used 
as received throughout the experiments.
3.2 Physical measurements
3.2.1 Elemental analysis
C, H and N were estimated microanalytically using a Perkin-Elmer 2400 CHN elemental 
analyzer.
3.2.2 IR studies
The IR spectra were recorded on a Nicolet 510 FTIR spectrometer, each compound was 
pressed into a KBr disk that was prepared in a sample holder by compressing a powdered 
sample with a ten-fold excess of KBr, which was preheated in an oven before use.
3.2.3 Electron Paramagnetic Resonance
ENDOR (Electron Nuclear Double resonance) spectroscopy is an EMR (Electron Magnetic 
Resonance) technique that is often described as EPR-Detected NMR. EPR and ENDOR 
spectra recorded on a Bruker ESP 300E series spectrometer fitted with a Bruker ESP 360 
DICE ENDOR system and an Oxford Instruments liquid helium variable temperature 
system. X-band EPR and ENDOR spectra were recorded using a Bruker EN 801 ENDOR 
cavity operating at a modulation frequency o f 12.5 kHz in both cases and the ENDOR 
spectra were obtained using an ENI A-300 RF power amplifier operating at an attenuation 
of 8  dB. Accurate g values were obtained at X-band using a Bruker ER 035 M NMR 
gaussmeter calibrated to the perylene radical cation in concentrated H2 SO 4 , g = 2.002569. 
Q-band EPR and ENDOR spectra were obtained using a Bruker ER 5106 QTE ENDOR 
cavity operating at a modulation frequency of 100 kHz for the EPR experiments and 12.5
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kHz for the ENDOR. The ENDOR spectra were recorded using an ENI ER 3200L RF 
power amplifier operating at a total attenuation o f 13 dB.
3.2.4 'H NMR and ,3C NMR spectra
NMR spectra were recorded on a Bruker Avance AMX-400 spectrometer. H and C 
NMR spectra were obtained from a solution of the compounds in d6 -DMSO. The chemical 
shifts are expressed in ppm relative to internal TMS.
3.2.5 X-ray crystallography
The crystallographic measurements for the complexes were made at 150 K on a Bruker 
Nonius Kappa CCD area detector using graphite monochromatised Mo K a  radiation, X — 
0.71073 A. The structures were solved by direct methods (SHELXS-97) and refined on F 2 
by full-matrix least squares (SHELXL-97) using all unique data and parameters. The 
hydrogen atoms on the amino groups o f sulfa drugs in the complexes and water molecules 
(where present) were located from the difference Fourier maps and refined freely.
3.3 Synthetic Procedure
The complexes were synthesized by the following simple reaction procedures: the sodium 
salt o f sulfadiazine (Nasdz), sulfamerazine (Hsmr) and the sodium salt o f sulfamethazine 
(Nasmz) were dissolved in 50 mL of hot methanol and the methanolic solution of the 
respective metal salts were added slowly with constant stirring on a hot plate, a precipitate 
was formed and the mixture was continued to stir for six hours. The precipitate was filtered 
and dried over silica gel. The complexes of transition metals were colored whereas those of 
zinc, cadmium and mercury were white powders.
Reaction scheme:
M2+ + 2(Na/Htsd)------------> M(tsd) 2  + 2Na+/2H+
[where M is any divalent metal ion and Htsd any sulfa drugs]
The precipitate was used for further reaction with secondary ligands in DMF solution to 
obtain the single crystals for the complexes (3) to (28).
M(tsd ) 2 + x h ------------> M(tsd)2 (L)*
Where L is any secondary ligand, bidentate when x = 1 and monodentate when x = 2.
49
Chapter 3
All the complexes are stable in air and at room temperature. The complexes are insoluble 
in water, alcohol and most organic solvents but soluble in DMF and DMSO.
We used the following metal salts:
1) Cobalt chloride (C0 CI2 .6 H2 O) (Pink precipitate)
2) Nickel chloride (NiCl2 .6 H2 0 ) (Light blue precipitate)
3) Copper chloride (CUCI2 .6 H 2 O) (Red precipitate)
4) Zinc chloride (ZnCh.bFLO) (White precipitate)
5) Cadmium acetate [(CH3 C 0 0 )2 Cd.6 H2 0 ] (White precipitate)
6 ) Mercury acetate [(CHaCOO^Hg.bFhO] (White precipitate)
These precipitates were dissolved in DMF/DMSO and a secondary ligand was added, 
stirred for 30 minutes, filtered and the filtrate was left for crystallization.
3.4 Syntheses of the complexes
3.4.1 Preparation of the crystal of sulfadiazine (1)
Solid sulfadiazine (0.563 g, 1 mmol) was dissolved in a minimum amount o f DMF and 
stirred for 30 minutes. It was filtered and left for crystallisation. After three days white 
block crystals were obtained. IR: (KBr disc), cm-1, 3461(s), 3365(s), 3125(s), 2956(sh), 
1625(vs), 1598, 1570, 1507(vs), 1465(sh), 1408, 1351, 1325(m)„ 1306, 1259, 1155(vs), 
1125(s), 1106, 1093(s), 1045, 1005(s), 945(vs), 881(vw), 796(vs), 746, 680(s), 656(m), 
633(vs), 589, 535(vs). ‘H N M R  (DMSO-d6): 5 11.35s [1H, N (ll) ] , 8.49d [1H, C(12/14), J  
= 11.7Hz], 6.59d [H, C(17/19), J =  8.7], 7.65d [1H, C(16/20), J =  8 .6 ], 6.99t [1H, C(13), J  
= 4.8], 6.00s [2H (-N H 2)]. 13C NMR (DMSO-d6)\ 6  157.5 [Cl 1], 158.6 [C12/14], 153.4 
[C18], 130.3 [C16/C20], 125.1 [C15], 115.9 [C13], 112.6 [C17/C19].
3.4.2 Preparation of the new polymorph of sulfamerazine (2)
Solid sulfamerazine (0.265g; 1 mmol) was dissolved in DMF (20 mL) and stirred for 30 
minutes, filtered and the clear solution o f sulfamerazine was left for crystallization. White 
block crystals o f sulfamerazine were obtained by slow evaporation o f the solution at room 
temperature. IR: (KBr disc): vcm ”1, 3468(m), 3370(s), 3238, 3120(s), 1630(vs), 1570(vs), 
1505(sh), 1446(sh), 1408(vs), 1372, 1343(m), 1331(vs), 1304(vs), 1245(sh), 1153(vs), 
1107(s), 1093(s), 1040(s), 973, 965(vs), 889(vw), 836, 798(vw), 748(vs), 717(sh), 681(s),
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636(s), 616(vs), 579, 548(vs). 'H  NMR (DMS0-<4): 6  11.20 [ 1 H, N ( ll) ] ,  8.37d [ 1 H, 
C(14), J =  4.8], 7.69d [2H, C(16)/C(20), J  = 8.2], 6.95d [2H, C(17)/C(19), J =  4.9], 6.62d 
[ 1 H, C(13), J  = 8.2], 6.07s [2 H N(14)], 2.41s [3H (CH3)]. 13CNMR (DMSO-cfc): 5 168.0 
[Cl 1], 157.5 [C12], 156.8 [C14], 152.9 [C18], 130.1 [C15], 124.9 [C16/20], 114.7 
[C17/19], 112.1 [C13], 23.3 [CH3],
3.4.3 Preparation of the complex {[Co(smz)2(H20)].DMF}„ (3)
The DMF solution was filtered and left for crystallisation. Two weeks later, pink prismatic 
crystals were obtained. It was filtered and dried over silica gel. The compound is soluble in 
DMF and DMSO but insoluble in water and all other organic solvents. Anal. Found: C, 
54.25, H, 3.40; N, 11.10%. Calc, for C3 2 H 3 0 C0 N 1 0O4 S2 : C, 54.20, H, 3.48; N, 11.15%. IR: 
(KBr disc), c m '1, 3435(m), 3353(s), 3291(s), 2925, 2873, 1665(vs), 1598, 1581, 1561(vs), 
1501 (sh), 1434(vs), 1395, 1373, 1344(m), 1301(vs), 1251(vs), 1178(sh), 1144(vs), 1126(s), 
1081, 999(s), 974(vs), 878(vw), 835, 7 9 4 ,733(vs), 678(s), 636(s), 598, 557, 522(vs).
3.4.4 Preparation of the complex [Ni(en)3][sdz)2].H20 (4)
To the solution o f nickel precipitate o f sulfadiazine, ethylenediamine (en) (0.5 mL) was 
added, stirred for 30 minutes. The solution was filtered and left for crystallisation. A few 
days later, white block crystals were obtained. It was filtered and dried over silica gel. The 
compound is soluble in DMF and DMSO but insoluble in water and all other organic 
solvents. Anal. Found: C, 41.31, H, 5.90; N, 25.89%. Calc, for C2 6 H4 4 NiN]4 0 5 S2 : C, 41.29, 
H, 5.87; N, 25.94%. IR: (KBr disc), cm-1, 3441(m), 3332(s), 3225(s), 1643(vs), 1596, 
1581, 1552(vs), 1470(sh), 1448(sh), 1439(vs), 1414, 1348, 1313(m), 1298(vs), 1268(vs), 
1181 (sh), 1161 (vs), 1134(s), 1102, 1091(s), 1083, 1061, 101 l(s), 975(vs), 840(vw), 828, 
811, 806, 763(vs), 681(s), 651(m), 644(s), 626(vs), 584, 558, 524(vs).
3.4.5 Preparation of the complex [Ni(smr)2(py)2].4py (5)
To prepare this complex, the light blue powder nickel precipitate of sulfamerazine was 
dissolved in pyridine and stirred for 30 minutes. The solution was filtered and left for 
crystallisation. A week later, pink crystals were obtained. It was filtered and dried over 
silica gel. The compound is soluble in DMF and DMSO but insoluble in water and all other 
organic solvents. Anal. Found: C, 58.95, H, 4.90; N, 18.40. Calc, for C 5 2 Hs2 NiN]4 0 4 S2 : C, 
58.93, H, 4.94; N, 18.5%. IR: (KBr disc), cm-1, 3438(m), 3349(s), 3223(s), 1632(vs), 
1595(vs), 1551, 1516, 1501, 1434(sh), 141 l(sh), 1351 (vs), 1338(m), 1316, 1295(vs),
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1266(vs), 1227(sh), 1177(vs), 1131(s), 1103, 1091, 1083(s), 1011(s), 1001, 973(vs), 
8 6 6 (vw), 852, 816, 801, 774(vw), 725(sh), 680(s), 645(m), 583(vs), 556(vs).
3.4.6 Preparation of the complex [Cu(en)2(sdz)2] (6)
To the DMF solution of copper precipitate o f sulfadiazine, ethylenediamine (en) (1 mL) 
was added, stirred for 30 minutes. Five days later, blue block crystals were filtered and 
dried over silica gel. The compound is soluble in DMF and DMSO but insoluble in water 
and all other organic solvents. Anal. Found: C, 38.14, H, 4.54; N, 22.21%. Calc, for 
C2 4 H3 4 CUN1 2O4 S2 : C, 38.12, H, 4.53; N, 22.24%. IR: (KBr disc), c m '1, 3439(m), 3341(s), 
3229(s), 1641 (vs), 1599, 1584, 1554(vs), 1469(sh), 1446(sh), 1439(vs), 1413, 1347, 
1312(m), 1297(vs), 1267(vs), 1178(sh), 1158(vs), 1131(s), 1102, 1091(s), 1081, 1058, 
1008(s), 977(vs), 840(vw), 763(vs), 678(s), 651(m), 643(s), 625(vs), 583, 556, 523(vs).
3.4.7 Preparation of the complex [Cu(dien)(sdz)2] (7)
With the same procedure but diethylenetriamine (dien) (1 mmol) was added in the solution 
and stirred for 30 minutes. After seven days, white block crystals were filtered and dried 
over silica gel. The compound is soluble in DMF and DMSO but insoluble in water and all 
other organic solvents. Anal. Found: C, 46.71, H, 5.75; N, 25.48%. Calc, for 
C 2 8 H4 4 C 11N 1 4O4 S2 : C, 46.73, H, 5.73; N, 25.51%. IR: (KBr disc), cm-1, 3452(m), 3379(s), 
3339(s), 3304(m), 3155(s), 1629(vs), 1598, 1578, 1537(vs), 1501(s), 1465(sh), 1417(vs), 
1362, 1315, 1301(m), 1265(vs), 1240, 1221, 1173(sh), 1126(s), 1091(s), 1071, 1000(s), 
968(vs), 835(vw), 809, 676(s), 661(m), 636(s), 574, 564, 528(vs).
3.4.8 Preparation of the complex [Cu(en)2(H20)2][smr)2] (8)
To the solution o f DMSO, a few drops o f ethylenediamine were added, stirred for 30 
minutes. After seven days, blue prismatic crystals were obtained. It was filtered and dried 
over silica gel. The compound is soluble in DMF and DMSO but insoluble in water, 
alcohol and acetonitrile. Anal. Found: C, 41.84, H, 5.67; N, 22.52%. Calc, for 
C 2 6 H4 2 CUN1 2O6 S2 : C, 41.81; H, 5.67; N, 22.56%. IR: (KBr disc): cm-1, 3523(m), 3387(s), 
3331(s), 3174(s), 3275(s), 3174, 1662(vs), 1597(vs), 1576(vs), 1558(m), 1504(vs), 
1458(sh), 1422(vs), 1400(m), 1365(s), 1317(m), 1294(sh), 1272(vs), 1228(m), 1178(m), 
1122(sh), 1089(s), 1074(m), 1037(s), 1008(w), 994(m), 971(w), 898(s), 828(s), 810(s), 
755(s), 719(vw), 680(w), 634(w), 625(vw), 591 (vs).
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3.4.9 Preparation of the complex [Cu2(en)4(H20)4][smr)2].H20  (9)
To the solution o f DMF, a few drops o f ethylenediamine were added, stirred for 30 
minutes. After filtration it was left for crystallization. A week later, blue prismatic crystals 
were obtained. It was filtered and dried over silica gel. The compound is soluble in DMF 
and DMSO but insoluble in water, alcohol and acetonitrile. Anal. Found: C, 40.87, H, 5.75; 
N, 22.93%. Calc, for C2 6 H 4 4 CUN1 2 O7 S2 : C, 40.83; H, 5.77; N, 21.99%. IR: (KBr disc): 
c m '1, 3524(m), 3387(s), 3331(s), 3275(s), 3174(m), 1660(m), 1597(vs), 1576(vs), 
1558(m), 1504(vs), 1454(sh), 1422(vs), 1394(m), 1363(s), 1318(m), 1294(sh), 1272(vs), 
1228(m), 1178(m), 1122(sh), 1089(s), 1074(m), 1037(s), 1010(w), 996(m), 971(w), 898(s), 
830(s), 807(s), 755(s), 719(vw), 680(w), 637(w), 621(vw), 592(vs), 555(vs).
3.4.10 Preparation of the complex [Cu2(smr)4].2DMF (10)
The DMF solution o f copper precipitate of sulfamerazine was left for crystallization. Ten 
days later, deep green plate like crystals were obtained. The compound is soluble in DMF 
and DMSO but insoluble in water, alcohol and acetonitrile. Anal. Found: C, 45.31, H, 4.40; 
N, 18.97%. Calc, for CsoH sgC uN igO ^: C, 45.26; H, 4.42; N, 19.02%. IR: (KBr disc): v 
cm"1, 3423(s), 3346(s), 3228(m), 1636(vs), 1597(vs), 1554(vs), 1502(vs), 1452(sh), 
1413(vs), 1386(vs), 1319(sh), 1282(vs), 1205(m), 1177(m), 1131(sh), 1078(s), 1046(w), 
971(w), 957(w), 872(w), 833, 811, 792(s), 779(vw), 716(vw), 682(s), 583(vs), 547(vs).
3.4.11 Preparation of the complex [Cu2(smr)4].2DMSO (11)
The DMSO solution o f the same precipitate was filtered and left for crystallization. Two 
weeks later, deep green block crystals were obtained. The compound is soluble in DMF 
and DMSO but insoluble in water, alcohol and acetonitrile. Anal. Found: C, 41.85, H, 4.60; 
N, 15.00%. Calc, for C2 6 H 3 4 CuN 8 0 6 S4 : C, 41.89; H, 4.59; N, 15.06%. IR: (KBr disc): v 
c m '1, 3420(s), 3341(s), 3232(m), 1639(vs), 1596(vs), 1552(vs), 1501(vs), 1450(sh), 
1414(vs), 1383(vs), 1317(sh), 1281(vs), 1204(m), 1178(m), 1130(sh), 1076(s), 1045(w), 
974(w), 953(w), 876(w), 830, 810, 789(s), 779(vw), 712(vw), 677(s), 589(vs).
3.4.12 Preparation of the complex [Cu(smz)2(apen)].3H2O.CH3OH (12)
To the DMSO solution o f copper precipitate o f sulfamethazine, a few drops of A,7V'(3- 
aminopropyl)-bis-ethylenediamine (apen) were added and stirred for 30 minutes, filtered 
and left for crystallization. After five days, blue prismatic crystals were obtained, filtered
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and dried over silica gel. The compound is soluble in DMF and DMSO but insoluble in 
water, alcohol and acetonitrile. Anal. Found: C, 44.95, H, 6.75; N, 19.10%. Calc, for 
C3 3 H 6 0 CUN1 2 O 8 S2 : C, 44.97; H, 6.81; N, 19.08%. IR: (KBr disc): cm-1, 3345(m), 3210(s), 
2980(m), 1625(s), 1598(vs), 1570(vs), 1520(m), 1506(vs), 1483(sh), 1423(vs), 1388(m), 
1350(s), 1315(m), 1294(sh), 1270(vs), 1214(m), 1182(m), 1120(sh), 1092(s), 1042(s), 
1020(w), 982(m), 938(w), 905(s), 845(s), 812(s), 768(s), 692(w), 634(w), 625(vw).
3.4.13 Preparation of the complex {[Cu(smz)2.NH3].2H20 } w (13)
The copper precipitate o f sulfamethazine was dissolved in NH 3 -H2 O (1:1) and stirred for 
30 minutes. A week later, green prismatic crystals were obtained. The compound is soluble 
in water, DMF and DMSO. Anal. Found: C, 41.63, H, 4.65; N, 18.57. Calc, for 
C2 4 H3 3 CUN9 O6 S2 : C, 42.94, H, 4.96; N, 18.78. IR: (KBr disc), cm"1, 3436(m), 3350(s), 
3237(m), 1629(vs), 1597(vs), 1581(sh), 1560(m), 1501(s), 1434(m), 1397(m), 1373(m),
1322(m), 1300(m), 1250(m), 1210(s), 1184(vs), 1143(m), 1127(sh), 1081(sh), 999(sh),
975(vs), 881 (s), 832(m), 791(vw), 735(sh), 677(s), 639(s), 600(vs), 557(vs).
3.4.14 Preparation of the complex [Zn(smz)2(NH3)2] (14)
The white zinc precipitate of sulfamethazine was dissolved in 1:1 NH 3 :H2 0  solution and 
stirred for 30 minutes. A week later, white block crystals were obtained. The compound is 
soluble in DMF and DMSO but insoluble in water, alcohol and acetonitrile. Anal. Found: 
C, 44.01; H, 4.95; N, 21.41%. Calc, for C2 4 H 3 2 Z11N 1 0O4 S2 : C, 44.03; H, 4.89; N, 21.40%. 
IR: (KBr disc): cm"1, 3544(m), 3365(s), 3272(s), 3150(m), 1640(m), 1599(vs), 1557(m), 
1501 (vs), 1434(sh), 1378(m), 1318(s), 1306(m), 1293(sh), 1244(vs), 1209(m), 1184(m),
1142(sh), 1117(s), 1081(m), 1050(s), 1010(w), 978(w), 885(s), 830(s), 794(s), 743(s),
677(w), 601 (vs), 548(vs). *H NMR (DMSO-<4): 5 7.58d [2H, C(16/20), J =  8.2 Hz], 6.42d 
[2H, C(17/19), J =  8.1], 6.33s [1H, C(13)], 5.50s [2H (-N H 2)], 2.49s [6 H, CH3], 13C NMR 
(DM SO-^): 6  167.5 [C(l 1)], 162.3 [C(12/14)], 151.2 [C(18)], 130.3 [C(l 5)], 129.8 
[C( 16/20)], 111.9 [C (l7 /C l9)], 110.3 [C(13)],23.3 [CH3].
3.4.15 Preparation of the complex [Zn(smz)2(py)2].2py (15)
The same precipitate of the previous experiment was dissolved in a 1:10 C sH sN ^ O  
solution and stirred for 30 minutes. Five days later, white prismatic crystals were obtained. 
The compound is soluble in DMF and DMSO but insoluble in water, alcohol and
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acetonitrile. Anal. Found: C, 59.95, H, 5.25; N, 19.10%. Calc, for C4 4 H4 6 Z 11N 1 2O4 S2 : C, 
59.96; H, 5.22; N, 19.08%. IR: (KBr disc): cm"1, 3464(m), 3387(s), 3174(m), 1629(m), 
1593(vs), 1552(vs), 1501 (vs), 1445(sh), 1416(vs), 1383(m), 1316(s), 1296(sh), 1260(vs), 
1214(m), 1138(m), 1116(sh), 1081(s), 1009(w), 979(w), 835(s), 784(s), 676(w), 589(vs), 
554(vs). *H NMR (DMSO-<4): 6  8 .6 8 d [2H, C (l/5), J =  4.6 Hz], 7.85t [ 1 H, C(3), J =  7.3 
Hz], 7.57d [2H, C(16/20), J =  8.3 Hz], 7.45t [2H, C(2/4) , J =  5.3 Hz], 6.43d [2H, C(17/19), 
J =  7.8], 6.32s [1H, C(13)], 5.56s [2H, (-N H 2)], 2.41s [6 H, CH3], 13C NMR (D M SO -^): 8
166.9 [C(l 1)], 162.4 [C(12/l4)], 151.2 [C(18)], 150.0 [C(l/5)], 136.4 [C(3)], 130.1 
[C (l5)], 129.2 [C( 16/20)], 124.2 [C(2/4)], 111.7 [C(17/C19)], 110.5 [C(13)],23.0 [CH3].
3.4.16 Preparation of the complex [Cd(dien)(sdz)2].DMF (16)
To the DMF solution, diethylenetriamine (dien) (1 mmol) was added, stirred for 30 
minutes. After seven days white block crystals were obtained. Anal. Found: C, 41.21, H, 
4.90; N, 21.36%. Calc, for C2 7H 3 8 CdN 1 2 0 5 S2 : C, 41.16, H, 4.87; N, 21.34%. IR: (KBr 
disc), cm"1, 3436(m), 3350(s), 3246, 2925(w), 2878(w), 1665(vs), 1629(s), 1593, 1547(vs), 
1501 (sh), 1449(sh), 1409(vs), 1357, 1317(m), 1265(vs), 1244, 1178(sh), 1132(s), 1096(s), 
1071, 1015(s), 979(vs), 841(vw), 800, 682(s), 579, 554. *H NMR (DMSO-<4): 6  8 . 1  Id [2 H, 
C(12/14), J =  4.7], 7.47d [2H, C(16/20), J =  8.2], 6.40t [1H, C(13), J  = 4.5], 6.45d [2H, 
C(17/19), J =  8.3], 5.39s [2H, (-N H 2)], 2.89d [4H, C(2/3), J =  6.3], 2.73d [4H, C (l/4), J  = 
5.8]. 13CNMR (DMSO-^6 ): 6  164.5 [C(12/14)], 157.5 [C(l 1)], 150.3 [C18], 133.3 
[C( 16/20)], 128.8 [C (l5)], 112.1 [C(13)], 109.7 [C(17/19)], 48.3 [C(2/3)], 31.1 [C(l/4)].
3.4.17 Preparation of the complex [Cd(dien)(smr)2].H20  (17)
To the DMF solution o f cadmium precipitate o f sulfamerazine, diethylenetriamine (dien) (1 
mL) was added and stirred for 30 minutes. A week later, white block crystals were 
obtained. The compound is soluble in DMF and DMSO but insoluble in water and all other 
organic solvents. Anal. Found: C, 41.01, H, 4.90; N, 22.29%. Calc, for C2 6 H 3 7 C dN n 0 5 S2 : 
C, 41.07, H, 4.92; N, 20.26%. IR: (KBr disc), c m '1, 3446(m), 3345(s), 3242(s), 2922, 
2872, 1645(vs), 1597, 1581, 1553(vs), 1470(sh), 1445(sh), 1439(vs), 1412, 1361, 1314(m), 
1294(vs), 1271(vs), 1181 (sh), 1162(vs), 1132(s), 1101, 1093(s), 1085, 1061, 1007(s), 
976(vs), 843(vw), 825, 811, 803, 762(vs), 684(s), 653(m), 642(s), 625(vs), 587, 559. !H 
NMR (DMSO-t/6): 5 8.24d [1H, C(14), J =  5.2], 7.76d [2 H, C(16, 20), J  = 8.4], 6.83d [2H, 
C(17, 19), J =  5.1], 6.53d[lH , C(13), J =  8.7], 5.89s [2H (-N H 2)], 2.88d [4H, C(2/3), J  =
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6.1], 2.79d [4H, C (l/4 ) ,y  = 5.9], 2.37s [3H (CH3)]. 13CNMR (DMSO-</6): 5 167.9 [C(l 1 )],
162.5 [C (l2)], 157.1 [C(14)], 151.0 [C(18)], 131.0 [C(15)], 129.5 [C(16/20)], 112.1 
[C (l7/19)], 110.1 [C (l3)], 47.6 [C(2/3)], 38.8 [C(l/4)], 23.6 [CH3].
3.4.18 Preparation of the complex [Cd(sdz)2(bpy)] (18)
To the DMF solution of cadmium precipitate o f sulfadiazine, 2,2'-bipyridine (bpy) (1 
mmol) was added, stirred for 30 minutes. Two weeks later, white block crystals were 
obtained. Anal. Found: C, 46.91, H, 3.40; N, 18.29%. Calc, for C3 2 H 3 oCdNio0 4 S2 : C, 
46.97, H, 3.42; N, 18.26%. IR: (KBr disc), cm-1, 3409(m), 3334(s), 3226(s), 1645(vs), 
1599, 1583, 1553(vs), 1471(sh), 1447(sh), 1438(vs), 1415, 1349, 1314(m), 1299(vs), 
1269(vs), 1180(sh), 1160(vs), 1133(s), 1101, 1092(s), 1082, 1060, 1010(s), 978(vs), 
841(vw), 829, 812, 805, 764(vs), 680(s), 652(m), 645(s), 627(vs), 585, 557, 525(vs), 
41 l(w). *H NMR (DMSO-<4): 5 9.14 [1H, C (l)], 8.63 [(1H, C(4)], 8.37d [2H, C(12/14), J  
= 4.7], 8.25 [1H, C(3)], 7.39d [2H, C(16/20), J =  6.7], 7.78 [1H, C(2)], 6.74t [1H, C(13), J  
= 4.8], 6.36d [2 H, C(17/19), J =  8.4], 5.58s [2 H, (-N H 2)]. 13CNMR (DMSO-<4): 5 162.9 
[C(12/14)], 158.8 [C(l 1)], 153.4 [C18], 155.2 [C(5)], 149.2 [C(l)], 137.1 [C(4)], 129.1 
[C( 16/20)], 125.8 [C (l5)], 124.9 [C(3)], 121.2 [C(2)], 112.2 [C(13)], 111.8 [C(17/19)].
3.4.19 Preparation of the complex [Cd(sdz)2(phen)] (19)
To the DMF solution of the same precipitate o f the previous experiment, 1,10- 
phenanthroline (1 mmol) was added, stirred for 30 minutes. A week later, white block 
crystals were obtained. The compound is soluble in DMF and DMSO but insoluble in 
water and all other organic solvents. Anal. Found: C, 48.55, H, 3.28; N, 17.74; Calc, for 
C 3 2 H3 0 CCIN1 0O4 S2 : C, 48.58, H, 3.31; N, 17.70. IR: (KBr disc), cm-1, 3431(m), 3339(s), 
3227(s), 1638(vs), 1598(vs), 1553, 1515, 1503, 1438(sh), 1413(sh), 1351(vs), 1339(m), 
1317, 1294(vs), 1265(vs), 1228(sh), 1178(vs), 1133(s), 1104, 1092, 1081(s), 1011 (s), 1003, 
978(vs), 8 6 8 (vw), 850, 816, 804, 773(vw), 727(sh), 680(s), 645(m), 583(vs), 556(vs), 
523(vw), 441 (w), 420(w), 409. 'H NMR (DMSO-</6): 6  9.60 [ 1 H, C (l)], 8.90 [( 1 H, C(2 )], 
8.43d [2H, C(12/14), J  = 3.7], 8.25 [1H, C(3)], 7.29d [2H, C(16/20), J  = 4.8], 8.18 [1H, 
C(6 )], 6.76t [1H, C(13), J =  4.7, 4.6], 6.30d [2H, C(17/19), J  = 7.8], 5.54s [2H, (-N H 2)]. 
I3CNMR (DMSO-rf6): 5 162.7 [C(12/14>], 158.8 [C (ll)], 152.8 [C18], 151.5 [C(5)], 150.8 
[C(l)], 138.4 [C(4)], 129.1 [C(16/20)], 127.4 [C(6 )], 124.9 [C(3>], 1 2 1 . 2  [C(2)], 112.2 
[C (l3)], 111.9 [C (l7/19)].
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3.4.20 Preparation of the complex [Cd(smr)2(phen)] (20)
To the DMF solution o f cadmium precipitate of sulfamerazine, 1,10-phenanthroline (1 
mmol) was added, stirred for 30 minutes. A week later, white block crystals were obtained. 
The compound is soluble in DMF and DMSO but insoluble in water and all other organic 
solvents. Anal. Found: C, 49.85, H, 3.68; N, 17.14; Calc, for C3 4 H 3 oCdNio0 4 S2 : C, 49.82, 
H, 3.69; N, 17.10. IR: (KBr disc), cm"1, 3438(m), 3345(s), 3236(s), 1631 (vs), 1596(vs), 
1583, 1551, 1511, 1503, 1433(sh), 1412(sh), 1360(vs), 1338(m), 1316, 1299(vs), 1268(vs), 
1223(sh), 1179(vs), 1132(s), 1103, 1090, 1083(s), 1012(s), 1001, 978(vs), 861(vw), 852, 
813, 807, 776(vw), 723(sh), 682(s), 645(m), 585(vs), 558(vs). ‘H NMR (DMSO-<4): 8  
9.26d [1H, C (l), J =  4.9], 8.69t [1H, C(2), J =  5.1], 8.30d [1H, C(14), J  = 5.1], 8.15d [1H, 
C(3), J =  4.8], 8.03s [1H, C(6 )], 7.72d [2H, C(16, 20), J =  8.2], 6.81d [2H, C(17, 19), 7  =
5.2], 6.51d[lH, C(13), J =  8 .6 ], 5.87s [2H (-N H 2)], 2.36s [3 H (CH3)]. 13CNMR (DMSO- 
d6): 8  168.1 [C (ll)] , 163.4 [C(12)], 156.2 [C(14)], 151.5 [C(18)], 150.3 [C(5)], 148.8 
[C(l)], 138.3 [C(4)], 130.5 [C(15)], 129.1 [C(16/20)], 127.3 [C(6 )], 124.7 [C(3)], 121.6 
[C(2)], 112.5 [C( 17/19)], 110.3 [C(13)], 23.4 [CH3].
3.4.21 Preparation of the complex [Cd(sdz)2(dmbpy)].2DMF (21)
The white cadmium precipitate o f sulfadiazine was dissolved in DMF and to this solution 
4,4'-dimethyl-2,2'-bipyridine (1 mmol) was added and stirred for 30 minutes. The solution 
was filtered and left for crystallisation. A few days later, white block crystals were 
obtained, filtered and dried over silica gel. The compound is soluble in DMF and DMSO 
but insoluble in water and all other organic solvents. Anal. Found: C, 48.55, H, 3.28; N, 
17.74; Calc, for C 3 2 H 3 oCdNio0 4 S2 : C, 48.58, H, 3.31; N, 17.70. IR: (KBr disc), cm-1, 
342l(m), 3353(s), 3240(s), 1669(vs), 1600(vs), 1578, 1549, 1501, 1486, 1440(sh), 
1418(sh), 1388(vs), 1352(m), 1322, 1296(vs), 1270(vs), 1239(sh), 1173(vs), 1139(s), 
1088(s), 1009(s), 976(vs), 834, 803, 737(vw), 719(sh), 684(s), 659(m), 639, 584(vs), 
530(vs), 518(vw), 472. NMR (DMSO-<4): S 9.07 [ 1 H, C (l)], 7.68 [(1 H, C(2 )], 8.56
[(1H, C(4)], 2.34 [3H, C(6 )], 8.38d [2H, C(12/14), J =  4.1], 7.36d [2H, C(16/20), J =  6.3], 
6.74t [1H, C(13), J =  4.8], 6.35d [2H, C(17/19), J =  8.2], 5.56s [2H, (-N H 2)]. 13CNMR 
(DMSO-^6 ): 6  162.6 [C(12/14)], 158.7 [C(l 1 )], 152.8 [C18], 151.5 [C(5)], 150.3 [C(l)],
137.4 [C(4)], 129.1 [C (l6/20)], 126.4 [C(6 )], 125.8 [C(15)], 121.2 [C(2)], 112.2 [C(13)],
111.5 [C (l7/19)], 21.3 [C(6 )].
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3.4.22 Preparation of the complex {[Cd(smz)2(H20)].D M F}w (22)
The cadmium precipitate o f sulfamethazine was dissolved in DMF filtered and left for 
crystallization and after fifteen days white block crystals were obtained. The compound is 
soluble in DMF and DMSO but insoluble in water and all other organic solvents. Anal. 
Found: C, 54.25, H, 3.40; N, 11.10; Cd, 7.68. Calc, for C3 2 H 3 oCdNio0 4 S2 : C, 54.20, H, 
3.48; N, 11.15; Cd, 7.79%. IR: (KBr disc), c m '1, 3437(m), 3351(s), 3292(s), 2923, 2871, 
1635(vs), 1597, 1582, 1560(vs), 1502(sh), 1433(vs), 1394, 1371, 1342 (m), 1303(vs), 
1250(vs), 1177(sh), 1145(vs), 1127(s), 1083, 998(s), 973(vs), 876(vw), 834, 793, 732(vs), 
679(s), 637(s), 599, 556, 524(vs). lH NMR (DMSO-^6): 6  7.59d (2 H, C(16/20), J =  8.4 
Hz], 6.43d [2H, C(17/19), J=  8.0], 6.40s [1H, C(13)], 5.54s [2H (-N H 2)], 2.49s [6 H, CH3], 
13C NMR (D M SO -^): 8  167.5 [C ll] , 162.3 [C12/14], 151.2 [C18], 130.4 [C15], 129.8 
[C16/20], 111.9 [C l7/C  19], 110.2 [C13], 23.3 [CH3].
3.4.23 Preparation of the complex {[Cd(smz)2(H20)].2H 20 } w (23)
The same precipitate was dissolved in a 1:1 water.ammonia mixture and stirred for 30 
minutes. The solution was filtered and left for crystallisation. After five days white block 
crystals were obtained. The compound is soluble in DMF and DMSO but insoluble in 
water and all other organic solvents. Anal. Found: C, 54.25, H, 3.40; N, 11.10; Cd, 7.68. 
Calc, for C3 2 H3 0 CCIN1 0O4 S2 : C, 54.20, H, 3.48; N, 11.15; Cd, 7.79%. IR: (KBr disc), cm '1, 
3540, 3461 (m), 3368(s), 3280(s), 3157, 1639(vs), 1598(vs), 1583, 1557, 1501, 1432(sh), 
1397(sh), 1377(vs), 1345(m), 1298(vs), 1245(vs), 1209(sh), 1178(vs), 1142(s), 1125, 
1080(s), 999(s), 980(vs),883(vw), 832, 804, 793(vw), 738(sh), 677(s), 636(m), 599(vs), 
558(vs). ‘H NMR (D M SO -*): 8  7.61d (2H, C(16/20), J =  8.5 Hz], 6.45d [2H, C(17/19), J  
= 8.4], 6.38s [1H, C(13)], 5.59s [2H (-N H 2)], 2.50s [6 H, CH3], 13C NMR (D M SO -*): 8
167.4 [C ll] , 162.2 [C12/14], 151.3 [C18], 130.2 [C15], 129.5 [C16/20], 111.8 [C17/C19],
110.3 [C l3], 23.2 [CH3],
3.4.24 Preparation of the complex [Cd(smz)2(en)].2DMF (24)
To the DMF solution o f the same precipitate, ethylenediamine (en) (1 mL) was added, 
stirred for 30 minutes. After seven days white block crystals were obtained. The compound 
is soluble in DMF and DMSO but insoluble in water and all other organic solvents. Anal. 
Found: C, 43.91, H, 5.47; N, 19.29%. Calc, for C3 2 H4 8 CdNi2 0 6 S2: C, 43.97, H, 5.50; N, 
19.24%. IR: (KBr disc), c m '1, 3443(m), 3359(s), 3334, 3226(s), 3165, 3063, 2930, 2873,
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2843, 1675(s), 1634(vs), 1595, 1579, 1562(vs), 1501(sh), 1432(sh), 1398, 1376, 1342(m), 
1291 (vs), 1262(vs), 1209, 1178(sh), 1139(vs), 1122(s), 1079(s), 994(s), 974(vs), 873(vw), 
835, 794(vs), 743, 718, 675(s), 636(s), 596, 555. NMR (DMSO-d6): 6  7.63d [2H, 
C( 16/20), J  = 8.5 Hz], 6.48d [2H, C(17/19), J  = 8 .6 ], 6.42s [1H, C(13)], 5.58s [2H 
(-N H 2)], 2 .73s  [4H, C(l/2)], 2 .51s  [6 H, CH3], 13C NMR (D M SO -^): 6  167.7 [C(l 1)],
162.2 [C(12/14)], 151.5 [C(18)], 130.0 [C(15)], 129.9 [C(16/20)], 112.0 [C(17/C19)],
110.2 [C (l3)], 45.3 [C(l/2)], 23.4 [CH3].
3.4.25 Preparation of the complex [Hg(sdz)2(dmf)2] (25)
To the DMF solution o f mercury precipitate o f sulfadiazine, a few drops o f ammonia was 
added and stirred for 30 minutes. A few days later, white block crystals were obtained. The 
compound is soluble in DMF and DMSO but insoluble in water, alcohol and acetonitrile. 
Anal. Found: C, 36.89, H, 3.85; N, 16.53%. Calc, for C^H^HgNjoOsS^ C, 36.94; H, 3.82; 
N, 16.57%. IR: (KBr disc): cm-1, 3467(s), 3365(s), 3048(m), 2930, 1655(s), 1614(vs), 
1588(vs), 1557(vs), 1506(vs), 1440(sh), 1414(vs), 1342(s), 1291(vs), 1184(w), 1127(sh), 
1086(s), 994(w), 958(w), 907(s), 820, 682(s), 651(w), 574(vs), 547(vs), 518(vw), 457(vw), 
416(w). *H NMR (DMSO-<4): 5 8.50d [2H, C(12/14), J  = 4.9], 7.78d [2H, C(16/20), J  = 
8.5], 6.98t [1H, C(13), J  = 4.8], 6.56d [2H, C(17/19), J =  8 .6 ], 5.92s [2H, (-N H 2)]. 13C 
NMR (DMSO-^6 ): 6  162.7 [C(12/14)], 158.8 [C(l 1 )], 153.0 [C18], 130.6 [C(16/20)], 126.1 
[C (l5)], 114.7 [C(13)], 112.4 [C(17/19)].
3.4.26 Preparation of the complex [Hg(smr)2] (26)
To the DMF solution o f mercury precipitate o f sulfamerazine, a few drops o f ammonia was 
added and stirred for 30 minutes. A few days later, white block crystals were obtained. 
The compound is soluble in DMF and DMSO but insoluble in water, alcohol and 
acetonitrile. Anal. Found: C, 36.89, H, 3.85; N, 16.53%. Calc, for C2 2 H 3 2 HgNg0 4 S2: C, 
36.94; H, 3.82; N, 16.57%. IR: (KBr disc): cm-1, 3436(s), 3317(s), 3228(m), 1632(vs), 
1598(vs), 1571 (vs), 1501(vs), 1465(sh), 1435(vs), 1392(vs), 1371(s), 1332(m), 1310(sh), 
1281 (vs), 1259(m), 1189(m), 1135(sh), 1093(s), 1010(w), 971(w), 945(w), 917(s), 869(w), 
823, 792(s), 769(vw), 716(vw), 689(s), 635(w), 582 (vs) and 546. !H NMR (DMSO-<4): § 
8.37d [1H, C(14), J  -  5.1], 7.84d [2H, C(16, 20), J =  8.5], 6.92d [2H, C(17, 19), J =  5.1], 
6.63d[lH, C(13), J  = 8 .8 ], 5.97s [2 H (-N H 2)], 2.39s [3H (CH3)]. ,3CNMR (DMSO-</6): 5
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168.4 [C(l 1)], 161.4 [C (l2)], 158.3 [C(14)], 152.9 [C(18)], 130.8 [C(15)], 126.2 
[C( 16/20)], 114.1 [C(17/19)], 112.2 [C(13)],23.6 [CH3].
3.4.27 Preparation of the complex [Hg(smr)2(bpy)] (27)
To the DMF solution o f mercury precipitate o f sulfamerazine, 2,2'-bipyridine (0.157g, 1 
mmol) was added, stirred for 30 minutes. After seven days, white block crystals were 
obtained. The compound is soluble in DMF and DMSO but insoluble in water, alcohol and 
acetonitrile. Anal. Found: C, 43.55, H, 3.40; N, 15.90%. Calc, for C32H3oHgNio04S2i C, 
43.51; H, 3.42; N, 15.86%. IR: (KBr disc): cm-1, 3445 (s), 3349 (s), 3241 (m), 1637 (vs), 
1599 (vs), 1577(vs), 1504(vs), 1459 (sh), 1432 (vs), 1389(vs), 1370(s), 1333(m), 1309(sh), 
1286 (vs), 1258(m), 1194 (w), 1180 (m), 1131(sh), 1093(s), 1009 (w), 971(w), 944 (w), 
915 (s), 869(w), 823, 792(s), 769 (vw), 716 (vw), 693 (w), 682 (s), 635 (w), 582 (vs), 546 
(vs). !H NMR (DMSO-<4): S 8.32d [1H, C(14), J  = 4.9], 7.77d [2H, C(16, 20), 8.3],
6.87d [2H, C(17, 19), J =  5.0], 6.57d[lH, C(13), J  = 8.4], 5.90s [2H (-N H 2)], 2.33s [3H 
(CH3)]. 13CNMR (DMSO-<4): 6 167.9 [C(l 1)], 159.9 [C(12)], 157.7 [C(14)], 152.8 
[C (l8)], 130.1 [C( 15)], 126.7 [C(16/20)], 113.1 [C(17/19)], 111.8 [C(13)],23.2 [CH3].
3.4.28 Preparation of the complex [Hg(smz)2(DMF)2] (28)
To the DMF solution of mercury precipitate o f sulfamethazine, a few drops o f ammonia 
was added and stirred for 30 minutes. After three weeks, white block crystals were 
obtained, filtered and dried over silica gel. The compound is soluble in DMF and DMSO 
but insoluble in water, alcohol and acetonitrile. Anal. Found: C, 34.62, H, 3.58; N, 15.54%. 
Calc, for C26 H3 2 HgN10O6S2 : C, 34.65; H, 3.51; N, 15.50%. IR: (KBr disc): c m '1, 3457(s), 
3360(s), 3247(m), 2919, 1660(vs), 1599(vs), 1577(vs), 1547(vs), 1506, 1429(sh), 1393(vs), 
1373(s), 1332(m), 1292(vs), 1258(m), 1194 (w), 1137(sh), 1086(s), 994(w), 965, 897(w), 
820, 779(vw), 682(s), 635(w), 589(vs), 549(vs). ‘H NMR (DMSO-d6): 5 7.80d [2H, 
C( 16/20), J  = 8.6 Hz], 6.57d [2H, C(17/19), J  = 8.7], 6.69s [1H, C(13)], 5.90s [2H 
(-N H 2)], 2 .51s  [6H, CH3]. 13CN M R (DMSO-rfs): 6 167.9 [C(l 1)], 159.6 [C(12/14)], 152.8 
[C(18)], 131.0 [C( 15)], 126.3 [C(16/20)], 113.1 [C(17/C19)], 112.0 [C(13)],23.5 [CH3].
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RESULTS AND DISCUSSION
The complexes were characterized by analytical and spectroscopic methods such as IR, 
EPR and NMR as well as by X-ray diffraction methods.
4.1 IR spectra
The infrared spectra o f the complexes taken in the region 4000 -  400 cm- 1  were compared 
with those o f the free ligands. The bands that appear between 3500 and 3400 cm - 1  due to
1 9<3 5 >7 tt(NH2 ) and sym(NH 2 ) vibrations of the amino (-N H 2 ) group ’ are modified with 
respect to those o f the free respective ligands. In general, these vibration modes appear at 
higher and lower wave numbers, compared with those o f the free ligands. When the amino 
nitrogen atom does not interact with the metal ions, these modifications are consequently 
due to the hydrogen bonds involving the amino groups. The vibrations for the water 
molecule present in the complexes appear in the same region as well.
The peak for the sulfonamidic (N-H) group in the free ligands at around 3125 cm-1, are not 
present in the spectra o f the complexes, confirming the deprotonation of the -S O 2 N H - 
moiety. The scissoring vibrations for the amino (-N H 2 ) groups appear in the range of 1614 
-  1662 cm - 1  and peaks due to phenyl ring appear at around 1547 and 1600 cm-1. The peaks 
around 1325 and 1331 cm - 1  are assigned to v^SCE), and those at 1155 -  1157 cm - 1  to 
^(SCE), show important changes upon complexation. The first one splits into two peaks at 
1291 -  1386 cm - 1  and the second one appears at around 1131 -  1194 cm - 1  in the 
complexes.
 1 O T
The 945-965 cm bands in the ligands are assigned to v(S-N) ’ and changed to higher 
frequencies (958 -  1046 cm-1) in all cases as a consequence of coordination to the metal. 
This shift to higher frequencies is in accordance with the shortening o f the S-N  bond 
lengths, which have been observed in the crystal structures o f complexes.
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Table 4.1: The IR spectra of the compounds 1 —28
compds NH 2 /H20 n h 2 Phenyl rings (S 0 2)as (SO 2)sy S -N
1 3461,3365 1625 1325 1157 945
2 3468, 3370 1630 1570 1331 1153 965
3 3435,3353 1665 1598 1344, 1301 1144 999,974
4 3441,3332 1643 1596, 1581 1348, 1298 1134 1011,975
5 3438,3349 1632 1595, 1551 1351,1295 1131 1011,973
6 3439, 3341 1641 1599, 1584 1347, 1297 1158 1002,977
7 3452,3379 1629 1598, 1578 1362, 1301 1173 1000,968
8 3523,3387 1662 1597, 1576 1365, 1294 1178 1008, 971
9 3524,3387 1660 1597, 1576 1363, 1294 r ll7 8 1010, 971
10 3423, 3346 1636 1597, 1554 1386,1282 1177 1046, 971
11 3420, 3341 1639 1596, 1552 1383,1281 1178 1045,974
12 3345,3210 1625 1598, 1570 1350, 1294 1182 1020,982
13 3436,3350 1629 1597, 1581 1372, 1300 1184 999,975
14 3544,3365 1640 1599, 1557 1378, 1306 1184 1010, 978
15 3464, 3387 1629 1593,1552 1383,1296 1134 1009, 979
16 3436, 3350 1665 1593, 1547 1357,1317 1178 1015, 979
17 3444, 3345 1645 1597, 1581 1361, 1294 1181 1007, 976
18 3409, 3334 1645 1599, 1583 1349,1299 1180 1010, 978
19 3431,3339 1638 1598,1553 1351, 1294 1178 1011,978
20 3421,3353 1669 1600,1578 1360, 1296 1173 1009, 976
21 3438, 3345 1631 1596,1583 1352,1299 1179 1012, 978
22 3437,3351 1635 1597,1582 1342, 1303 1177 998, 973
23 3540, 3461 1639 1598, 1583 1345,1298 1178 999,980
24 3443,3359 1634 1595, 1579 1342, 1291 1178 994,974
25 3467, 3365 1614 1588,1557 1342, 1291 1184 994, 958
26 3436,3317 1632 1598, 1571 1371, 1281 1189 1010, 971
27 3445, 3349 1637 1599, 1577 1370,1309 1180 1009, 971
28 3457, 3360 1660 1599,1577 1373, 1292 1194 994,965
4.2 Electron Paramagnetic Resonance
Figure 4.4 shows that the X-band EPR spectra obtained from the complexes (8 ), (9) and 
( 1 2 ) in a DM F-^/toluene-ds frozen solution at 1 0 K suggests that the copper ions are in a 
very similar molecular environments in all the complexes and in these cases each copper 
ion is surrounded by four nitrogen atoms and two oxygen atoms with the general formula 
o f CUN4 O2 . Acceptable simulations of the X-band spectra obtained for the complexes (8 ), 
(9) and (12) are shown in Figure 4.1.
The simulation o f the complex (9) is shown in Figure 4.2 and the Q-band spectrum for the 
complex (12) is shown in Figure 4.3. The spin Hamiltonian parameters were: g|| = 2.208, 
g± = 2.042, ^ ||( 6 3 Cu) = 185 Gauss, ^ i ( 6 3 Cu) = 25 Gauss, /f ||( 6 5 Cu) = 197.7Gauss, /f i( 6 5 Cu)
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= 26.7 Gauss, 4 x 14N A± = 14 Gauss. The perpendicular hyperfine values for both the 
copper and the nitrogen nuclei must be considered approximate due to the low resolution in 
the perpendicular region of the spectrum; the 14N value for the parallel features was set to 
an arbitrary value o f 1 Gauss.
(12)
1.92.1 2.02.3 2.22.5 2.4
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Figure 4.1
The X-band EPR spectra fo r  the complexes (8 ), (9) and (12) in D M F-dftoluene-dg
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Figure 4.2
The X-band simulated EPR fo r  the complex (8 )
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simulation
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Figure 4.3
The Q-band EPR spectrum and simulation o f  the complex [Cu(smz) 2 (apen)] .3 H2 O.CH3 OH  
(12)
In order to obtain accurate coupling constants for the nitrogen nuclei, X-band ENDOR 
spectra of the complex were recorded. For brevity, only the ENDOR spectra for (9) and 
(12) are shown in Figures 4.4 and 4.5 respectively. These spectra were complex with 
features arising from protons covering a wide frequency range and thus likely to obscure 
any features arising from 14N nuclei. The Q-band spectra only showed features arising from 
protons; the nitrogen signals, presumably being too weak and broad for detection by c.w. 
techniques in this instance and therefore did not provide any additional information.
_  150
100
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-100
-150
2 20 226 B 10 12 16 18*
Figure 4.4
The X-band simulated ENDOR spectrum fo r  the complex (9)
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v /M H z
Figure 4.5
The X-band ENDOR spectrum o f  the complex [ Cu(smz)2 (apen)]. 3 H2 O. CH 3 OH (12) 
showing overlapping couplings to the 1 Hs and 4N  nuclei
In order to determine which features, if any, were due to 1 4N, a second set of spectra were 
recorded at Q-band (Figure 4.6). These spectra, however, only showed features arising 
from protons; the nitrogen signals, presumably being too weak and broad for detection by 
c. w. techniques in this instance.
60555040 45
v / M H z
Figure 4 . 6
The Q-band ENDOR spectrum o f  the complex [ Cu(smz)2 (apen)J.3 H 2 0 . CH 3 OH (12) 
showing couplings to the ]H  only
Nevertheless, the above spin Hamiltonian data confirms the X-ray structures obtained from 
the complex. The ‘g ’ and hyperfine splitting values are characteristic of a copper (II)
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complex with octahedral symmetry distorted by a large Jahn-Teller elongation in the z- 
direction. It is interesting to note that the two copper atoms in the complex (9) are exactly 
equivalent and there does not appear to be any identifiable magnetic interaction between 
them.
For the complex (9) we also got four lines according to the following equation:
No of lines = 2n l + 1
where n = the number o f equivalent nuclei the electron couples to and I  = nuclear spin and 
for the copper atom it is I2 .
So the number o f lines for the complex (9) is 2 .1 . 3 / 2  + 1 = 4 as there are two unidentifiable 
copper ions in the complex. If there were two identifiable copper ion then we got the 
number o f lines 2 2 ? 12 + 1 = 7 .
E x p e r t i m e n t a l
S i m u l a t e d
2600 2800  3000 3200 3400 3600
M a g n e t i c  F i e l d  ( G a u s s )
Figure 4.7
The X-band EPR spectrum and simulation o f  the complex [Cu(smz)2(NHs)].2H20 (13)
The experimental and simulated X-band EPR spectrum of (13) is shown in Figure 4.7. 
Owing to the complexity of the system (i.e., six interacting nitrogen nuclei in the complex) 
the EPR spectrum was very difficult to simulate accurately. This was particularly the case 
in the perpendicular region of the spectrum, where the number o f superhyperfine lines 
originating from six interacting nitrogen nuclei (with slightly different environments and 
therefore slightly different couplings) was very difficult to reproduce. Nevertheless, a
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qualitative simulation is shown in Figure 4.8 based on the spin Hamiltonian parameters of 
g,l = 2.285, gj. = 2.04, A,|(6 3 Cu) = 132G, Aj.(6 3 Cu) = 25G, A,|(65Cu) = 142G, Aj.(65Cu) = 
26G, 6  x l4N A i = 14.7G. It should be noted that these parallel values for complex (13) are 
significantly different compared to those observed for complexes (8 ), (9) and (12). In the 
latter case parallel components o f gy = 2.208, A||(63Cu) = 185G, A||(65Cu) = 197G, were 
observed. These values are typical of Cu2+ complexes containing four interacting nitrogen 
atoms . 14 In the case o f (13), the parallel components are very different [gy = 2.285, 
A,|(6 3 Cu) = 132G, Ay(65Cu) = 142G] and suggestive o f a higher symmetry for the ion which 
is consistent with the crystal structure.
Since in the complexes (10) and (11), the copper ions have five coordination numbers and 
one is metal-metal bonded, so there are no unpaired electrons and the complexes are EPR 
silent. This is due to the very strong spin-spin interactions that occur between the two 
copper centres, causing large zero field splitting terms are not visible in the X-ban 
measurements.
4.3 NMR and 13C NMR spectra
*H and 13C NMR spectra were obtained from a solution of the sulfa drug molecules and the 
complexes in </-DMSO. The chemical shifts are expressed in ppm relative to internal 
TMS. The compounds present simple NMR spectra with two equivalent sulfa drug 
molecules and secondary ligands where applicable.
R 2
Sulfadiazine when Ri and R2  are hydrogen (H)
Sulfamerazine when R\ is H and R2  is methyl group (CH 3 )
Sulfamethazine when R\ and R2  are methyl group (CH 3 )
The !H spectra of the complexes are consistent with the X-ray structure obtained. The 
spectra consist o f two doublets for the para substituted phenyl ring and one singlet for the 
amino group on the phenyl ring in all the complexes.
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The pyrimidine ring o f sulfadiazine showed one doublet integrating for two hydrogen 
atoms and one triplet integrating for one hydrogen atom, sulfamerazine showed two 
doublets for one hydrogen atom each and one singlet for substituted methyl group and 
sulfamethazine showed one singlet for pyrimido hydrogen atom and one singlet for 
substituted two methyl groups. All integrals are consistent with this assignment. Small 
shifts in resonances are observed for the complexes compared to the parent ligands.
In each case the N (11)-H  peak has disappeared upon complexation with metal(II) ion and 
a downfield shift was observed for the C ( l l)  resonance o f sulfa drug molecules and from 
this observation it is probable that the metal(II) ions are bonded to the N (11) atom. Due to 
the complexation, the shift in signal for the aromatic protons occurred as observed in the 
’H NMR spectra of the metal complexes.
The 13C NMR spectra ((/-D M SO ) of the complexes are relatively simple to interpret and 
are similar to those observed for the free ligands with seven peaks for sulfadiazine, nine for 
sulfamerazine and eight for sulfamethazine.
In the zinc complex [Zn(smz)2 (NH3 )2 ] (14) there are two molecules o f ammonia as 
secondary ligands and it showed the spectra for the sulfamethazine molecules.
Table 4.2: XH  NMR and 13C NMR shift assignment of sulfamethazine and its zinc
Assignment 'H(smzH) AH(14) UC(smzH) UC(14) A8  (H)b A8  (C)b
N (ll)-H 1 1 . 2 0
C (ll) 165.6 167.5 +1.9
C(12)/C(14) 157.0 162.3 +5.3
C(13)-H 6.45 6.33 112.3 110.3 - 0 . 1 2 -2.3
C(15) 130.8 130.3 -0.5
C( 16)-H /C(20)-H 7.69 7.58 125.4 129.8 - 0 . 1 1 +4.4
C(17)-H/C(19)-H 6.60 6.42 114.0 111.9 -0.18 - 2 . 1
C(18) 153.2 151.2 - 2 . 0
n h 2 5.98 5.50 -0.48
c h 3 2 . 2 2 2.49 23.4 23.3 +0.27 - 0 . 1
b AS_
A 8  S (co m p lex ) S (srn z )
Due to the presence o f pyridine molecules, the NMR spectrum of the complex 
[Zn(smz)2 (py)2 ].2 py (15) shows two additional triplets for the meta- and para- hydrogen 
atoms and one doublet for 6>/+/70-hydrogen atoms.
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Table 4.3: *11 NMR and 13C NMR shift assignment of sulfamethazine and pyridine
Assignment ^(sm zH ) AH(15) JC(smzH) 1JC(15) A8  (H)b A8  (C)b
N(11)-H 1 1 . 2 0
C (ll) 165.6 166.9 +1.4
C(12)/C(14) 157.0 162.4 +5.4
C(13)-H 6.45 6.32 112.3 110.5 -0.13 - 1 . 8
C(15) 130.8 130.1 -0 .7
C(16)-H/C(20)-H 7.69 7.57 125.4 129.2 - 0 . 1 2 +3.8
C( 17)-H/C( 19)-H 6.60 6.43 114.0 111.7 -0.17 -2.3
C(18) 153.2 151.2 - 2 . 0
n h 2 5.98 5.56 -0.42
c h 3 2 . 2 2 2.41 23.4 23.0 +0.19 -0 .4
Py
C(l)/C(5) 8.59 8 . 6 8 150.0 149.9 +0.09 - 0 . 1
C(2)/C(4) 7.35 7.45 124.2 124.4 + 0 . 1 0 + 0 . 2
C(3) 7.73 7.85 136.4 137.4 + 0 . 1 2 + 1 . 0
A8  S (co m p lex ) S (sm z )
The 13C NMR spectra showed two peaks for diene molecule for the complexes 
[Cd(sdz)2 (dien)].DMF (16) and [Cd(smr)2 (dien)].H2 0  (17) at 31.1 and 38.8 ppm 
respectively for or-carbon and 48.3 and 47.6 ppm respectively for /7-carbon atoms (Tables
4.4 and 4.5).
Table 4.4: NMR and 13C NMR shift assignment of sulfadiazine and dien and
their Cd complex [Cd(sdz)2 (dien)].DMF (16) in DMSO-</6a
Assignment ^ (sd z H ) lH(16) 1JC(sdzH) UC(16) A8  (H)b A8  (C)b
N(11)-H 11.35
C (ll) 158.6 164.5 +5.9
C(12)-H/ C(14)-H 8.50 8 . 1 1 157.5 157.5 -0.39 + 0 . 0
C(13)-H 7.00 6.40 115.9 1 1 2 . 1 -0 .60 -3 .8
C(15) 125.1 128.8 +3.7
C( 16)-H /C(20)-H 7.75 7.47 130.3 133.3 -0.28 +3.0
C(17)-H/C(19)-H 6.58 6.45 1 1 2 . 6 109.7 -0.13 -2 .9
C(18) 153.4 150.3 -2 .9
n h 2 6 . 0 0 5.39 -0.61
dien
C(l)/C(4) 2.84 2.73 41.9 31.1 - 0 . 1 1 - 1 0 . 8
C(2)/C(3) 2.97 2.89 52.9 48.3 -0.08 -4 .6
Relative to TMS with DMS0-^6 peak as reference ( ‘H, 2.60 ppm, C, 43.5 ppm)
A8  “  S (c o m p le x )  — 6 ( s u |fa d ia z in e )
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Table 4.5: !H NMR and 13C NMR shift assignment of sulfamerazine and its Cd
complex fCd(smr)2(dlien)].H2<3 (17) in DMSO-rf6a
Assignment ^ (sm rH ) ‘H(17) 1JC(smrH) 1JC(17) A8  (H)b A8  (C)b
N (ll)-H 1 1 . 2 0
C(l l ) 164.3 167.9 +3.6
C(12) 157.5 162.5 +5.0
C(13)-H 6.62 6.53 1 1 2 . 1 1 1 0 . 1 -0 .09 - 2 . 0
C(14)-H 8.37 8.24 156.8 157.1 -0.13 -0.3
C(15) 130.1 130.1 0 . 0
C( 16)-H /C(20)-H 7.69 7.76 124.9 126.7 +0.07 + 1 . 8
C( 17)-H/C( 19)-H 6.95 6.83 114.7 1 1 1 . 8 - 0 . 1 2 -2 .9
C(18) 152.9 152.8 - 0 . 1
n h 2 6.07 5.90 -0.17
c h 3 2.41 2.37 23.3 23.6 -0.04 +0.3
dien
C(l)/C(4) 2.84 2.79 41.9 38.8 -0.05 -3.1
C(2)/C(3) 2.97 2 . 8 8 52.9 47.6 -0.09 -5 .3
a Relative to TMS wit' 
b A5 — 8 fcr>mnlex> — $
i D M S 0-a?6  peak as reference ( H, 2.60 ppm, C, 43.5 ppm).
'( o m p ) ° ( s m r )
Due to the presence of 2,2'-bipyridine in the complex [Cd(sdz)2 (bpy)] (18) two additional 
doublets and two triplets were observed in the !H NMR spectrum.
Table 4.6: !H NMR and 13C NMR shift assignment of sulfadiazine, 2,2'-bipyridine and
Assignment ^ (sd zH ) ‘H(18) 1JC(sdzH) n 00 A6  (H)b A8  (C)b
N(11)-H 11.35
C (ll) 158.6 162.9 +4.3
C(12)-H/ C(14)-H 8.50 8.38 157.5 158.8 - 0 . 1 2 +1.3
C(13)-H 7.00 6.75 115.9 1 1 2 . 2 -0.25 -3 .7
C(15) 125.1 125.8 +0.7
C(16)-H/C(20)-H 7.75 7.37 130.3 129.1 -0.38 - 1 . 2
C( 17)-H/C( 19)-H 6.58 6.35 1 1 2 . 6 1 1 1 . 8 -0.23 - 0 . 8
C(18) 153.4 151.5 -1 .9
n h 2 6 . 0 0 5.58 -0.42
lH(bpy) ,JC(bpy)
C (l)-H 8.70 9.15 149.2 140.4 +0.45 - 8 . 8
C(2)-H 7.45 7.78 120.4 1 2 1 . 2 +0.33 + 0 . 8
C(3)-H 7.95 8.25 124.0 124.9 +0.30 +0.9
C(4)-H 8.40 8.65 137.1 140.0 +0.25 +2.9
C(5) 152.2 151.4 - 0 . 8
A8  8 (c o m p le x )  ^(sL ilfad iazine o r bpy)
The ]H NM R spectra o f complexes [Cd(sdz)2 (phen)] (19) and [Cd(sm r)2 (phen)] (20) 
exhibited one singlet, one doublet and two triplets for the 1,10-phenanthroline molecules.
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Table 4.7: NMR and 13C NMR shift assignment of sulfadiazine, 1,10-
Assignment ^ (sd zH ) fH(19) 1 3C(sdzH) 13C(19) AS (H)b AS (C)b
N ( ll) -H 11.35
C (ll) 158.6 162.7 +4.1
C (12)-H /C (14)-H 8.50 8.45 157.5 158.8 -0.05 +1.3
C(13)-H 7.00 6.78 115.9 1 1 2 . 2 - 0 . 2 2 -3 .7
C(15) 125.1 125.7 + 0 . 6
C( 16)-H /C(20)-H 7.75 7.30 130.3 129.1 -0.45 - 1 . 2
C( 17)-H/C( 19)-H 6.58 6.30 1 1 2 . 6 111.9 -0.28 -0 .7
C(18) 153.4 152.8 - 0 . 6
n h 2 6 . 0 0 5.58 -0.42
^ (p h en ) 1 3C(phen)
C (l)-H 9.05 9.60 145.6 150.8 +0.55 + 0 . 6
C(2)-H 8.45 8.90 123.2 1 2 1 . 2 +0.45 + 0 . 8
C(3)-H 7.95 8.25 126.6 124.9 +0.30 +0.9
C(4) 136.1 138.4 +1.3
C(5) 149.9 151.5 0 . 0
C(6 )-H 7.75 8.18 128.4 127.4 +0.45
AS S (co m p lex ) ^ (s u lfa d ia z in e  o r phen)
Table 4.8: NMR and 13C NMR shift assignment of sulfamerazine and its Cd
complex Cd(smr)2(p hen)] (20) in D M S O - r f 6 a
Assignment 'HCsmrH) *H(20) 1 3C(smrH) ljC(20) AS (H)b AS (C)b
N(11)-H 1 1 . 2 0
C (ll) 164.3 167.1 +2 . 8
. C( 12) 157.5 163.4 +5.9
C(13)-H 6.62 6.51 1 1 2 . 1 110.3 - 0 . 1 1 - 1 . 8
C(14)-H 8.37 8.30 156.8 156.2 -0.07 - 0 . 6
C(15) 130.1 130.5 +0.4
C( 16)-H /C(20)-H 7.69 7.72 124.9 129.1 +0.03 +4.2
C( 17)-H/C( 19)-H 6.95 6.81 114.7 112.5 -0.14 - 2 . 2
C(18) 152.9 151.5 -1 .4
n h 2 6.07 5.87 - 0 . 2 0
c h 3 2.41 2.36 23.3 23.3 -0.05 0 . 0
*H(phen) iJC(phen)
C (l)-H 9.05 9.26 145.6 148.8 +0.55 +0 . 6
C(2)-H 8.45 8.69 123.2 1 2 1 . 6 +0.45 +0 . 8
C(3)-H 7.95 8.15 126.6 124.7 +0 . 2 0 +0.9
C(4) 136.1 138.3 +1.3
C(5) 149.9 150.3 0 . 0
C(6 )-H 7.75 8.03 128.4 127.3 +0.28
Relative to TMS with D M SO -^ peak as reference ( H, 2.60 ppm,
A S  — S (c o m p le x )  — 8 ( s m r)
13C, 43.5 ppm)
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In complex [Cd(sdz)2 (dmbpy)] (21) two doublets and two singlets were observed for 4,4'- 
dimethyl-2,2'-bipyridine molecule as shown in Figure 4.9.
Table 4.9: NMR and 13C NMR shift assignment of sulfadiazine, 4,4'-dimethyI-2,2'-
bipyridine and their Cd complex fCd(sdzWdmbpy)l (
Assignment 'H(sdzH) !H(21) C(sdzH) C(21) AS (H)b AS (C)b
N(11)-H 11.35
C (ll) 158.6 162.6 +4.0
C(12)-H/ C(14)-H 8.50 8.38 157.5 158.7 - 0 . 1 2 + 1 . 2
C(13)-H 7.00 6.74 115.9 1 1 2 . 2 -0.26 -3 .7
C(15) 125.1 125.8 +0.7
C( 16)-H /C(20)-H 7.75 7.36 130.3 129.1 -0.39 - 1 . 2
C(17)-H/C(19)-H 6.58 6.35 1 1 2 . 6 111.5 -0.23 - 1 . 1
C(18) 153.4 152.8 -0.5
n h 2 6 . 0 0 5.56 -0.44
*H(dmbpy) 1 3C(dmbpy)
C (l)-H 8.73 9.07 149.9 150.3 +0.34 +0.4
C(2)-H 7.62 7.68 121.4 1 2 1 . 2 +0.06 - 0 . 2
C(3) 126.4 124.9 +1.5
C(4)-H 8.41 8.56 137.1 137.4 +0.15 +0.3
C(5) 151.2 151.5 +0.3
C(5) 2.31 2.34 2 1 . 0 21.3 +0.03 +0.3
AS S i m p l e x )  b ( Suifa diaz ine  or dm bpy)
The polymeric cadmium complexes {[Cd(smz)2 (H2 0 )].DMF}„ (22) and
{[Cd(smz)2 (H2 0 )].2 H 2 0 }„ (23) showed characteristic peaks for the sulfamethazine 
molecules.
Table 4.10: NMR and 13C NMR shift assignment of sulfamethazine and its
Assignment *H(smzH) *14(22) 1JC(smzH) 1jC(22) AS (H)b AS (C)b
N(11)-H 1 1 . 2 0
C (ll) 165.6 167.5 +1.9
C(12)/C(14) 157.0 162.7 +5.7
C(13)-H 6.45 6.40 112.3 1 1 0 . 2 -0.05 - 2 . 1
C(15) 130.8 130.4 -0.4
C( 16)-H/C(20)-H 7.69 7.59 125.4 129.8 - 0 . 1 1 -4.4
C(17)-H/C(19)-H 6.60 6.43 114.0 111.9 -0.17 - 2 . 1
C(18) 153.2 151.2 - 2 . 0
n h 2 5.98 5.54 -0.44
c h 3 2 . 2 2 2.49 23.4 23.3 +0.27 - 0 . 1
AS S(compiex) S(smz)
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Table 4.11: !H NMR and 13C NMR shift assignment of sulfamethazine and its
cadmium complex {[Cd(smz 2(H20)1.2H2(3}„ (23) in DMSO-J6a
Assignment *H(smzH) *H(23) 1JC(smzH) 1JC(23) A8  (H)b A5 (C)b
N (ll)-H 1 1 . 2 0
C (ll) 165.6 167.4 + 1 . 8
C(12)/C(14) 157.0 162.2 +5.2
C(13)-H 6.45 6.38 112.3 110.3 -0.17 - 2 . 0
C(15) 130.8 130.2 - 0 . 6
C( 16)-H /C(20)-H 7.69 7.61 125.4 129.5 -0.08 -4.1
C( 17)-H/C( 19)-H 6.60 6.45 114.0 1 1 1 . 8 -0.15 - 2 . 2
C(18) 153.2 151.3 -1.9
n h 2 5.98 5.59 -0.39
c h 3 2 . 2 2 2.50 23.4 23.2 +0.28 - 0 . 2
Relative to TMS with D M S0-g?6  peak as reference ( H, 2.60 ppm,
A 8  — 6 ( Com plex) — S ( sm z)
C, 43.5 ppm).
The ethylenediamine molecule in complex [Cd(smz)2 (en)] .DMF (24) showed one singlet at 
2.51 ppm indicating a downfield shift due to complexation with the cadmium ion.
Table 4.12: ‘H NMR  
cadmium <
and 13C NMR shift assignment of sulfamethazine and its
m u c n  j a
Assignment 'HCsmzH) 1H(24) ljC(smzH) 1JC(24) A5 (H)b A5 (C)b
N(11)-H 1 1 . 2 0
C (ll) 165.6 167.7 +2 . 1
C(12)/C(14) 157.0 162.2 +5.2
C(13)-H 6.45 6.42 112.3 1 1 0 . 2 -0.03 - 2 . 1
C(15) 130.8 130.0 - 0 . 8
C( 16)-H /C(20)-H 7.69 7.96 125.4 129.9 +0.30 +4.5
C( 17)-H/C( 19)-H 6.60 6.48 114.0 1 1 2 . 0 - 0 . 1 2 - 2 . 0
C(18) 153.2 151.5 -2 .3
n h 2 5.98 5.58 -0.40
c h 3 2 . 2 2 2.51 23.4 23.4 +0.29 - 0 . 0
en
C(l)/C(2) 2.48 2.73 45.3 40.9 +0.25 -4 .4
A8  (^complex) d(smz)
73
Chapter 4
The complex [Hg(sdz)2 (DMF)2 ] (25) displayed peaks for the sulfadiazine ligand only. 
Table 4.13: NMR and 13C NMR shift assignment of sulfadiazine and its Hg
Assignment ^(H sdzH ) *H(25) u C(HsdzH) 1JC(25) A6  (H)b A5 (C)b
N(11)-H 11.35
C (ll) 158.6 162.7 +4.1
C( 12)-H/C( 14)-H 8.50 8.48 157.5 158.8 - 0 . 0 2 +1.3
C(13)-H 7.00 6.98 115.9 114.7 - 0 . 0 2 - 1 . 2
C(15) 125.1 126.1 + 1 . 8
C( 16)-H /C(20)-H 7.75 7.78 130.3 130.6 +0.03 +0.3
C( 17)-H/C( 19)-H 6.58 6.56 1 1 2 . 6 112.4 - 0 . 0 2 - 0 . 2
C(18) 153.4 153.0 -0 .4
n h 2 6 . 0 0 5.92 +0.08
Relative to TMS with DMSO - ^ 6  peak as reference ( H, 2.60 ppm,
A 5  — S (co m p lex ) — S ( sd z)
C, 43.5 ppm).
The complex [Hg(smr)2 ] (26) showed the peaks for the sulfadiazine only.
Table 4.14: NMR and 13C NMR shift assignment of sulfamerazine and its Hg
Assignment ‘H(smrH) rH(26) 1 3C(smrH) 1JC(26) A5 (H)b A5 (C)b
N(11)-H 1 1 . 2 0
C (ll) 164.3 168.4 +4.1
C(12) 157.5 161.4 +3.9
C(13)-H 6.62 6.63 1 1 2 . 1 1 1 2 . 2 +0 . 0 1 + 0 . 1
C(14)-H 8.37 8.37 156.8 158.3 0 . 0 0 +1.5
C(15) 130.1 130.8 +0.7
C( 16)-H /C(20)-H 7.69 7.84 124.9 126.2 +0.15 +1.3
C(17)-H/C(19)-H 6.95 6.92 114.7 114.1 -0.03 - 0 . 6
C(18) 152.9 152.9 0 . 0
n h 2 6.07 5.97 - 0 . 1 0
c h 3 2.41 2.39 23.3 23.6 - 0 . 0 2 +0.3
A 8  S (co m p lex ) b (s m r)
The and 13C NMR spectra o f [Hg(smr)2 (bpy)] (27) are comparable to those observed for 
the complex [Cd(sdz)2 (bpy)] (18).
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Table 4.15: *H NMR and 13C NMR shift assignment of sulfamerazine and its Hg
complex [Hg(smr)2 (bpy)] @7) in DMSO-gfc*
Assignment 'HCsmrH) iH(27) ljC(smrH) 13C(27) AS (H)b AS (C)b
N(11)-H 1 1 . 2 0
C (ll) 164.3 167.9 +3.6
C(12) 157.5 159.9 +2.4
C(13)-H 6.62 6.57 1 1 2 . 1 1 1 1 . 8 -0.05 -0.3
C(14)-H 8.37 8 . 2 2 156.8 157.7 -0.15 +0.9
C(15) 130.1 130.1 0 . 0
C( 16)-H /C(20)-H 7.69 7.77 124.9 126.7 +0.08 + 1 . 8
C(17)-H/C(19)-H 6.95 6.87 114.7 113.5 -0.08 - 1 . 2
C(18) 152.9 152.8 - 0 . 1
n h 2 6.07 5.90 -0.17
c h 3 2.41 2.36 23.3 23.2 -0.05 - 0 . 1
‘HCbpy) UC(bpy)
C (l)-H 8.70 8.81 149.2 149.8 + 0 . 1 1 + 0 . 6
C(2)-H 7.45 7.77 120.4 1 2 1 . 2 +0.32 +0 . 8
C(3)-H 7.95 8.03 124.0 124.9 +0.08 +0.9
C(4)-H 8.40 8.47 137.1 138.4 +0.07 +1.3
C(5) 152.2 152.2 0 . 0
a Relative to TMS wit i  DMSO-cfo peak as reJbrence (‘H, 2.60 ppm, 1 3C, 43.5 ppm).
AS S ( Com plex) 5 (s m r)
The complex [Hg(smz)2 (DMF)2 ] (28) exhibited peaks for the sulfamethazine ligand only.
Table 4.16: NMR and 13C NMR shift assignment of sulfamethazine and its
mercuryf complex (2£\) in DMSO-rf6a
Assignment ‘HCsmzH) [H(28) 1 3C(smzH) 1JC(28) A6  (H)b AS (C)b
N(11)-H 1 1 . 2 0
C (ll) 165.6 167.9 +2.3
C(12)/C(14) 157.0 159.6 +2 . 6
C(13)-H 6.45 6.57 112.3 113.1 +0 . 1 2 +0 . 8
C(15) 130.8 131.0 -0.3
C( 16)-H /C(20)-H 7.69 7.80 125.4 126.3 + 0 . 1 1 +0.9
C( 17)-H/C( 19)-H 6.60 6.69 114.0 1 1 2 . 0 -0 .09 - 2 . 0
C(18) 153.2 152.8 -0 .4
n h 2 5.98 5.90 -0.08
c h 3 2 . 2 2 2.51 23.4 23.5 +0.29 + 0 . 1
a Relative to TMS with DMSO-cfc peak as reference ( H, 2.60 ppm, C, 43.5 ppm).
A S  — 5 ( Com plex ) — 8 (s m z )
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4.4 Structure of sulfadiazine (1) and sulfamerazine (2)
We solved the crystal structure for sulfadiazine with a lower .R-factor and synthesized a 
new polymorph for sulfamerazine. These were characterized by X-ray diffraction methods. 
The crystal data and refinement details for sulfadiazine (1) and sulfamerazine (2) are 
summarized in Table 4.17.
Table 4.17: Crystal data and details of data collection and structure refinement for 
sulfadiazine (1) and sulfamerazine (2)
Sulfadiazine (1) Sulfamerazine (2)
Empirical formula C,oH1 0N 4 0 2 S C 1 1H,2N4 0 2S
Formula weight 250.28 264.31
Temperature (K) 150(2) 150(2)
Wavelength (A) 0.71073 0.71073
Crystal system Monoclinic Monoclinic
Space group P 2\/c P 2\!c
a (A) 13.6881(6) 11.0966(5)
* (A ) 5.8485(3) 8.3152(5)
c (  A) 14.8657(8) 13.9640(7)
P O 114.946(2) 99.327(4)
K(A“3) 1079.04(9) 1271.43 (11)
Z 4 4
Calculated density (Mg/m3) 1.541 1.381
Absorption coefficient (mm ) 0.295 0.255
F(0 0 0 ) 520 552
Crystal size/mm 0 .1 5 x 0 .1 2 x 0 .1 0 0 .2 2 x 0 .20x0 .18
#-Range for data collection (°) 3.28 -2 7 .5 0 2.96 -  27.47
Reflections collected 7910 11168
Unique reflections 2444 2872
R'mi 0.0617 0.0910
Index ranges —17<=h<=15 —1 1 <=h< = 1 1
-7  <=k<=7 —15 <=k<=15
—19<=1<= 19 - 2 0 <=1 < = 2 0
Max. and min. transmission 0.9711 and 0.9570 0.9556 and 0.9461
Goodness-of-fit on F1 1.078 1.043
Data / parameters in the refinement 2444/162 2872/176
Final R indices [( />  2 o(I)\ 0.0446/0.1115 0.0522/0.1160
R indices (all data) 0.0554/0.1182 0.0778/0.1288
Largest diff. peak and hole (e.A~3) 0.414 and -0.616 0.290 and -0.549
The numbering scheme and the geometry o f the sulfadiazine (1) and sulfamerazine (2) 
molecules are shown in Figures 4.8 and 4.9 together with the crystallographic atom 
numbering scheme used. The bond lengths and angles of the compounds are listed in Table 
4.18.
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Table 4.18: Selected bond lengths [A] and angles [°] in (1) and (2)
Bond (1) (A) (2) (A) Angle (1) (°) (2) (°)
S (ll)-0 (1 1 ) 1.429(2) 1.429(2) 0(11 )-S(l 1)-0(12) 119.26(9) 119.2(1)
S(11)-0(12) 1.437(2) 1.440(2) 0(11 )-S(l 1 )-N(l 1) 1 1 0 .0 1 (8 ) 109.0(1)
S(11)-N(11) 1.650(2) 1.654(2) 0(12)-S(11)-N(11) 1 0 1 .6 8 (8 ) 102.3(1)
S(11 )-C(l 5) 1.740(2) 1.733(2) 0(11 )-S(l 1 )-C(l 5) 108.82(9) 109.5(1)
N(1 1 )-C(1 1 ) 1.386(2) 1.389(3) 0(12)-S(11)-C(15) 109.82(9) 109.2(1)
N(12)-C(12) 1.340(2) 1.345(2) N(11)-S(11)-C(15) 106.42(9) 106.7(1)
N(12)-C(l 1) 1.344(2) 1.327(2) C(11)-N(11)-S(11) 125.90(13) 126.1(2)
N(13)-C(l 1) 1.334(2) 1.337(2) C(12)-N(12)-C(l 1) 115.93(16) 116.1(2)
N(13)-C(14) 1.342(3) 1.336(3) C(11)-N(13)-C(14) 115.06(17) 114.6(2)
N(14)-C(18) 1.384(2) 1.367(3) N(13)-C(l 1)-N(12) 126.86(17) 127.5(2)
The bond lengths and angles are comparable with those found in the previously reported 
structures. The shortening of the C(18)-N(14), S(11)—C(15) and S(11)-N (11) bond lengths 
from the expected single bond distances have been attributed to d n -p n  interactions. The 
C(18)-N(14) bond distances o f 1.384(2)A for ( 1 ) and 1.367(3)A for (2 ) are comparable 
with the values o f [1.43(3)A ] 4  and [1.386(8)A]5 in sulfadiazine, [1.363(12)A]6, 
[1.357(7)A ] 7 and [1.354(7)A ] 7 in sulfamerazine and [1.367(3)A]8 and [1.36(1 )A]9 in 
sulfamethazine molecules which are shorter than the value o f [1.470(5)A ]10 for the length 
of a C(sp2)-N (sp2) single bond.
0 1 2
N12N11
C20
S11 C12C19 C11
C15
,C13
011
N13C18 C16N14
C14
Figure 4.8
X-ray structure o f  sulfadiazine (1) showing crystallographic atom numbering scheme used. 
Thermal ellipsoids are drawn at 50% probability level.
The S(1 1 )—C ( 1 5) bond distances of 1.740(2)A for ( 1 ) and 1.733(2)A for (2 ) are comparable 
with the values of [1.74(2)A]4 and [1.736(5)A]5 in sulfadiazine, [1.357(7)A]6, [1.732(4)A]7 
and [1.736(4)A]7 in sulfamerazine and [1.746(3)A]8 and [1.765(9)A]9 in sulfamethazine 
molecules and are in good agreement with the theoretical value of 1.75A calculated from
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the atomic radii and electronegativities11 and 1.750(18)A in /2-sulfanilamide12 and the 
S(1 1 )-N ( 1 1 ) bond distances of 1.650(2)A for (1) and 1.654(2)A for (2) are in agreement 
with the values o f other sulfa drugs reported in the literatures.4-9,13
The endocyclic angle at C ( ll)  o f 126.85(2)° for (1) and 127.5(2)° for (2) are comparable 
with the corresponding values in the other sulfa drugs and these are considerably larger 
than the value usually observed for a pyrimidine ring.
The planes o f the benzene and pyrimidine rings are inclined to each other at 74.63(20)° for 
(1) and 64.39(2)° for (2) which is compared to the values o f [770]1, [78.6(3)°]2 and [75.7° ] 13  
in sulfadiazine, [71(1)°]6, [61.5(5)°]7 and [58.5(5)°]7 in sulfamerazine and [83.0(3)°]8 and 
[78.16(6)°]9 in sulfamethazine. These indicate that the molecules adopt gauche 
conformation when viewed along the S-N  axis.
N13
0 1 1
C14
N11
.C20 C11
S11
C19
C15 C13
N12
012
C12
C16
C18
N14 C111C17
Figure 4.9
X-ray structure o f  the new polymorph o f  sulfamerazine (10) showing cryst alio graphic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level.
The S( 1 1 )-0  bond distances of 1.429(2) and 1.437(2)A for ( 1 ) and 1.429(2) and 1.440(2)A 
for (2 ) are also comparable with the corresponding values of other sulfa drugs reported in 
the literatures . 4 - 9
The tetrahedral geometry around the S ( ll)  atom is distorted and this is evident from the 
deviations in the values o f the bond angles around the S(11) atom from 109.5°.
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The crystal structure is stabilized by the network of hydrogen bonds and van der Waals’ 
forces. The interesting point here is to note that the sulfonamidic nitrogen atom is involved 
in hydrogen bonding with one o f the pyrimido nitrogen atoms of its symmetry generated 
molecules by -x + 1 , —y+ 1 , -z+ 1 in sulfadiazine (1 ) and -jc+ 1  , - y ,  - z  in sulfamerazine (2 ).
Two centrosymmetrically related molecules in the crystal form a dimer through a pair of 
hydrogen bonds N (11)-H (11)-N (12 ') and N(1 T )-H (l l ') -N (1 2 ) in (1) and N (11)-H (11)~ 
-N(13') and N(1 1')—N(13) in (2) as shown in Figures 4.10 and 4.11 respectively.
These hydrogen bonds are fairly strong as indicated by the dimensions of H(11)-N(12') or 
H(1 T)-N (12) = 2.108(3)A and ZN (11)-H (11)-N (12') or ZN(1 l ') -H (ll ') -N (1 2 )  = 
158.39(1)° for sulfadiazine (1) and H (ll)-N (1 3 ')  or H (ll')-N (1 3 ) = 1.964(4)A and 
ZN (11)-H (11)-N (13') or Z N (1 l')-H (l l')-N (13) = 174.46(4)° sulfamerazine (2) which 
indicates the linearity of the hydrogen bond.
.C 13
C 1 2C 1 4
N 1 2
N 1 3
C 1 1
011 N11
H11
C 1 6 S 1 1C 1 7
N 1 2 ‘C 1 5
C 1 8
0 1 2
C 2 0
C 1 9
Figure 4.10
X-ray structure o f  sulfadiazine molecules showing the formation o f  dimer through N (ll) -  
H(11) ...N (12) hydrogen bonds with the symmetry -x+1, -y+1, -z+1.
The present structure of sulfamerazine crystallises in the monoclinic crystal system with 
the space group o fP 2\/c , but two others were crystallised in the orthorhombic form . 3 , 4
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C18 C20
N14 C19
Figure 4.11
Two centrosymmetrically related molecules in the crystal form  a dimer through a pair o f  
hydrogen bonds with the symmetry -x+ 1, -y, -z .
The packing diagrams are shown in Figures 4.12 and 4.13 for sulfadiazine and 
sulfamerazine molecules respectively where the various hydrogen bonds and short contacts 
are shown by dashed lines.
Figure 4.12
The packing diagram o f  sulfadiazine (1) where hydrogen bonds are shown by dashed lines
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Table 4.19: Possible hydrogen bonds in sulfadiazine (1) and angles given in A and deg 
___________ respectively.__________________________________________________________
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N i l  -H ll N i l  ....N12 (1) H ll  ...N12 (1) N i l  -H ll  ...N12 (1)
0.860(2) 2.924(4) 2.108(3) 158.39(1)
N14 -H14A N14 ....012(2) H14A...012 (2) N14 -H14A...012 (2)
0.948(2) 2.975(3) 2.046(3) 166.23(1)
Equivalent positions:
( 1 ) -x + 1 , -y + 1 , - z + 1 ; (2 ) x, -y+V^+z+Vi
Figure 4.13
The packing diagram o f  sulfamerazine (2) molecule where hydrogen bonds are shown by 
dashed lines.
Table 4.20: Possible hydrogen bonds in sulfamerazine (2) (distances and angles
given in A  and deg respectively)
Donor-H Donor... Acceptor H...Acceptor Donor-H.....Acceptor
N il  -H ll N i l  ....N13 (1) H l l  ...N13 (1) N i l  -H ll ...N13 (1)
0.950(4) 2.911(4) 1.964(4) 174.46(4)
N14 -H14A N14 ....012 (2) H14A...012 (2) N14 -H14A...012 (2)
0.947(2) 2.985(1) 2 . 1 1 1 ( 1 ) 152.75(2)
N14 -H14B N 14....011 (3) H14B...011 (3) N14 -H 14B...011 (3)
0.946(1) 3.091(1) 2.241(1) 149.01(4)
Equivalent positions: (1) -x+1, -y, -z; (2) x, +y-l, +z; (3) x, -y-Vi, +z+ 1/ 2
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4.5 Cobalt complex {[Co(smz)2(H20)].DMF}„ (3)
This is a new polymeric cobalt complex o f sulfamethazine and has been characterised by 
analytical and spectroscopic data as well as by single crystal X-ray diffraction methods. 
The crystal data and refinement details for the complex (3) are summarized in Table 4.21.
Table 4.21: Crystal data and details of data collection and structure refinement for
{ICo(smz)2(H20)].DM F}#l (3)
(3)
Empirical formula C2 7 H 3 5 C 0 N 9 O6 S2
Formula weight 704.69
Crystal system Monoclinic
Space group P2\/c
a (A) 16.4001(4)
b (A) 14.6508(3)
c(A ) 13.1430(3)
P O 100.8292(10)
V(Ai) 3101.69(12)
z 4
Crystal size/mm 0 .1 8 x 0 .1 5 x 0 .1 2
#-Range for data collection (°) 3 .0 5 -2 7 .4 7
Reflections collected 28696
Unique reflections 7084
^int 0.0989
Index ranges —18<=h<=21 
—19<=k<=18 
—17<=1<=16
Data/parameters 7084/428
Final R indices [(/>  2o(I)] 0.0506/0.1060
R indices for all data 0.0857/0.1219
Largest diff. peak and hole (e.A-3) 0.437 an d -0 .5 4 5
The asymmetric unit o f the crystal structure o f the complex {[Co(smz)2 (H2 0 )].DMF}„ (3) 
is shown in Figure 4.14 together with the crystallographic atom numbering scheme used. 
The polymeric form and the packing diagram of the complex is shown in Figures 4.15 and 
4.16 respectively. The selected bond lengths and angles are given in Table 4.22 and the 
possible hydrogen bond dimensions are given in Table 4.23.
The complex [Co(smz)2 (H2 0 )].DMF (3) consists o f an independent polymeric crystal 
structure o f {[Co(smz)2 (H2 0 )].DMF}„ held together in the crystal by very strong hydrogen 
bonds and van der Waals’ interactions. The cobalt ion in the complex exhibits a distorted
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octahedral geometry, being coordinated to the sulfonamidic [N (ll)  and N (2 1 )] and 
pyrimido [N(12) and N(22)] nitrogen atoms o f two bidentate sulfamethazine ligands 
generating four-membered rings. The nitrogen [N(24)] atom from the terminal amino 
group of a third sulfamethazine, which is bonded to the adjacent Co(II) ion, and the 0 (1) 
atom of water molecule complete the coordination sphere. The N(14)-C(18) bond distance 
of 1.385(4)A is shorter than the N(24)-C(28) bond distance with the value of 1.428(4)A 
which is comparable with the corresponding value o f 1.413(9)A in the polymeric complex 
{[Cd(smz)2 (H2 0 )].2 H2 0 } „ 1 and is longer than the corresponding distances in the free 
ligand [1.384(6)A], which is consistent with the coordination of the terminal amino group 
[N(24)J to the adjacent Co(II) ion. The bond lengths and angles of the phenyl rings 
conform well to those found in the free sulfamethazine . 9 , 1 0
cm
C13 C27 C28C12 N24C112 C26C14
022
N13 C29
0 1 1 N12 S21 C25 C30C11
Co1 N21S11
C20 N11C15 C21 021
C19 N22 *& r
® r-,^ C2 2
C211
N23
01
C16
C24C18 C23C17 C212N14
Figure 4.14
X-ray structure o f  the complex [Co(smz)2(H20)].DMF (3) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms and DM F molecule are omitted fo r  clarity.
The packing of the complex units is governed by the long chains formed by the bridging 
ligands which are bound to Co(II) via N(24) nitrogen atom of the amino group [N(24)-Co 
= 2.225(2)A]
In the complex units, the intramolecular hydrogen bonds exist between the amino (-N H 2 ) 
groups and the sulfonyl oxygen atoms o f different ligands, and between the sulfonyl 
oxygen atoms and the coordinated water molecule and DMF molecule.
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Table 4.22: Selected bond lengths [A] and angles [°1 in {[Co(smz)2(H2Q)1.DMF}/l
Bond (A) Bond (A )
C o (l)-0 (l) 2 .1 1 2 (2 ) Co(l)-N (l 1) 2.142(2)
Co(l)-N(21) 2.147(2) Co(l)-N(12) 2.187(2)
Co(l)-N(22) 2 .2 0 0 (2 ) Co(l)-N(24)#l 2.225(2)
S(11 )-0 (l 2) 1.447(2) S (ll)-0 (1 1 ) 1.451(2)
S(11)-N(11) 1.595(2) S(11 )-C(l 5) 1.757(3)
S(21)-0(22) 1.446(2) S(21)-0(21) 1.457(2)
S(21)-N(21) 1.590(2) S(21)-C(25) 1.764(3)
N (1 1 )-C(1 1 ) 1.380(4) N(14)-C(18) 1.385(4)
N(21)-C(21) 1.374(3) N(24)-C(28) 1.428(4)
Angle (°) Angle (°)
0 (l)-C o(l)-N (l 1) 93.36(8) 0(l)-C o(l)-N (21) 87.51(8)
N(1 l)-Co(l)-N(21) 179.10(9) 0(l)-C o(l)-N (12) 87.34(8)
N(1 l)-Co(l)-N(12) 61.72(8) N(21)-Co(l)-N(12) 118.57(9)
0(l)-C o(l)-N (22) 145.01(8) N(1 l)-Co(l)-N(22) 117.88(9)
N (21 )-Co( 1 )-N(22) 61.35(8) N(12)-Co(l)-N(22) 93.79(8)
0(1 )-Co( 1 )-N(24)# 1 103.79(8) N(1 l)-Co(l)-N (24)#l 90.70(9)
N (21 )-Co(l )-N(24)#l 88.88(9) N(12)-Co(l)-N(24)#l 151.10(9)
N(22)-Co(l)-N(24)#l 91.89(8) 0(12)-S(11)-0(11) 114.84(12)
0 (1 2)-S(l 1)-N(11) 113.57(12) 0 (1 1)-S(11)-N(11) 105.66(12)
0(12)-S(11 )-C(l 5) 107.61(13) 0 (1 1)-S(11)-C(15) 108.17(13)
N (ll)-S (ll)-C (15 ) 106.60(13) 0(22)-S(21)-0(21) 115.20(12)
0(22)-S(21)-N(21) 113.96(12) 0(21)-S(21)-N(21) 104.90(12)
0(22)-S(21 )-C(25) 108.05(13) 0(21)-S(21)-C(25) 106.76(12)
N(21)-S(21)-C(25) 107.52(12) C(28)-N(24)-Co( 1 )#2 115.05(16)
N(13)-C(l 1)-N(12) 127.0(3) N(23)-C(21 )-N(22) 126.6(2)
Symmetry transformations used to generate equivalent atoms: # 1  -x , y+14, -z+Vr, #2 -x ,
y-Vz, -z+ lA
Figure 4.15
Structure o f  [Co(smz)2(H20)].DMF (3) in the polymeric form  where cobalt ion is bonded 
to the terminal N(24) atom o f  the adjacent cobalt ion.
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The ligands are chelated to cobalt atoms symmetrically in the octahedral structure. The 
C o -N (ll)  and Co-N(21) bond distances o f 2.142(2) and 2.147(2)A respectively are 
comparable with those in the 2,2'-bipyrimidine cobalt(II) complex 
[Co(bipym)(H2 0 )2 ][(N 0 3 )2 ] [2.176(5) and 2.177(5)A], and [Co2 (bipym)3 (H2 0 )4 ][(N 0 3 )4 ] 
[2.140(2), 2.144(2) and 2.125(2)A] and [Co2 (bipym)3 (H2 0 )2 (S0 4 )2 ].1 2 H2 0  [2.155(2), 
2.146(2)A and 2.131(2)A] reported by Munno et a l}5 and C o-O (l) distance o f 2 .1 1 2 (2 )A 
is longer than the value o f 2.053(5) and 2.046(5)A in [Co(bipym)(H 2 0 )2 ][(N 0 3 )2 ], 2.049(2) 
and 2.068(2)A in Co2 (bipym)3 (H2 0 )4 ][(N 0 3 )4 ] and 2.093(2) and 2.031(2)A in 
[Co2 (bipym)3 (H2 0 )2 (S0 4 )2 ].1 2 H 2 0  due to the formation of polymer. Co-N(12) and 
C o-N (2 2 ) distances o f 2.187(2) and 2.200(2)A respectively are also comparable with the 
values of 2.173(3) -  2.197A in the polymeric cobalt complex
{[Co(CioH8N 2 )(H2 0 )4 ](C 8 H4 0 4 )-2 H2 0 }„16. The C o-N (l 1)/N(21) bond distance is shorter 
than the Co-N(12)/N(22) bond in the complex.
Figure 4.16
Packing diagram o f  the complex [Co(smz)2(H20)].DMF (3) where the hydrogen bonds are 
shown by dashed lines
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In this polymeric complex there are several hydrogen bonds which are shown by dashed 
lines between the acceptors and hydrogen atoms in the packing diagram (Figure 4.16) and 
the hydrogen bonds are listed in Table 4.23.
Table 4.23: The hydrogen bonds in [Cu(smz)2(H20)].DMF (3) (distances and angles
given in A and (°) respectively)
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
O l -H1A O l . . . . 0 2  (0 ) H 1A ...02  (0) O l -H 1A ...02  (0)
0.971(2) 2.769(2) 1.842(4) 158.68(1)
Ol -H1B O l . . . . 0 2 1  (0 ) H1B ...021 (0) O l -H1B ...021 (0)
0.886(5) 2.748(8) 1.925(6) 154.01(4)
N14 -H14A N14 ....012(1) H14A...012 (1) N14 -H14A...012 (1)
0.949(7) 3.057(8) 2.128(7) 166.05(4)
N14 -H14B N14 ....012 (2) H14B...012 (2) N14 -H14B...012 (2)
0.949(8) 2.966(2) 2.263(4) 130.19(2)
N24 -H24A N 24....011 (3) H 24A ...011 (3) N24 -H 24A ...011 (3)
0.948(8) 2.922(9) 2.009(9) 161.08(4)
N24 -H24B N24 ....022 (4) H24B...022 (4) N24 -H24B...022 (4)
0.948(4) 3.001(2) 2.117(9) 154.57(2)
Equivalent positions:
(0) x, y, z; (1) x,-y+/4+l, +z+!/2; (2) -x+E+y+V^-z+l^; (3) -x,+y-l/2 ,-z+l/ 2; (4) x^y+V^+z+’/a
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4.6 Nickel complexes of triple sulfa drugs
The nickel complexes [Ni(en)3 ][(sdz)2 ].H 2 0  (4) and [Ni(smr)2 (py)2 ].4 py (5) are new 
compounds. The crystal data, details of data collection and structure refinement for 
complexes [Ni(en)3 ][(sdz)2 ].H2 0  (4) and [Ni(smr)2 (py)2 ].4 py (5) are given in Table 4.24.
Table 4.24: Crystal data and details of data collection and structure refinement for
complexes [Ni(en)3l|(sdz)2].H20 (4) and [Ni(smr)2(py)21.4py (5)
(4) (5)
Em pirical Form ula C26H44N14N i05S 2 C 52H52N14N i04S 2
Form ula W eight 755.58 1059.91
Crystal System O rthorhom bic T riclinic
Space Group Pbcn P \
a(A) 7.7894(1) 9.9781(2)
6 (A) 15.8762(3) 10.0610(2)
c( A) 27.7420(5) 13.2582(4)
O 90 89.7440(8)
PC) 90 82.2380(8)
X°) 90 84.1440(13)
V/As 3430.74(10) 1311.85(5)
z 4 1
77K 150 (2) 150 (2)
Crystal S ize/m m 0 .1 5 x 0 .1 2 x 0 .1 2 0 .1 8 x 0 .1 6 x 0 .1 6
Shape B lock B lock
Colour Pink Pink
G range for data co llection 2 .9 1 -2 7 .4 8 3.03 -2 7 .4 8
R eflection  C ollected 19897 24079
U nique R eflection s 3931 5955
■^ int 0.0711 0.1594
Index ranges -6 < = h < = 1 0 —12 < = h < = 12
-2 0 < = k < = 2 0 —13<=k<=13
-35<=1<=35 -17<=1<=17
Data/param eters 3931/219 5955/340
Final R ind ices (all data) 0.0416/0.0955 0.0530/0.1299
R indices |7>2 o (/)] 0.0677/0.1063 0.0746/0.1407
Largest diff. peak and h o le  (e. A-3) 0.526 and -0.518 0.514 a n d -1.108
4.6.1 Nickel complex of sulfadiazine [Ni(en)3][(sdz)2].H20 (4)
The crystal structure o f the complex [Ni(en)3 ][(sdz)2 ].H 2 0  (4) is shown in Figure 4.17 
together with the crystallographic atom numbering scheme used. The bond lengths and 
angles are given in Table 4.25. The complex consists o f discrete molecules of [Ni(en)3 ]2+ 
cation, [sdz]~ anion and the lattice water molecule in the ratio o f 1 :2 :1 , held together by 
hydrogen bonds and van der Waals’ interactions. In the cation the Ni(II) ion is N,N'~
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chelated by three neutral ethylenediamine molecules, it lies in a three fold axis and has a 
slightly distorted octahedral geometry being coordinated by six nitrogen atoms from three 
ethylenediamine molecules.
The three ethylenediamine molecules in the [Ni(en)3 ]2+ cation are oriented around the Ni 
atom in a (lel) 3  conformation thus the cation exists either in A(T2Jl) or A(SSS) form.
The average atom distance between the two N-atoms o f the ethylenediamine molecule is 
2.79A and the average bond angle is 82.15°. These values are in good agreement with those
1 7—9Treported previously.
In this complex, the [Ni(en)3 ]2+ cation has an octahedral geometry around the Ni(II) atom 
with three bidentate ethylenediamine molecules. The sulfadiazinato anions remain in the 
ionic form in the structure and these are joined with lattice water through the hydrogen 
bonding of 0(11).. .0(1)-H (1E) (lattice water).
0 1
C17
£16
0 1 1
N14 C18 SC15
C20 S11 '012
N11
N12 IC11
N13C12
C13 C14
cr ci
N1
.Nil
N2 N2'
N3N3'
Figure 4.17
X-ray structure o f  the complex [Ni(en)3] [(sdz)2] .H2 O (4). Thermal ellipsoids are drawn at 
50% probability level. The hydrogen atoms are omitted fo r  clarity. The hydrogen bonds 
between water molecule and sulfadiazinato anions are shown by dashed lines.
The octahedral geometry around Ni atom is distorted showing only minor variations from 
ideal geometry o f the mutually cis 90° and trans 180° angles. This is evident from the 
values of the trans angles range between 170.94(10) and 174.40(7)° and also from the cis 
angles which vary from 82.15(11) to 94.30(8)°.
Chapter 4
The Ni-N(en) distances of the complex are N i-N (l) = 2.123(2), N i-N (2) = 2.117(2) and 
N i-N (3 ) = 2.128(2)A are comparable with the corresponding bonds o f the values of 
2.121(6) -  2.139(1 )A  in the complex [Ni(en)3 ][N(N0 2 )2 ]2 2 4  and 2.099(3) -  2.135(2)A in 
the complex tris(ethylenediamine-A^,7V’)nickel(II) tetrathiomolybdate [Ni(en)3 ][MoS4 ]2 2 5  
and 2.113(4) -  2.150(5)A in [Ni(en)3 ][L ] 2 6  (L = 2,4-bis(4-methoxyphenyl)-l,3,2,4- 
dithiadiphosphetane-2,4-disulfide).
Table 4.25: Selected bond lengths [A] and angles [degj in [Ni(en)3 ][(sdz)2 ].H2Q (4)
Bond (A) Bond (A)
Ni(l)-N(2) 2.117(2) N i(l)-N (l) 2.123(2)
Ni(l)-N(3) 2.128(2) S(11)-0(12) 1.448(2)
S (ll)-0 (11) 1.461(2) S(11)-N(11) 1.575(2)
S(11)-C(15) 1.766(2) N(11)-C(11) 1.371(3)
N(12)-C(12) 1.331(3) N(12)-C(l 1) 1.351(3)
N(13)-C(14) 1.337(3) N(13)-C(l 1) 1.348(3)
N(14)-C(18) 1.375(3)
Angle (°) Angle o
N(2')-Ni(l)-N(2) 170.94(10) N (2')-N i(l)-N (l) 91.30(6)
N (2)-N i(l)-N(l) 82.25(6) N (l')-N i(l)-N (l) 89.55(10)
N(2)-Ni(l)-N(3') 93.24(7) N (l)-N i(l)-N (3 ') 94.30(8)
N(2')-Ni(l)~N(3) 93.24(7) N(2)-Ni(l)-N(3) 93.58(7)
N(T)-Ni(l)-N(3) 94.30(8) N (l)-N i(l)-N (3) 174.40(7)
N(3')-Ni(l)-N(3) 82.15(11) 0(12)-S(11)-0(11) 113.51(9)
0(12)-S(1 l) -N (ll) 115.37(10) 0 (1 1)-S(11)-N(11) 104.33(10)
0(12)-S(H)-C(15) 107.17(10) 0 (1 1)-S(11)-C(15) 106.75(10)
N(11)-S(H)-C(15) 109.38(10) C(11)-N(11)-S(11) 121.79(15)
N(13)-C(H)-N(12) 124.6(2) N(13)-C(l 1)-N(11) 122.25(19)
Symmetry transformations used to generate equivalent atoms: (') -x , y, -z+'A
It can be seen that in the [Ni(en)3] ion, four N-atoms exist in the equatorial position 
forming a parallelogram and two other N-atoms occupying the axial sites.
N V
Figure 4.18
Octahedral structure o f  the cation [Ni(en)^]2+ in the complex (4)
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The several hydrogen bonds are shown in Table 4.26 and the intermolecular hydrogen 
bondings are shown by open bonds in the packing diagram (Figure 4.19). The hydrogen 
bonds are very strong with short donor-acceptor distances and the linearity of the angles.
Table 4.26: Possible hydrogen bonds in [Ni(en)3(sdz)2]*H20 (4) (distances and angles
given in A and deg respectively)
Donor-H Donor... Acceptor H... Acceptor Donor-H.....Acceptor
01 -HIE 
0.948(12)
O l ....011(0) 
2.723(1)
H IE  ...O il (0) 
1.781(2)
O l -H IE ...O il (0) 
172.25(5)
N14 -H14A 
0.948(3)
N14 ....N12 (1) 
3.238(4)
H14A...N12 (1) 
2.455(4)
N14 -H14A...N12 (1) 
139.88(1)
NI -H1A 
0.920(2)
N I ....012(2) 
3.066(3)
H1A ...012 (2) 
2.268(2)
N I -H1A ...012 (2) 
144.78(4)
N3 -H3B 
0.920(2)
N3 ....N13 (3) 
3.101(3)
H3B ...N13 (3) 
2.279(2)
N3 -H3B ...N13 (3) 
148.58(3)
NI -H1B 
0.920(2)
NI ....011(3) 
3.210(3)
H 1B ...011 (3) 
2.333(2)
N I -H 1B ...011 (3) 
159.14(1)
N2 -H2B 
0.920(1)
N2 ....N il (3) 
3.250(1)
H2B ...N il (3) 
2.362(5)
N2 -H2B ...N il (3) 
162.35(2)
N2 -H2A 
0.920(1)
N2 ....012(4) 
3.130(7)
H2A ...012 (4) 
2.315(3)
N2 -H2A ...012 (4) 
147.58(2)
N3 -H3A 
0.920(1)
N3 ....Ol (5) 
2.986(.004)
H 3A ...01 (5) 
2.125(3)
N3 -H 3A ...01 (5) 
155.35(2)
N3 -H3A 
0.920(1)
N3 ....Ol (6 ) 
2.986(4)
H 3A ...01 (6 ) 
2.125(3)
N3 -H 3A ...01 (6 ) 
155.35(2)
Equivalent positions:
(0) x, y, z; (1) x+!/2 ,-y+!/2 ,-z; (2) x-1/ 2 ,+y+1/ 2 ,-z+1/2; (3) -x-V^+y+^+z; (4) x,+y+l,+z; (5) - 
x,+y+l,-z+!/2; (6 ) x+1/2, +y-lA, -z+Yz
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Figure 4.19
Packing diagram o f  the complex [Ni(en)s][(sdz)2].H 2 0  (4)  showing the hydrogen bonds by 
open line between the atoms.
4.6.2 Nickel complex of sulfamerazine [Ni(smr)2(py)2].4py (5)
The structure o f the complex [Ni(smr)2(py)2].4py (5) is shown in Figure 4.20 together with 
the crystallographic atom numbering scheme used. The numbering o f atoms with prime (') 
indicates that these atoms are generated from the original atoms by an inversion centre. 
Selected bond lengths and angles are given in Tables 4.27 and the possible hydrogen bond 
dimensions and short contacts are listed in Table 4.28.
The nickel atom in the complex (5) sits on a centre o f symmetry, and is a distorted 
octahedral structure with two bidentate ^-coordinated sulfamerazinato anions and two 
pyridine molecules in trans positions making up the coordination sphere and the lattice 
four pyridine molecules are hydrogen bonded with the terminal amino (-N H 2 ) group of the 
sulfamerazine molecules. The sulfamerazine molecule coordinates to Ni(II) as a mono­
negative bidentate ligand with pyrimido nitrogen and sulfonamidic nitrogen atoms.
The relative orientations o f the sulfamerazine and the pyridine molecules are such that they 
are nearly perpendicular to each other. Such orientations o f the ligands around the nickel 
atom appear to be dictated more by steric considerations than any other factors.
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Figure 4.20
X-ray structure o f  the complex [Ni(smr)2 (py)2]-4 py (5) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms are omitted fo r  clarity. The hydrogen bonds are shown by dashed lines.
Bond (A) Bond (A)
N i(l)-N (l) 2.080(2) N i(l)-N(12) 2.100(2)
N i(l)-N (l 1) 2.139(2) S(11)-0(12) 1.443(2)
S (ll)-0 (11 ) 1.445(2) S ( ll) -N ( ll) 1.614(2)
S(ll)-C(15) 1.760(2) N(11)-C(11) 1.358(3)
N(14)-C(18) 1.367(3)
Angle (°) Angle (°)
N (T)-N i(l)-N (l) 180.00(11) N(T)-Ni(l)-N(12) 92.00(7)
N (l)-N i(l)-N(12) 88.00(7) N(12')-Ni(l)-N(12) 180.0(9)
N (l)-N i(l)-N (l 1') 90.37(7) N (l)-N i(l)-N (l 1) 89.63(7)
N (12 ')-N i(l)-N (ll) 116.66(7) N(12)-Ni(l)-N(l 1) 63.34(7)
N (1T )-N i(l)-N (ll) 180.00(10) 0(12)-S(11)-0(11) 116.68(10)
0(12)-S(11)-N(11) 104.93(10) 0 (1 1)-S(11)-N(11) 111.74(10)
0(12)-S(11)-C(15) 108.80(10) 0 (1 1)-S(11 )-C(l 5) 107.20(10)
N(11)-S(11)-C(15) 107.11(10) C(12)-N(l 1)-C(13) 125.2(2)
Symmetry transformations used to generate equivalent atoms: -x , -y , - z
The unique N i-N  bond distances, in the present complex involving the sulfonamidic 
nitrogen [N(l 1)], pyrimido nitrogen [N (l2)] atoms and the pyridine molecules [N (l)] of 
2.139(2), 2.100(2) and 2.080(2)A respectively, are comparable with the corresponding N i- 
N distances with the values of 2.117(2), 2.123(2) and 2.128(2)A in the previous complex 
[Ni(en)3 ][(sdz)2 ].H2 0  (4), 2.129(4)A in [Ni(L)2 (py)2 ].2 H2 0  (where, L = 4,5-diazofluorene- 
9-one quinaldinoylhydrazone and py = pyridine)27 and 2.127(3)A in [Ni(i-pr2 dtp)2 (py)2 ] 
(where dtp = dithiophosphate and pr = isopropyl)28 which are also consistent with the value 
of 2.11(1)A in [Ni(Et2dtp)2(py)2]29, 2.116(4)A in [Ni(Bu2dtp)2(py)2]30 and 2.100(5) -
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2.123(5)A in the complex [Ni(L)(py)2]31 (L = 6-phenyl-15-aza-6-phospha-3,9- 
dithiabicy clo [9,3,1 Jpentadeca-1 (15), 11,13-triene).
The S ( ll)  atoms are sp3 hybridised and this is distorted as in the case of sulfamerazine 
molecule. The endocyclic angle at C ( ll)  of pyrimidine ring of sulfamerazine in the 
complex is 125.2(2)° which is decreased compared to the corresponding angle in pure 
sulfamerazine 127.5(2)° due to the formation of bonds of sulfonamidic and pyrimido 
nitrogen atom with the nickel atom.
In the packing diagram (Figure 4.21), the several hydrogen bonds and short contacts are 
shown by dashed lines.
Figure 4.21
Packing diagram o f  the complex (5) showing the hydrogen bonds with dashed lines
Table 4.28: Possible hydrogen bonds and short interactions for [Ni(smr)2(py)2l.4py (5)
Donor-H Donor...Acceptor H...Acceptor Donor-H... Acceptor
N14 -H14A N14 ....NIB (0) H14A...N1B (0) N14 -H14A...N1B (0)
0.949(3) 3.065(3) 2.135(3) 166.25(4)
N14 -H14B N14 ....N1A(0) H14B...N1 A (0) N14 -H14B...N1A (0)
0.947(4) 3.029(5) 2.094(4) 168.91(3)
C2 -H2 C2 ....O il (1) H2 ...O il (1) C2 -H2 ...O il (1)
0.950(4) 3.108(4) 2.414(2) 129.72(4)
C3B -H3B C3B ....O il (2) H3B ...O il (2) C3B -H 3B ...011 (2)
0.950(4) 3.284(5) 2.340(2) 172.42(4)
Equivalent positions: (0) x, y, z; (1) -x+1, -y, -z; (2) -x+1, -y+1, -z-1
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4.7 Copper complexes of triple sulfa drugs
In this section, we will discuss the copper complexes of four coordinate with square planar 
geometry [Cu(en)2 ][(sdz)2 ] (6), five coordinate with square pyramidal containing a metal - 
metal bond [Cu2(smr)4].2DMF (10) and [Cu2(smr)4].2DMSO (11) and six coordinate with 
octahedral [Cu(dien)(sdz)2] (7), [Cu(en)2(H20)2][(smr)2] (8), [Cu(en)2(H20)2][(smr)2]2.H20
(9), [Cu(smz)2 (apen)].3 H2 0 .CH3 0 H (12) and {[Cu(smz)2(NH3)].2H20}„ (13) around the 
copper centres. The crystal data for the complexes are listed in Table 4.29.
4.7.1 Crystal Structure of [Cu(en)2] [(sdz)2] (6)
The crystal structure o f the complex (6) is shown in Figure 4.23 together with the 
crystallographic atom numbering scheme used. Selected bond lengths and angles are given 
in Table 4.30 and the hydrogen bond dimensions are given in Table 4.31.
C2 012
Figure 4.23
X-ray structure o f  the complex [Cu(en)2][(sdz)2]  (6)  showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms are omitted fo r  clarity.
The X-ray structure o f the complex [Cu(en)2 ][(sdz)2] (6) shows the formation o f a “cation- 
anion pair” involving the [Cu(en)2] cation and [sdz] anions which are held together in 
the crystal by very strong intermolecular hydrogen bonds and van der W aals’ interactions.
The structure has a distorted square planar geometry around the Cu(II) atom with four 
nitrogen atoms from the two ethylenediamine molecules. The N -C u -N  trans angles 
N (l)-C u (l)-N (T ) and N (2)-C u(l)-N (2 ') are 180° and the cis angles have the values 
ranging from 84.87(12) to 95.13(12)° showing small variations from the ideal value of 90°.
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Table 4.29: Crystal data and details of data collection and structure refinement for [Cu(en)2 (sdz)2 ] (6), [Cu(dien)(sdz)2 j (7),
[Cu(en)2(H20)2][(smr)2] (8) and [Cu(en)2(H20)2][(smr)2]2.H20  (9), [Cu2(smr)4].2DMF (10), [Cu2(smr)4].2DMSO (11),
[Cu(smz)2(apen)].3H2O.CH3OH (12) and {[Cu(smz)2(NH3)].2H20}„ (13)
(6) (7) (8) (9) (10) (11) (12) (13)
Empirical Formula ' C24H34CUN12O4S2 C2gH44CuN]404S2 C26H42CuNi206S2 C26H44C11N12O7S2 C5oH5gCu2NjgOjoS4 C26H34CuNg06S4 C33H60CuN12O8S2 C24H33CuN90 6S2
Formula Weight 682.29 768.43 746.38 764.39 1326.46 746.39 880.59 671.25
Crystal System Monoclinic Monoclinic Triclinic Triclinic Orthorhombic Rhombohedral Monoclinic Monoclinic
Space Group P2x/c P2x/c P\ PI P2xln P2x/n P2xlc P2(l)/n
*(A ) 10.8610(5) 14.5950(3) 7.5224(2) 7.56470(10) 13.63740(10) 18.8480(8) 9.4530(10) 13.6802(4)
b( A) 10.6329(4) 7.8230(2) 8.1435(2) 15.0976(3) 32.7241(3) 18.8480(8) 12.3456(10) 13.8369(5)
c(A ) 12.5227(6) 15.9670(5) 14.7025(4) 16.0079(3) 13.78540(10) 8.9830(4) 34.7476(5) 15.8383(6)
a<°) 90 90 75.8094(9) 104.5786(13) 90 90 90 90
f t 0) 93.3022(17) 111.0650(12) 82.9174(9) 99.8549(11) 113.9274(4) 90 90.8372(4) 96.3389(11)
K°) 90 90 79.4520(9) 91.8427(9) 90 90 90 90
V/AJ 1443.77(11) 1701.23(8) 855.51(4) 1737.84(5) 5623.33(8) 3191.2(2) 4054.71(8) 2979.73(18)
z 4 2 1 2 4 4 4 4
T/K 150 150 150 150 150 150 150 150
Crystal Size/mm 0.15 x0.12 x0.12 0.12 xO.10 x0.08 0.18 x0.15 x0.12 0.12 x0.08 xO.08 0.20 x0.15 x0.06 0.50 x0.45 xO.42 0.15 x0.12 xO.10 0.20 x0.18 x0.18
Shape Block Block Block Block Prism Prism Block Prism
Colour Blue Blue Blue Blue Green Green Blue Green
Grange data collection 3.08-27 .47 2.94 - 27.52 3.01-27 .52 2 .98-27.51 2.97 -  27.50 3.06 -  27.45 2.94-27.71 2.94-27.58
Reflection Collected 9385 12097 14556 30508
Unique Reflections 3290 3882 3889 7900 12633 3387 9033 6811
Pint 0.0892 0.0609 0.1014 0.0812 0.0950 0.0698 0.0572 0.0571
Index ranges -14<=h<=13, —18<=h<=15 -9<=h<=9 -9<=h<=9 -1 6<=h<=17 -18<=h<=24 —12<=h<—11 —17<=h<=15
— 13<=k<=13 -9<=k<=8 - 10<=1<= 10 —19<=k<=19 -42<=k<=42 -1 6<=k<=24 -15<=k<=15 -16<=k<=17
-14<=1<=16 —20<—1<—18 -19<=k<=19 - 20<H<=20 - 17<=1<=14 -1 !<=!<= 11 -44<=1<=45 - 20<=1<=20
Data/parameters 3290/196 3882/231 3889/231 7900/480 12633 3387 9033 6811/383
Final R indices [I>2o(I)] 0.0547/0.1295 0.0436/0.0927 0.0393/0.0951 0.0437/0.1068 0.0504/0.1121 0.0565/0.1260 0.0479/0.1179 0.0605/0.1685
R indices (all data) 0.0808/0.1446 0.0721/0.1130 0.0479/0.1008 0.0679/0.1182 0.0856/0.1286 0.0849/0.1562 0.0706/0.1368 0.0842/0.1841
Largest diff. peak/hole (e .A -3) 0.779 and -0.491 0.366 and -0.615 0.336 and -0.669 0.413 and -0.653 1.424 and -0.721 0.583 and -0.457 0.546 and -0.871 1.674 and -0.535
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The bond lengths within the sulfadiazine and ethylenediamine are as expected. The Cu-N 
distances o f 2.005(3) and 2.013(3)A, involving the ethylenediamine molecules, are 
comparable with the corresponding values in the complex bis(ethylenediamine)copper(II) 
tetracyanonickelate [Cu(en)2 ][Ni(CN)4 ] [1.997(3) and 2.001(3)A]32, in diaqua-
bis(ethylenediamine)copper(II) sulfathiazolate [Cu(en)2 (H2 0 )2 ]-[(stz)2 ].2 H 2 0  [2.033(3) 
and 2.042(3)A]33, in diaqua-bis-(ethylenediamine)copper(II) ethylenediaminebicarboxylate 
[Cu(en)2 (H2 0 )2 ][(0 0 CNH-CH2 CH2NHC 0 0 )].2 H2 0  [1.996(2) and 2.022(3)A]34, in
diaqua-bis(ethylenedi-amine)copper(II) N-carboxy glycynate [Cu(en)2 (H2 0 )2 ] -
[(0 0 CCH2 NHC 0 0 )].H 2 0  [2.007(3) -  2.024(3)A]34, in bis(ethylenediamine)copper(II)- 
bis(O,0 '-diethyl dithiophosphate) [Cu(C2H8N 2)2]-q[(C4Hio0 2 PS2 )2 ] [2.016(2) and
2.019(2)A]35, in /r<3 «5 -Bis(ethylenediamine)bis(p-nitrobenzoxasulfamato)copper(II) 
[Cu(nbs)2 (en)2 ] [2.007(3) and 2.010(3)A]36 [where nbs is the p-nitrobenzoxasulfamate 
anion (C6 H 3 N 2 O5 S)'].
Table 4.30: Selected bond lengths [A] and angles [deg] in [Cu(en)2 l[(sdz)2 ] (3)
Bond (A) Bond (A)
Cu(l)-N (2) 2.005(3) C u (l)-N (l) 2.013(3)
S ( ll)-0 (1 2 ) 1.449(3) S ( ll) -0 (1 1 ) 1.458(2)
S(11)-N(11) 1.589(3) S (ll)-C (1 5 ) 1.765(3)
N (11)-C(11) 1.372(4) N(14)-C(18) 1.390(4)
Angle (°) Angle (°)
N(2')-Cu(l)-N(2) 180.0 N (2)-Cu(l)-N (l) 84.87(12)
N (2)-Cu(l)-N (l') 95.13(12) N (l)-C u(l)-N (T) 180.0
0(12)-S(11)-0(11) 113.36(15) 0(12)-S(11)-N(11) 115.92(15)
0 (1 1)-S(11)-N(11) 105.23(14) 0(12)-S(11 )-C(l 5) 107.32(15)
0 (1 1)-S(11)-C(15) 106.62(15) N(11)-S(11)-C(15) 107.93(14)
N(13)-C(l 1)-N(12) 124.2(3)
Symmetry transformations used to generate equivalent atoms: (') -x , -y , - z + 1
The S ( l l ) - 0  bond distances of 1.458(3) and 1.449(3)A are longer than the corresponding 
bonds in the pure sulfadiazine (1 ) with the values of 1.429(2) and 1.437(2)A. The sulfonyl 
SO2  and amino NH 2  groups o f sulfadiazine and NH 2  groups o f ethylenediamine molecules 
appear to be hydrogen bonded. The hydrogen bonds and short contacts have week 
interactions between donor and acceptors as the angles don’t show any linearity. The 
hydrogen bondings are shown in the packing diagram, Figure 4.24, by open bonds between 
the atoms.
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Figure 4.24:
The packing diagram o f  the complex [Cu(en)2 (sdz)2]  (6 ) where the hydrogen bonds are 
shown by dashed lines.
Table 4.31: Possible hydrogen bonds and short interactions for [Cu(en)2 (sdz)2 ] (6) 
____________(distances and angles given in A  and deg respectively)___________________
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N14 -H14B N14 ....N12 (1) H14B...N12 (1) N14 -H14B...N12 (1)
0.800(2) 3.116(3) 2.415(1) 147.02(3)
C19 -H I9 C19 ....012 (2) H19 ...012 (2) C19 -H19 ...012 (2)
0.930(3) 3.293(4) 2.448(2) 151.10(4)
NI -H1A NI ....011(3) HI A ...O il (3) NI -HI A ...Ol 1 (3)
0.900(4) 2.959(3) 2.167(2) 146.35(2)
N2 -H2B N2 ....N13 (3) H2B ...N13 (3) N2 -H2B ...N13 (3)
0.900(2) 3.021(1) 2.269(4) 140.84(2)
N2 -H2A N2 ....O il (4) H2A ...011 (4) N2 -H 2A ...011 (4)
0.900(5) 3.070(7) 2.305(5) 142.71(8)
Equivalent positions:
(1) -x+ l,-y+ l,-z+ l; (2) x-Viry+Viy+z-Vi; (3) -x+l,-y,-z+l; (4) x-l,+y,+z
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4.7.2 Crystal structure of [Cu(dien)(sdz)2] (7)
The crystal structure o f [Cu(dien)(sdz)2 ] (7) is shown in Figure 4.25 together with the 
crystallographic atom numbering scheme used. The bond lengths and angles are given in 
Table 4.32 and the hydrogen bond dimensions are given in Table 4.33.
In this complex, the [Cu(dien)2 ]2+ cation has an octahedrally arrangement around the Cu(II) 
atom with the two tridentate diethylenetriamine molecules. In the complex the 
sulfadiazinato anions do not coordinate to the copper centre and are joined through the 
hydrogen bonding o f sulfonyl oxygen 0(12) atom with the hydrogen atoms of amino 
groups o f the diethylenetriamine molecules.
The Cu-N distances in the present complex involving the diethylenetriamine molecules are 
C u-N (l) = 2.339(3), Cu-N(2) = 2.031(2) and Cu-N(3) = 2.116(2)A. The Cu-N(2) is the 
shortest bond formed by the central -N H - group of dien molecule with the copper atom. 
The Cu-N(dien) bond distances are shorter than the corresponding bonds of the values o f 
2.459(26), 2.040(23) and 2.350(28)A in the complex [Cu(dien)2 ][Br2 ].H 2 0 37 and than the 
values o f 2.098(15) -  2.140(9)A in the complex [Cu(dien)(0Ac)]„[(C104)„]38, 1.998(4) -  
2.019(4) A in [Cu(dien)(cnge)(0N02)2]39, 1.98(2) -  2.05(2)A in
[Cu(bimH2)(dien)][(C104)2]40, 2.002(10) -  2.265(23)A in [Cu(dien)2] cation41 and 2.014(3) 
-  2.032(3)A in [Cu(dien)Ag(CN)2 ]42 but the middle Cu-N(dien) bond are similar with the 
corresponding bonds in related the complexes.37"42
It is seen that in this complex the Cu-N bonds of 2.339(3)A are longer compared to the 
four short bonds in a square planar arrangement, so that the overall geometry is highly 
distorted octahedral and the origin of this type of distortion is attributed to the Jahn-Teller 
effect.
The octahedral geometry around the Cu atom is distorted from the ideal geometry and this 
is evident from the values of three trans angles o f 180.0° and also from the cis angles 
which vary from 80.49(9) to 99.51(9)°.
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Figure 4.25
X-ray structure o f  the complex [Cu(dien)2][(sdz)2]  (7) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The ring 
hydrogens are omitted fo r  clarity. The hydrogen bonds are shown by dashed line.
Table 4.32: Selected bond lengths [A] and angles [°] in [Cu(dien)2 l[(sdz)2 ] (7)
Bond (A) Bond (A)
Cu(l)-N(2) 2.031(2) Cu(l)-N(3) 2.116(3)
C u(l)-N (l) 2.339(3) S (ll)-0 (1 1 ) 1.446(2)
S(11 )-0 (l 2) 1.456(2) S(11 )-N(l 1) 1.587(2)
S(11)-C(15) 1.762(3) N(11)-C(11) 1.368(3)
N(13)-C(l 1) 1.366(3) N(14)-C(18) 1.370(4)
Angle (°) Angle (°)
N(2')-Cu(l)-N(2) 180.0 N(2')-Cu(l)-N(3) 95.64(9)
N(2)-Cu(l)-N(3) 84.36(9) N(3')-Cu(l)-N(3) 180.00(14)
N (3)-Cu(l)-N (l') 91.90(9) N (2')-C u(l)-N (l) 99.51(9)
N (2)-Cu(l)-N (l) 80.49(9) N(3)-Cu(l)-N (l) 88.10(9)
N (l')-C u(l)-N (l) 180.0 0(11)-S(11)-0(12) 113.72(13)
0 (1 1)-S(11)-N(11) 105.92(12) 0(12)-S(11)-N(11) 113.96(12)
0 (1 1)-S(11 )-C(l 5) 107.02(12) 0(12)-S(11)-C(15) 106.70(12)
N(11)-S(11 )-C(l 5) 109.28(12) N(12)-C(l 1)-N(13) 124.5(3)
Symmetry transformations used to generate equivalent atoms: (') -x , -y+ 1, -z+ 1
This complex also forms a “cation-anion pair” involving the [Cu(dien)2 ]2+ cation and two 
sdz” anions. This is affected by the formation of strong hydrogen bonds involving the 
coordinated dien molecules [N(l) and N(3)] and the sulfonyl oxygen [0(12)] atom anions 
which are shown in the packing diagram of the complex in Figure 4.26.
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Figure 4.26
The packing diagram o f  the complex [Cu(dien)2 (sdz)2]  (7) where the hydrogen bonds are 
shown by open bonds.
Table 4.33: Possible hydrogen bonds and short interactions in [Cu(dien)2 ][(sdz ) ] 2  (7) 
(distances and angles given in A  and deg respectively)
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
NI -H1A 
0.920(5)
N I ....012(0) 
2.887(4)
H1A ...012(0) 
2.061(1)
NI -H1A ...012 (0) 
148.65(1)
N14 -H14A 
0.898(4)
N 14....N 13(1)
3.438(4)
H14A...N13 (1) 
2.558(4)
N14 -H14A...N13 (1) 
166.37(2)
N14 -H14B 
0.948(5)
N14 ....N12 (2) 
3.160(14)
H14B...N12 (2) 
2.433(7)
N14 -H14B...N12 (2) 
133.32(1)
NI -H1B 
0.920(4)
NI ....N il (3) 
3.121(4)
H1B...N11 (3) 
2.237(3)
NI -H1B ...N il (3) 
161.06(1)
N3 -H3A 
0.920(6)
N3 ....N il (3) 
3.283(9)
H3A...N11 (3) 
2.441(6)
N3 -H3A ...N il (3) 
152.15(3)
C4 -H4B 
0.990(5)
C4 ....O il (3) 
3.361(8)
H 4B ...011 (3) 
2.461(5)
C4 -H4B ...O il (3) 
150.89(3)
N2 -H2 
1.008(4)
N2 ....N13 (4) 
3.065(7)
H2 ...N13 (4) 
2.061(5)
N2 -H2 ...N13 (4) 
174.06(1)
N3 -H3B 
0.920(3)
N3 ....012(5) 
3.071(6)
H3B ...012 (5) 
2.201(4)
N3 -H3B ...012(5 ) 
157.24(3)
C2 -H2B 
0.990(6)
C2 ....O il (6) 
3.340(9)
H2B ...O il (6) 
2.416(6)
C2 -H2B ...O il (6) 
155.15(6)
Equivalent positions:
(0) x, y, z; (1) -x -l,+ y + ,/ 2 ,-z+1/2; (2) -x-E + y-^-z+ V E  (3) x ,+ y+ l,+ z; (4) -x ,-y ,-z+ l; (5) -x,- 
y + l,-z+ l; (6 ) -x,+y+V2 ,-z+V2
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4.7.3 Structures of the complexes [Cu(en)2(H20)2].2[smr] (8) and
{[Cu(en)2(H20)2].[(smr)2]}2.H20 ( 9 )
• 04 - ____________________________________________ _The complexes consist of discrete molecules o f the [Cu(en)2(H20)2] cation and [smr] 
anions and are held together by very strong hydrogen bonds and van der Waals’
04-interactions. In the complexes, the [Cu(en)2(H20)2] cation has a distorted octahedral 
arrangement o f copper(II) atom with two ethylenediamine and two water molecules which 
are in the trans position and the sulfamerazinato anions are bonded through the hydrogen 
bonding. The selected bond lengths and angles for the complexes (8) and (9) are given in 
Table 4.6.
Table 4.34: Selected bond lengths [A] and angles [°] in the complexes (8) and (9)
Bond m M (9) [A] Angle (8) [°1 (9 ) n
C u(l)-N (l) 2.034(2) 2.030(2) 2.029(2) N (l)-C u(l)-N (T) 180.0 180.0(1) 180.0(1)
Cu(l)-N(2) 2.006(2) 2.001(2) 2.009(2) N(2)-Cu(l)-N(2') 180.0 180.0(2) 180.0(2)
C u(l)-0(1) 2.501(2) 2.506(2) 2.509(2) N (2)-Cu(l)-N(l) 85.3(1) 94.7(1) 84.7(1)
S(11)-0(H ) 1.460(2) 1.464(2) 1.460(2) N(2')-Cu(l)-N (l) 94.7(1) 85.3(1) 95.3(1)
S (ll)-0 (12 ) 1.454(2) 1.462(2) 1.462(2) 0(1)-C u(l)-0(1 ') 179.9(1) 180.0(1) 180.0(1)
S(11 )-N(l 1) 1.584(2) 1.580(2) 1.588(2) 0(1)-C u(l)-N (l) 91.4(1) 91.92(1) 86.35(1)
S(ll)-C(15) 1.760(2) 1.759(2) 1.762(2) 0(1)-Cu(l)-N(2') 97.6(1) 96.78(1) 88.67(1)
N(11)-C(11) 1.376(3) 1.380(3) 1.377(3) 0(1)-C u(l)-N (l') 88.6(1) 88.08(1) 88.62(1)
N(14)-C(18) 1.375(3) 1.366(3) 1.366(3) N(12)-C(l 1)-N(13) 125.1(2) 124.9(2) 125.3(2)
Symmetry transformations used to generate equivalent atoms: (a) —jc, -y , -z ,  (b) -x , -y , - z + \
The crystal structures o f the complexes (8) and (9) are shown in Figures 4.27 and 4.28 
together with the crystallographic atom numbering scheme used.
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Figure 4.27
X-ray structure o f  the complex [Cu(smr) 2 (H2 O) 4]  ■ 2 [smr]~ (8 )  showing the crystallographic 
atom numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen except bonding hydrogen atoms are omitted fo r  clarity.
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Figure 4.28
X-ray structure o f  [Cu(en)2 (H2 0 ) 2][smr)2].H 2 0  (9) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms are omitted fo r  clarity.
In the complex (9), there are two Cu(II) ions in the structure although both the Cu ions are 
of the same symmetry which is proved by the EPR data. The ethylenediamine molecules 
are chelated to the Cu atoms symmetrically in the octahedral structure.
The Cu(II) ion in the complexes is coordinated to two ethylenediamine molecules and two 
oxygen atoms from the water molecules, forming the tetragonally distorted octahedral 
structures. In the complexes the sulfamerazine molecules are bonded through the H- 
bondings. These structures show that the Cu(II) ions are six coordinated with four nitrogen 
atoms [N(l)/N(2)] from two ethylenediamine molecules and two oxygen [0(1)] atoms 
from two coordinated water molecules. The oxygen atoms are coordinated with longer 
interactions [C u-O (l) = 2.501 (2)A in (8) and 2.506(2)A in (9)] compared to the Cu-N  
bonds of the distances o f 2.034(2) -  2.006(2)A in (8) and 2.001(2) -  2.03 0(2) A in (9) and 
this is attributed to the Jahn-Teller effect.
The Cu-N(en) distances are comparable with the corresponding values of 2.013(3) and 
2.005(3)A in the previous copper ethylenediamine complex [Cu(en)2 ][(sdz)2 ] (6) and the 
other complexes32”36, 1.996(2) and 2.022(3)A in diaquabis-(ethylenediamine)copper(II) 
ethylenediaminebicarboxylate [Cu(en)2(H20)2] [(OOCNH-CH 2 CH 2 NHCOO)] .2 H2 O and
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2.007(3) -  2.024(3)A in diaqua-bis(ethylenediamine)copper(II) TV-carboxyglcynate 
[Cu(en)2(H20 ) 2][(OOCCH2NHCOO)].H20 43 and 2.018(4) -  2.021(4)A in diaqua- 
bis(ethylenediamine)copper(II) bis(4-fluorobenzoate) [Cu(C2H8N2)(H20 ) 2](C7H4F02)2.44
The C u -0  distances of 2.507(2)A are comparable with the values o f 2.556(2)A in diaqua- 
bis(ethylenediamine)copper(II) ethylenediaminebicarboxylate [Cu(en)2(H20 )2] [(OOCNH- 
CH2CH2N H C 00)].2H 20  and 2.591(3) and 2.741(3)A in o f A-carboxyglycinate 
[Cu(en)2(H20 ) 2][(00C C H 2N H C 00)].H 20 34, 2.0579(4)A in diaqua-bis-(ethylenediamine)- 
copper(II) bis(4-fluorobenzoate) [Cu(C2HgN2)(H20 ) 2](C7H4F02)2.44
• • 2 4“ •The complexes form “cation-anion pair” involving the [Cu(en)2(H20 ) 2] cation and two 
[smr]- anions which are affected by the formation of strong hydrogen bonds involving the 
coordinated and lattice water molecules [0(1) in (8) and 0(1), 0 (2) and 0(3) in (9)], 
ethylenediamine molecules [N(l) and N(2)] and the sulfonyl oxygen [0(11) and 0(12)] 
atoms and pyrimido and terminal amino nitrogen atoms of the [smr]- anions in (9).
The 0 (1 )-H (1 A )-0 (1 1 ), N (1)-H (1A )-0(12) and N (2 )-H (2 A )-0 (1 1) hydrogen bonds in 
the complexes present very short donor-acceptor distances and nearly linear donor-acceptor 
angles indicating strong interactions.
Figure 4.29
The packing diagram o f  the complex [Cu(en)2 (H2 0 ) 2] [(sm r)2]  (8) where the hydrogen 
bonds are shown by dashed lines.
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Table 4.35: Possible hydrogen bonds in (8) (distances and angles given in [A] and [°]
respectively)
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
NI -H1A N I ....012(0) H1A ...012(0) N I -H1A ...012(0)
0.900(1) 3.250(2) 2.448(2) 148.64(3)
Ol -H1C O l ....011(0) H 1C ...011 (0) O l -H1C ...O il (0)
0.948(2) 2.816(2) 1.941(2) 152.49(4)
N14 -H14A N14 ....N13 (1) H14A...N13 (1) N14 -H14A...N13 (1)
0.948(2) 2.981(3) 2.036(2) 174.15(5)
N14 -H14B N 14....011 (2) H 14B...011 (2) N14 -H 14B ...011 (2)
0.864(1) 2.975(1) 2.255(1) 140.86(2)
NI -H1B N I ....012(3) H1B ...012 (3) NI -H1B ...012(3 )
0.900(1) 3.207(2) 2.418(1) 146.55(2)
N2 -H2A N2 ....O il (5) H 2A ...011 (5) N2 -H2A ...O il (5)
0.900(1) 3.161(1) 2.403(1) 142.03(2)
N2 -H2B N2 ....012(6) H2B ...012 (6) N2 -H2B ...012(6 )
0.900(2) 3.015(2) 2.142(1) 163.44(3)
Ol -HID Ol ....N il (7) H ID  ...N il (7) O l -HID ...N il (7)
0.983(1) 2.859(2) 1.892(2) 167.08(3)
Equivalent positions:
(0) x,y,z; (1) x-l,+y+l,+z; (2) x,+y+l,+z; (3) -x+l,-y,-z; (4) x+l,+y,+z; (5) -x,-y,-z; (6) x- 
l,+y,+z;(7)-x-l,-y ,-z
Figure 4.30
The packing diagram o f  the complex {[Cn(en)2 (H2 O)2] [(sm r)2] } 2 - I f O  (9) where the 
hydrogen bonds are shown by dashed lines.
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Table 4.36: Possible hydrogen bonds in the complex [Cu(en)2(H20)2][(smr)2].H20  (9)
(distances and angles are given in A and deg respectively)
Donor-H Donor...Acceptor H...Acceptor Donor-H.... Acceptor
Ol -H1A O l ....N il (0) H1A...N11 (0) Ol -HIA ...N il (0)
0.894(2) 2.896(4) 2.036(3) 160.87(4)
N2 -H2D N2 ....012(0) H2D ...012(0) N2 -H2D ...012(0)
0.920(2) 3.002(3) 2.091(2) 170.56(3)
N3 -H3A N3 ....03 (0) H3A...03 (0) N3 -H3A...03 (0)
0.920(1) 2.988(2) 2.080(2) 168.47(2)
N4 -H4B N4 ....021 (0) H4B ...021 (0) N4 -H4B ...021 (0)
0.920(1) 3.075(1) 2.195(5) 159.81(2)
Ol -H1B Ol ....011(1) H1B ...O il (1) Ol -H1B ...O il (1)
0.919(3) 2.844(4) 2.006(3) 150.91(5)
03 -H3E 03 ....022(1) H3E ...022(1) 03 -H3E ...022(1)
0.944(2) 2.847(2) 1.911(1) 171.21(2)
03 -H3F 03 ....012(1) H3F ...012(1) 03 -H3F ...012(1)
0.967(2) 2 .888(2) 1.987(1) 154.05(2)
N24 -H24B N24 ....O il (2) H24B...011 (2) N24 -H24B...011 (2)
0.880(2) 3.016(2) 2.376(1) 129.84(3)
N24 -H24B N24 ....N12 (2) H24B...N12 (2) N24 -H24B...N12 (2)
0.880(2) 3.150(4) 2.371(3) 147.72(3)
N2 -H2C N2 ....O il (2) H2C ...O il (2) N2 -H2C ...O il (2)
0.920(2) 3.160(2) 2.343(1) 147.75(2)
N24 -H24A N24 ....N13 (3) H24A...N13 (3) N24 -H24A...N13 (3)
0.880(3) 2.969(5) 2.150(3) 154.48(5)
N14 -H14A N14....N23 (4) H14A...N23 (4) N14 -H14A...N23 (4)
0.880(3) 2.984(5) 2.149(3) 158.17(5)
N4 -H4A N4 ....022(5) H4A ...022 (5) N4 -H4A ...022 (5)
0.920(2) 2.972(2) 2.067(1) 167.17(2)
N14 -H14B N14 ....021 (5) H14B...021 (5) N14 -H14B...021 (5)
0.880(2) 2.971(2) 2.292(1) 133.93(3)
02  -H2A 02  ....N21 (5) H2A...N21 (5) 0 2  -H2A...N21 (5)
1.022(2) 2.900(4) 1.901(3) 165.06(4)
02  -H2B 02  ....021 (6) H2B ...021 (6) 02  -H2B ...021 (6)
0.986(3) 2.924(4) 1.954(3) 167.41(5)
Equivalent positions:
(0) x,y,z; (1) x-l,+y,+z; (2) -x+l,-y,-z; (3) -x,-y,-z; (4) -x+2,-y,-z+l; (5) -x+l,-y,-z+l; (6) - 
x,-y,-z+i
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4.7.4 Structures of [Cu2(smr)4].DMF (10) and [Cu2(smr)4].DMSO (11)
These complexes contain dimeric copper atoms where a metallic Cu -  Cu bond exists. The 
bond lengths and angles are for the complexes are shown in Table 4.37.
Table 4.37: Selected bond lengths [A] and angles [°] in [Cu2(smr)4].2DMF (10) and
[Cu2(smr)4].2DMSO (11)
Bonds (10) (11) Angles (10) (11)
Cu—Nsuif 2 . 0 5 2 ( 3 ) 2 . 0 4 0 ( 5 ) Npyr—C u —Nsulf 9 0 9 0
C u  Npyr 1 . 9 8 4 ( 3 ) 1 . 9 9 8 ( 5 ) N  pyr—C u —N  pyr 1 7 6 . 7 7 ( 1 1 ) 1 7 8 . 3 ( 3 )
C u - C u 2 . 6 0 9 ( 5 ) 2 . 6 1 4 ( 5 ) Nsulf~Cu—N suif 1 5 8 . 8 2 ( 1 1 ) 1 6 1 . 8 ( 3 )
S - 0 1 . 4 4 6 ( 2 ) 1 . 4 4 4 ( 4 ) N p y r - C u - C u 9 1 . 6 3 ( 8 ) 9 0 . 8 5 ( 1 4 )
S ( 1 1 ) - N ( 1 1) 1 . 6 2 1 ( 3 ) 1 . 6 4 1 ( 5 ) N s u i f - C u - C u 7 9 . 4 6 ( 8 ) 8 0 . 9 0 ( 1 3 )
S ( 1 1)—C ( 1 5) 1 . 7 5 5 ( 3 ) 1 .7 5 4 ( 6 ) N ( 1 2 ) - C ( l  1 ) - N ( 1 3 ) 1 2 3 . 9 ( 3 ) 1 2 3 . 2 ( 5 )
N ( l l ) - C ( l l ) 1 . 3 6 6 ( 4 ) 1 .3 6 0 ( 7 )
N ( 1 4 ) - C ( 1 8 ) 1 . 3 7 8 ( 5 ) 1 .3 6 2 ( 8 )
Symmetry transformations used to generate equivalent atoms: #1 -x,-y+l,z #2 y-Vi,-
x + ! /2 ,- z + 1 ! /2  #3 -y+V2,x+l/ 2,-z+\ V2
The X-ray structures showed that in the complexes [Cu2 (smr)4].DMF (10) and 
[Cu2(smr)4 ].DMSO (11) the Cu(II) atoms adopt a square pyramidal geometry arrangement 
and the five coordinate geometry consisted of four nitrogen atoms from the bridging 
sulfamerazine molecules occupying the basal plane and the other Cu(II) atom in an 
elongated apical site completes the coordination sphere.
The Cu-Cu distances o f 2.609(5) and 2.614(2)A respectively in the complexes (10) and 
(11) are longer than those found in the dinuclear copper complex of sulfamethazine 
[2.5412(6)A]43 but shorter than that found in adenine complexes45 and in [Cu2(stz)4] 
[2.671 (2)A ]46 (where stzH = sulfathiazole).
The Cu-N distances involving the four sulfamerazinato ligands are 1.977(3) -  2.061(3)A in 
(10) and 2.077(2) -  2.082(2)A in (11) are very similar with the values o f 1.922(5) -  
2.100(5)A in [Cu2(stz)4]46 and 2.02(1) -  2.36(1)A in [Cu(B-ats)(NH3)2]247, 1.951(6) -  
2.043(6)A in the sulfonamidic complex48 and also in the related systems.49,50
The structure o f the complex [Cu2(smr)4].DMF (10) is shown in Figure 4.31 together with 
the crystallographic atom numbering scheme used.
105
Chapter 4
Figure 4.31
X-ray structure o f  the complex [Cu2 (smr)4].DM F (10) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The ring 
hydrogen atoms and DMF molecules are omitted fo r  clarity.
Figure 4.32
The packing diagram o f  the complex [Cu2 (smr)4] .2DMF (10) where the hydrogen bonds 
are shown by dashed lines.
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Table 4.38: Possible hydrogen bonds and short interactions in [Cu2(smr)4].2DMF 
___________ (10) (distances and angles given in A and [°] respectively)_______________
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H I4A N14 ....02 (0) H14A...02 (0) N14 -H14A...02 (0)
0.933(5) 3.100(5) 2.247(3) 151.53(8)
N34 -H34A N34 ....02 (0) H34A...02 (0) N34 -H34A...02 (0)
0.940(7) 2.983(8) 2.064(8) 165.23(2)
N44 -H44A N 44....01 (0) H44A...01 (0) N44 -H44A...01 (0)
0.930(9) 2.959(6) 2.137(5) 146.73(1)
N24 -H24A N 24....011 (1) H 24A ...011 (1) N24 -H 24A ...011 (1)
0.926(1) 3.134(3) 2.226(9) 166.46(2)
C43 -H43 C43 ....021 (2) H43 ...021 (2) C43 -H43 ...021 (2)
0.950(4) 3.253(8) 2.359(5) 156.53(5)
N34 -H34B N34 ....042 (3) H34B...042 (3) N34 -H34B...042 (3)
0.938(8) 3.024(1) 2.145(8) 155.35(3)
C23 -H23 C23 ....031 (4) H23 ...031 (4) C23 -H23 ...031 (4)
0.950(8) 3.191(3) 2.353(2) 146.83(1)
Equivalent positions:
(0) x,y,z; (1) -x,-y,-z+l; (2) x+l,+y,+z; (3) x 9-y+l/2y+z+l/2; (4) x,+y,+z-l
The crystal structure of the complex [Cu2 (smr)4 ].DMSO (11) is shown in Figure 4.33 
together with the crystallographic atom numbering scheme used.
Figure 4.33
X-ray structure o f  the complex [Cii2 (smr)4] .DMSO (11) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50%  probability level. The 
hydrogen atoms and DMSO molecules are omitted fo r  clarity.
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Several hydrogen bonds exist in the complex (11), listed in Table 4.39, and in the packing 
diagram (Figure 4.34) these are shown by dashed lines.
Figure 4.34
The packing diagram o f  the complex [Cu2 (sm r)J.2 DMSO (11) where the hydrogen bonds 
are shown by dashed lines.
Table 4.39: Possible hydrogen bonds and short interactions in [Cu2 (smr)4 ].DMSO  
 ___________ (11) (distances and angles given in A and deg respectively)_______________
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H I4A N 14....01  (1) H14A...01 (1) N14 -H14A...01 (1)
0.945(3) 2.825(2) 1.925(6) 158.26(4)
N14 -H14B N 14....01  (2) H14B...01 (2) N14 -H14B...01 (2)
0.938(3) 3.169(3) 2.309(6) 152.14(6)
C14 -H14 C 14....011 (3) H 14...011 (3) C14 -H 14...011 (3)
0.930(1) 3.320(4) 2.425(2) 161.59(2)
C2 -H2C C2 ....012(4) H2C ...012 (4) C2 -H2C ...012(4)
0.960(2) 3.351(2) 2.433(6) 159.87(3)
Equivalent positions:
(1) y-l,-x,-z+l; (2) -y,+x+l,-z+ l; (3) y-V^-x+V^-z+Va; (4) -y+V^+x+VVz-HA+l
The square pyramidal geometry around the Cu atoms in both the complexes is distorted 
showing a small variation from ideal geometry of the mutually cis 90° and trans 180°
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angles. This is evident from the values o f the trans angles vary from 158.67(11) to 
176.82(11) and also from the cis angles which vary from 88.85(11) to 93.72(8)° in complex
(10) and from 161.8(3) to 178.3(3) and also from the cis angles which vary from 89.7(2) to 
90.85(14)° in complex (11).
The Cu-Cu bonding and their environment in both the complexes have the same 
arrangement and the pattern of the complex (10) is shown only.
N23N21
N33
N31
Cu2Cu1
N41
N43
N13N11
Figure 4.35
The metal-metal bond in the complex [Cu2 (smr)4] .2DMF (10) showing only bonded 
nitrogen atoms
The interesting aspect of the present structures is the formation of a “metal-metal bond” 
involving two copper atoms in the complexes. The solvent DMF molecule in (10) and 
DMSO in (11) are attached to the complex by the formation o f strong hydrogen bonds 
involving the terminal amino group [N(14), N(24), N(34) and N(44) atoms of [smr]~ anion 
in (10) and N(14) in the complex (11)]. Additional hydrogen bonds and van der W aals’ 
interactions hold the whole crystal together.
The copper atoms in the complexes bind with the sulfonamidic nitrogen atom of one 
sulfamerazine molecule and pyrimido nitrogen atom of the other sulfamerazine molecules, 
i.e., the sulfonamidic nitrogen atom binds to one copper atom and at the same time the 
pyrimido nitrogen atom binds to other copper atom. In the complexes the sulfamerazinato 
anions behave as bridging ligands similar to that found in the acetate dimers such as in the 
compounds [Cu2(OCOCH3)4].2L where L is acetic acid,51 methanol,51 DMF,51 water,52 
urea,53 pyridine54,55 and quinoline.56 Each copper atom is surrounded by four nitrogen
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atoms forming square planar geometry which are eclipsed with each other shown in Figure 
4.36.
N21 N33
N23 N31
Cu
Cu2
N41
N11N43
N13
Figure 4.36
The square planar geometries on the copper atoms are eclipsed with each other in the 
complex [Cu2 (smr)4].2DM F (10)
4.7.5 Structure of the complex [Cu(smz)2(apen)].3H2O.CH3OH (12)
The crystal structure of the complex [Cu(smz)2 (apen)].3 H 2 0 .CH3 0 H (12) is shown in 
Figure 4.37 together with the crystallographic atom numbering scheme used. The selected 
bond lengths and angles are collected together in Table 4.40 and the dimensions of the 
hydrogen bonds are listed in Table 4.41.
In the complex, the [Cu(smz)2 (apen)] molecule has a distorted octahedral arrangement 
around copper(II) atom with one apen [A(A^(3-aminopropyl)-bis-(ethylenediamine)] 
molecule in which the bonds are through the four nitrogen atoms and the sulfamethazinato 
anions are bonded through the sulfonyl oxygen atoms.
Equatorial N4 ligation is provided by the apen molecule, while apical C u-0 bonds result 
from coordination o f two sulfonyl oxygen atoms from sulfamethazine molecules.
The observed C u-0 bond lengths of 2.351(4) and 2.621 (4)A differ significantly; the longer 
length just falls within the range of 2.575 (6)-2.676 (10) A in related complexes containing 
C11N4O2 chrom ophores.59
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The Cu-N(apen) distances in the present complex involving all the AfTV’Q-aminopropyl)- 
bis-(ethylenediamine) ligand are similar and lie between 2.018(2) and 2.058(2)A which are 
comparable with the corresponding bonds with the values 2.010(8) -  2.038(8)A in 
[Cu(apen)(C104)2].H20 ,57 2.012(8) -  2.031(8)A in [Cu(apen)(C104)].C104.!/2H20 ,58 and 
2.016(6)—2.032(6)A in [Cu(apen)(C104)2].59
Table 4.40: Bond lengths [A] and angles (°) in [Cu(smz)2 (apen)].3 H 2 0 .CH3 0 H (12)
Bond (A) Bond (A )
C u(l)-N (l) 2.018(5) Cu(l)-N(4) 2.040(6)
Cu(l)-N(3) 2.044(5) Cu(l)-N(2) 2.058(6)
C u (l)-0 (11) 2.351(4) Cu(l)-0(21) 2.621(4)
S (ll)-0 (12 ) 1.452(5) S (ll)-0 (11 ) 1.463(5)
S(11)-N(11) 1.575(5) S(11)-C(15) 1.766(6)
N(11)-C(11) 1.385(8) N(14)-C(18) 1.379(8)
S(21)-0(22) 1.457(5) S(21)-0(21) 1.460(4)
S(21)-N(21) 1.594(5) S(21)-C(25) 1.763(6)
N(21)-C(21) 1.370(8) N(24)-C(28) 1.377(8)
Angle (°) Angle (°)
N (l)-Cu(l)-N(4) 88.6(2) N (l)-Cu(l)-N (3) 177.0(2)
N(4)-Cu(l)-N(3) 94.1(2) N (l)-Cu(l)-N (2) 93.1(2)
N(4)-Cu(l)-N(2) 174.6(2) N(3)-Cu(l)-N(2) 84.3(2)
N (l)-C u(l)-0 (11) 87.6(2) N (4)-C u(l)-0(11) 97.3(2)
N (3)-C u(l)-0(11) 90.6(2) N (2)-C u(l)-0(11) 87.8(2)
0(21)-C u(l)-0 (11) 171.3(2) 0(21)-Cu(l)-N(3) 85.5(2)
0(21)-C u(l)-N (l) 95.9(2) 0(21)-Cu(l)-N(2) 84.1(2)
N (2)-C u(l)-0(11) 171.33(2) 0(12)-S(11)-0(11) 112.9(3)
0(12)-S(11)-N(11) 117.4(3) 0 (1 1)-S(11 )-N( 11) 105.2(3)
0(12)-S(11)-C(15) 107.7(3) 0 (1 1)-S(11 )-C(l 5) 106.2(3)
N(11)-S(11)-C(15) 106.7(3) S(11)-0(1 l)-C u(l) 133.3(3)
N(12)-C(l 1)-N(13) 125.6(6) 0(22)-S(21)-0(21) 113.9(3)
0(22)-S(21)-N(21) 113.5(3) 0(21)-S(21)-N(21) 105.0(3)
0(22)-S(21)-C(25) 107.2(3) 0(21)-S(21)-C(25) 106.7(3)
N(21)-S(21)-C(25) 110.4(3) N(22)-C(21)-N(23) 124.7(6)
The O u-O (l 1) distance, involving the sulfonyl oxygen atom of the sulfamethazinato anion, 
o f 2.351(4)A is shorter than the second C u-0(21) bond distance with the value of 
2.621(4)A in this complex which is comparable with the values 2.66(2)A  in 
[Cu(apen)(C104)2].H20,57 2.539(7)A in [Cu(apen)(C104)].C104.‘/2H20 ,5S and 2.667(5) and 
2.527(5)A in [Cu(apen)(C1 0 4)2 ]59 and all these complexes are bonded through the oxygen 
atom of the perchlorate anion. The octahedral geometry around the Cu atom is distorted 
with longer C u -0  bond lengths due to the Jahn-Teller effect which is also confirmed by 
the EPR spectroscopy.
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Figure 4.37
X-ray structure o f  [Cu(smz)2 (apen)]. 3 H2 O. CH3 OH (12) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The ring 
hydrogens are omitted fo r  clarity.
The complex forms several hydrogen bonds involving the coordinated N,N*(3- 
aminopropyl)-bis-(ethylenediamine) molecule and sulfamethazine molecule which are 
listed in Table 4.41.
0
Figure 4.38
The packing diagram o f  the complex [Cu(smz)2 (apen)].3 H 2 O.CH3 OH (12) where the 
hydrogen bonds are shown by dashed lines.
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Table 4.41: The hydrogen bonds in the complex [Cu(smz)2 (apen)].3 H 2 0 .CH3 0 H (12)
(distances and angles given in A and deg respectively)
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
N1 -H1A N1 ....012(0) H1A ...012(0) N1 -HI A . ..012 (0 )
0.900(1) 3.250(2) 2.448(2) 148.64(3)
01 -H1C O l ....011(0) H 1C ...011 (0) O l -H1C ...O il (0)
0.948(2) 2.816(2) 1.941(2) 152.49(4)
N14 -H14A N 14....N 13(1) H14A...N13 (1) N14 -H14A...N13 (1)
0.948(2) 2.981(3) 2.036(2) 174.15(5)
N14 -H14B N 14....011 (2) H 14B...011 (2) N14 -H 14B ...011 (2)
0.864(1) 2.975(1) 2.255(1) 140.86(2)
N14 -H14B N14 ....N12 (2) H14B...N12 (2) N14 -H14B...N12 (2)
0.864(1) 3.190(2) 2.478(2) 140.12(2)
N1 -H1B N1 ....012(3) H1B ...012 (3) N1 -H1B ...012 (3)
0.900(1) 3.207(2) 2.418(1) 146.55(2)
N1 -H1B N1 ....N il (4) H1B ...N il (4) N1 -H1B ...N il (4)
0.900(1) 3.283(1) 2.492(1) 146.93(2)
N2 -H2A N2 ....O il (5) H 2A ...011 (5) N2 -H 2A ...011 (5)
0.900(1) 3.161(1) 2.403(1) 142.03(2)
N2 -H2B N2 ....012(6) H2B ...012(6) N2 -H2B ...012 (6)
0.900(2) 3.015(2) 2.142(1) 163.44(3)
01 -HID O l ....N il (7) H ID  ...N il (7) O l -HID  ...N il (7)
0.983(1) 2.859(2) 1.892(2) 167.08(3)
Equivalent positions:
(0) x, y, z; (1) x-l,+y+l,+z; (2) x,+y+l,+z; (3) -x+l,-y,-z; (4) x+l,+y,+z; (5) -x,-y,-z; (6) x- 
l,+y,+z; (7) -x-l,-y,-z
4.7.6 Structure of the complex {[Cu(smz)2(NH3)].2H20 } /I (13)
The crystal structure of the complex {[Cu(smz)2(NH3)].2H20}„ (13) is shown in Figure 
4.39 together with the crystallographic atom numbering scheme used, the selected bond 
lengths are listed in Tables 4.42.
The copper ion in the complex exhibits a high distorted octahedral geometry, being 
coordinated to the two sulfonamidic [N(l 1)/N(21)] and two pyrimido N[(12)/(22)] nitrogen 
atoms of two bidentate sulfamethazine ligands generating four-membered rings. The
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nitrogen atom N(14) from the terminal amino group o f a third sulfamethazine, which is 
bonded to the adjacent Cu(II) ions, and the N (l) atom of the ammonia molecule complete 
the coordination sphere. Although both the ligands are bound to copper, only one 
sulfamethazine presents almost equivalent C u-N  bond distances [C u (l) -N (ll)  and 
Cu(l)-N (12) are 2.044(3) and 2.035(3)A respectively] and are comparable with the values 
o f 2.083(13) and 2.071(11)A in the complex [Cu(sdz)2 (NH 3 )2 ].32 The packing of the 
complex units is governed by long chains formed by the bridging sulfamethazine ligands
which is bound to C u(l) viaN(21)/N(22) and Cu(2) v iaN H 2  [N(14)-Cu = 2.660(3)A].
Figure 4.39
X-ray structure o f  the complex [Cu(smz)2 (N H f ]. 2 H 2 O (13. Thermal ellipsoids are drawn 
at 50% probability level. The hydrogen atoms are omitted fo r  clarity. The hydrogen bonds 
o f water with sulfonyl oxygen and pyrimido nitrogen atoms are shown by dashed lines
The complex [Cu(smz)2(NH3)].H20 (13) consists of an independent polymeric crystal 
structure o f {[Cu(smz)2 (NH3 )] .H2 O } „ held together in the crystal by very strong hydrogen 
bonds and van der W aals’ interactions shown in Figure 4.40.
Figure 4.40
Structure o f  [Cu(smz)2 (NHs)].2 H2 0  (13) in the polymeric form  where cobalt ion is bonded 
to the terminal N(14) atom o f  the adjacent cobalt ion.
N14 C211
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Table 4.42: Selected bond lengths [A] and angles [°] in {[Cu(smz)2(NH3)].2H2Q}/i (13)
Bond (A) Bond (A )
Cu(l)-N (l) 1.973(3) Cu(l)-N(21) 2.007(4)
Cu(l)-N(12) 2.035(3) C u(l)-N (l 1) 2.044(3)
Cu(l)-N(22) 2.563(3) Cu(l)-N(14') 2.660(3)
S(11 )-0 (l 2) 1.426(3) S (ll)-0 (1 1 ) 1.451(3)
S(11)-N(11) 1.603(3) S(11 )-C(l 5) 1.755(4)
N(11)-C(11) 1.365(5) N(14)-C(18) 1.394(6)
S(21)-0(22) 1.441(3) S(21)-0(21) 1.457(3)
S(21)-N(21) 1.610(4) S(21)-C(25) 1.759(4)
N(21)-C(21) 1.393(5) N(24)-C(28) 1.389(5)
Angle (°) Angle (°)
N (l)-Cu(l)-N(21) 94.68(14) N (l)-Cu(l)-N (12) 160.67(14)
N(21)-Cu(l)-N(12) 104.49(14) N (l)-C u(l)-N (l 1) 95.53(14)
N(21)-Cu(l)-N(l 1) 166.50(14) N(12)-Cu(l)-N(l 1) 65.15(13)
N(l)-Cu(l)-N(22) 93.91(14) N(22)-Cu(l)-N(12) 94.15(13)
N(14')-Cu(l)-N(l 1) 86.11(13) N(14')-Cu(l)-N(22) 158.34(13)
0(12)-S(11)-0(11) 115.8(2) 0(12)-S(11)-N(11) 113.2(2)
0 (1 1)-S(11)-N(11) 104.8(2) 0(12)-S(11)-C(15) 106.8(2)
0 (1 1)-S(11)-C(15) 109.1(2) N(11)-S(11 )-C(l 5) 106.7(2)
N(12)-C(l 1)-N(13) 126.9(3) N(23)-C(21)-N(22) 126.8(4)
Symmetry transformations used to generate equivalent atoms: (') -x , -y , z
The Cu-N(22) distance of 2.563A is longer than the corresponding bond with the value of
2.225(2)A in the polymeric complex {Co(smz)2(H20)].DMF (3). The N(14) atom, bonded 
to an adjacent copper atom to form a polymer, shows a weaker longer interaction. The 
N(14)-C(18) bond distance of 1.394(6)A and the N(24)-C(28) o f 1.389(7)A are similar to 
each other and are also comparable with the corresponding distance in the free ligand 
[1.384(6)A].
Figure 4.41
The packing diagram o f  the complex [ Cu(smz)2 (NHf]. 21FO (13) where the hydrogen 
bonds are shown by dashed lines.
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In the complex unit there are hydrogen bonds between the NH 2  groups and SO2  groups of 
different sulfamethazine and between SO2  and ammonia molecules and between the lattice 
water molecules. The N (1)-H (1B )-0(11), 0 ( l ) -H ( lE ) -0 (2 ) ,  N (14)-H (14A )-0(21), 
N(24)-H(24A)—0(11) and N(24)-H(24B)~-0(22) hydrogen bonds in the complex present 
very short donor-acceptor distances and nearly linear donor-acceptor angles, which indicate 
that these interactions are very strong.
Table 4.43: The hydrogen bonds in [Cu(smz)2(NH3)].2H20 (13) (distances and angles
given in A and deg respectively)
Donor-H Donor... Acceptor H...Acceptor Donor-H.... Acceptor
N1 -H1B 
0.912(1)
N1 ....011(0) 
3.003(5)
H 1B...011 (0) 
2.121(6)
N1 -H1B .. 
162.28(2)
.O il (0)
01 -HID 
0.950(3)
Ol ....N13 (0) 
3.227(7)
HID ...N13 (0) 
2.355(6)
O l -H ID .. 
152.45(3)
.N13 (0)
02  -H2A 
0.987(4)
0 2  ....021 (0) 
2.958(6)
H2A ...021 (0) 
2.280(2)
0 2  -H2A .. 
124.94(2)
.021 (0)
02  -H2A 
0.987(4)
0 2  ....N23 (0) 
3.364(9)
H2A ...N23 (0) 
2.480(8)
0 2  -H2A .. 
148.98(3)
.N23 (0)
N14 -H14A 
0.955(5)
N 14....021 (1) 
3.067(5)
H14A...021 (1) 
2.136(3)
N14 -H14A...021 (1) 
164.64(3)
N24 -H24B 
0.924(1)
N24 ....022 (2) 
2.899(7)
H24B...022 (2) 
1.996(9)
N24 -H24B...022 (2) 
165.01(2)
N1 -H1C 
0.890(7)
N1 ....012(4) 
2.940(9)
H1C ...012 (4) 
2.102(6)
N1 -H1C . 
156.39(4)
..0 1 2 (4 )
Ol -HIE 
0.959(3)
O l ....02 (5) 
2.865(5)
H IE ...02 (5) 
1.910(4)
O l -H IE .. 
173.09(3)
.02  (5)
02  -H2B 
0.966(9)
0 2  ....021 (6) 
3.087(2)
H2B ...021 (6) 
2.171(7)
0 2  -H2B . 
157.93(8)
..021 (6)
N14 -H14B 
0.999(5)
N 14....01  (7) 
3.142(9)
H14B...01 (7) 
2.386(7)
N14 -H14B...01 (7) 
131.81(4)
N24 -H24A 
0.881(6)
N 24....011 (8) 
3.054(9)
H24A...011 (8) 
2.239(7)
N24 -H 24A ...011 (8) 
153.92(4)
Equivalent positions:
(0) x,y,z; (1) x+1/2,-y+,A,+z+!4; (2) -x+1/2,+y+!/2,-z+1/2; (3) -x+V^+y+'/^-z+Va+l; (4) -x,-y,- 
z+1; (5) x,+y-l,+z; (6) -x,-y+l,-z+l; (7) x+'/Vy-V^+z+l^; (8) x+W y+V ^+z-1/-*
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4.8 Structure of the zinc complexes
The compounds [Zn(smz)2 (NH3 )2 ] (14) and [Zn(smz)2 (py)2 ].2 py (15) are new complexes 
and have been characterised by independent analytical and spectroscopic data and also by 
X-ray diffraction methods. The crystal data and refinement details for the complexes (14) 
and (15) are summarized in Table 4.44.
Table 4.44: Crystal data and details of data collection and structure refinement for 
[Zn(smz)2(NH3)2] (14) and [Zn(smz)2(py)2].2py (15)
(14) (15)
Empirical formula C24H32Nio04S2Zn C4 4 H4 6 N i2 0 4 S2Zn
Formula weight 654.09 880.59
Crystal system Monoclinic Monoclinic
Space group P2i/c C2/c
« (A) 37.6123(14) 9.45300(10)
b( A) 6.2170(2) 12.34560(10)
c(A ) 25.4271(11) 34.7476(5)
f iO 90.148(3) 90.8372(4)
v ( V ) 5945.7(4) 4054.71(8)
z 4 4
Crystal size/mm 0 .1 5 x 0 .1 2 x 0 .1 0 0 .1 8 x 0 .1 5 x 0 .1 2
#-Range for data collection (°) 3 .2 0 -2 7 .5 8 2 .9 4 -27 .71
Reflections collected 11621 30461
Unique reflections 6197 9033
Rmi 0.0609 0.0572
Index ranges -22<=h<=48 —1 2 <=h< = 1 1
-7<=k<=7 —15<=k<=15
-32<=1<=33 -44<=1<=45
Data/parameters in the refinement 6197/414 9033/558
Goodness-of-fit on F 1 1.066 1.058
Final R indices [(7> 2o(I)] 0.0689/0.1720 0.0479/0.1179
R indices (all data) 0.1131/0.2001 0.0706/0.1368
Largest diff. peak and hole (e. A-3) 1.876 and -0.821 1.025 and -0.498
4.8.1 Structure of the complex [Zn(smz)2(NH3)2] (14)
The crystal structure of the complex [Zn(smz)2 (NH3)2 ] (14) is shown in Figure 4.42 
together with the crystallographic atom numbering scheme used. The selected bond lengths 
and angles, and the possible hydrogen bond dimensions are given in Tables 4.45 and 4.46 
respectively.
The complex (14) consists of the independent crystal structure o f [Zn(smz)2 (NH3)2 ] only 
and is held together in the crystal by very strong intermolecular hydrogen bonds and van
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der Waals’ interactions. The zinc ion is four coordinated and is bound to two nitrogen 
[N(l 1 )/N(21)] atoms from two sulfamethazine ligands and two nitrogen [N(l)/N(2)] atoms 
from two ammonia molecules.
C2 11
N 1 4
C 1 7 012C 1 6
C 2 2 0 2 3C 1 5C 1 8 N 2
C 1 9 011
0 2 4020 S 11
N 2 2
C21
C212
N11
N 1 3
N 2 3C11 Zn1 N21cm
0 3 0C 1 2
0 2 9' N 1 2  N1 
0 1 4 0 2 8C 2 5C 1 3 C 2 6022
C 2 7
N 2 40112
Figure 4.42
X-ray structure o f  the complex [Zn(smz)2 (NHs)2]  (14)  showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms are omitted fo r  clarity.
Table 4.45: Selected bond lengths [A] and angles [deg] in [Zn(smz)2 (NH3 )2 ] (14)
Bond (A) Bond (A)
Zn(l)-N (l) 2.019(5) Zn(l)-N(21) 2.036(3)
Zn(l)-N(2) 2.041(5) Zn(l)-N (l 1) 2.045(3)
S(11)-0(12) 1.446(3) S (ll)-0 (11 ) 1.450(3)
S ( ll) -N (ll) 1.602(3) S(11)-C(15) 1.765(4)
S(21)-0(22) 1.443(3) S(21)-0(21) 1.446(3)
S(21)-N(21) 1.605(3) S(21)-C(25) 1.761(4)
N(11)-C(11) 1.395(5) N(14)-C(18) 1.398(5)
N(21)-C(21) 1.378(5) N(24)-C(28) 1.390(5)
Angle (°) Angle (°)
N(l)-Zn(l)-N(21) 110.1(2) N (l)-Zn(l)-N (2) 100.1(3)
N(21)-Zn(l)-N(2) 114.2(2) N (l)-Z n(l)-N (l 1) 113.2(2)
N(21)-Zn(l)-N(l 1) 108.7(2) N(2)-Zn(l)-N(l 1) 110.4(2)
0(12)-S(11)-0(11) 114.6(2) 0(12)-S(11)-N(11) 105.9(2)
0(11 )-S(l 1)-N(11) 112.6(2) 0(12)-S(11)-C(15) 106.9(2)
0 (1 1)-S(11)-C(15) 107.4(2) N(11)-S(11)-C(15) 109.3(2)
0(22)-S(21)-0(21) 115.4(2) 0(22)-S(21 )-N(21) 105.0(2)
0(21)-S(21)-N(21) 112.7(2) 0(22)-S(21 )-C(25) 107.1(2)
0(21)-S(21)-C(25) 107.6(2) N(21)-S(21)-C(25) 108.8(2)
N( 13)-C( 11 )-N( 12) 126.6(4) N(22)-C(21 )-N(23) 125.3(4)
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The geometry o f the zinc complex (14) is tetrahedral with four nitrogen atoms. Both the 
ammonia and sulfamethazine molecules are bound to zinc, two Zn-N  bonds are almost 
equivalent. The bond distances for the complex [Zn(smz)2 (NH3 )2 ] (14), Zn-N(amm) of 
2.019(5) and 2.041(5)A are comparable with the corresponding distances o f 2.022(7) and 
2.071 (9)A in the zinc tetrahedral complex [Zn(sdz)2 (NH3 )2]60 and 2.036(4) and 2.050(4)A 
in the same complex [Zn(sdz)2 (NH3 )2 ]61 and the Zn-N(smz) distances of 2.045(3) and 
2.036(3)A, are also in good agreement with the distances of 2.087(8) and 2.100(6)A in the 
complex [Zn(sdz)2 (NH3 )2 ]60 and 2.078(4) and 2.166(4)A in the same complex 
[Zn(sdz)2(NH3)2]61, 2.017(3) and 2.060(2)A in the complex [Zn(sdz)2]62 and 1.998(3)A in 
the complex Zn(Lpr)63 (where LprH is 77-tt-propylsacyaldimine).
There are several hydrogen bonds in the complex which are shown by dashed lines in the 
packing diagram shown in Figure 4.43.
Figure 4.43
Packing diagram o f  the complex [Zn(sm z)i(NH f2]  (14)  where the hydrogen bonds are 
shown by dashed lines
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Table 4.46: Possible hydrogen bonds in [Zn(smz)2 (NH3 )2 ] (14) (distances and angles 
___________ given in A  and deg respectively)________________________________
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N1 -H1C N1 ...N12 (0) H1C ...N12 (0) N1 -H1C ...N12 (0)
0.948(4) 3.011(7) 2.411(5) 120.98(3)
N2 -H2A N2 ...012 (0) H2A ...012 (0) N2 -H2A ...012 (0)
0.949(7) 2.920(6) 2.222(7) 129.63(6)
N14 -H14A N14 ...021 (1) H14A ...021 (1) N14 -H14A ...021 (1)
0.948(4) 3.194(5) 2.458(5) 134.30(3)
N14 -H14B N14 ...022 (2) H14B ...022 (2) N14 -H14B ...022 (2)
0.949(5) 3.008(5) 2.087(6) 163.45(4)
N24 -H24A N24 ...012 (3) H24A ...012 (3) N24 -H24A ...012 (3)
0.949(4) 3.075(5) 2.215(5) 150.19(3)
N24 -H24B N24 ...O il (4) H24B ...O il (4) N24 -H24B ...O il (4)
0.950(5) 3.230(5) 2.390(7) 147.22(5)
N1 -H1B N1 ...021 (6) H1B ...021 (6) N1 -H1B ...021 (6)
0.950(5) 2.964(6) 2.047(6) 161.66(4)
N2 -H2B N2 ...O il (6) H2B ...O il (6) N2 -H2B ...O il (6)
0.949(4) 2.933(6) 2.027(5) 159.12(4)
N1 -H1A N1 ...N13 (6) H1A ...N13 (6) N1 -H1A ...N13 (6)
0.950(7) 3.434(7) 2.506(7) 165.69(5)
Equivalent positions:
(0) x, y, z; (1) x,-y+l,+z-!/2; (2) x.-y^z-Vi; (3) x,-y,+z+72; (4) x,-y+l,+z+72; (5) x,+y-l,+z
4.8.2 Structure of the complex [Zn(smz)2(py)2].2py (15)
The crystal structure of the complex [Zn(smz)2(py)2].2py (15) is shown in Figure 4.44 
together with the crystallographic atom numbering scheme used. The selected bond lengths 
and angles are given in Table 4.47 and the possible hydrogen bond dimensions and short 
interactions are given in Table 4.48.
The zinc ion lies on a two-fold axis in the complex and exhibits a highly distorted 
octahedral geometry, being coordinated to the sulfonamidic [N (ll)] and pyrimido [N(l 2)] 
nitrogen atoms of two bidentate sulfamethazine ligands generating four-member rings. The 
nitrogen atoms N (l) from the pyridine molecules complete the coordination sphere. The 
octahedral geometry is highly distorted since the pyridine molecules lie on one side and the 
two larger sulfamethazine molecules lie on the other
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The two Zn-N bonds are almost equivalent, the Z n (l)-N (l) and Z n ( l) -N (ll)  bond 
distances o f 2.108(3) and 2.122(3)A respectively are very similar to those found in the 
previous complex [Zn(smz)2(NH3)2 ] (14) and are in good agreement of the bond lengths in 
the tetrahedral complex [Zn(sdz)2 (NH3 )2]61,62 but the Zn(l)-N (12) bond distance of 
2.324(3)A is longer indicating weak interaction.
C2
C1C3C17N14 C16 C4'
0 1 2
N1
C1 C5
N11C15
ZnfC19
C20 0 1 1 |
C11N1
C1
C13
C112
Figure 4.44
X-ray structure o f  the complex [Zn(smz)2 (py)2]-2py (15) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms and the lattice pyridine molecules are omitted fo r  clarity.
Table 4.47: Selected bond lengths [A] and angles [deg] in [Zn(smz)2(py)21.2py (15)
Bond (A) Bond (A)
Zn(l)-N (l) 2.108(3) Z n(l)-N (ll) 2.122(3)
Zn(l)-N(12) 2.324(3) S (ll)-0 (11 ) 1.443(3)
S(11)-0(12) 1.446(3) S ( ll) -N ( ll) 1.600(3)
S(11)-C(15) 1.765(4) N (ll) -C (ll) 1.367(4)
N(14)-C(18) 1.394(6)
Angle (°) Angle (°)
N (l)-Zn(l)-N (T) 95.97(16) N (l)-Zn(l)-N (l T) 106.48(11)
N (l)-Zn(l)-N (l 1) 95.56(11) N(1 T)-Zn(l)-N (l 1) 146.97(16)
N(l)-Zn(l)-N (12') 165.75(11) N(11)-Zn(l)-N(12') 94.09(11)
N(l)-Zn(l)-N(12) 91.31(11) N (l')-Zn(l)-N (12) 165.75(11)
N(11)-Zn(l)-N(12) 60.49(10) N(12')-Zn(l)-N(12) 84.36(13)
0 (1 1)-S(11)-0(12) 116.48(16) 0 (1 1)-S(11)-N(11) 113.17(16)
0(12)-S(11)-N(11) 104.95(16) 0 (1 1)-S(11)-C(15) 107.27(17)
0(12)-S(11)-C(15) 106.45(16) N (ll) -S (l 1)-C(15) 108.09(16)
N(13)-C(l 1)-N(12) 125.8(3)
Symmetry transformations used to generate equivalent atoms: (') -x+1, y, -z+'A
The Zn-N(py) bond distance of 2.108(3)A is shorter than the corresponding distance 
found in the complex [Zn(smpz)2(py)2 ]43 (2.1841(17)A) and is in agreement with the bond
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distance o f 2.079(9)A in [[Zn(S2CNMe)2(py)2 ]64> 2.116(3) and 2.134(3)A in 
[Zn(Py)(chxn(Cl-sal)2)]65 and 2.104(8) and 2.081(8)A in the complex [Zn(Py)(chxn(Br- 
sal)2)] [where chxn is cyclohexanediamine and Cl-sal and Br-sal are 5-chloro- and 5- 
bromosalicylaldehyde respectively], 2.110(5)A in [Zn(TeR')2(py)2]66, 2.042(6) and 
2.092(6)A in [Cr(acacen)py2] [ZnCl3py]67, 2.049(3)A in [ZnCl2(py)2]68 and 2.13(1)A in 
[V(salen)(py)2][ZnCl2py]69 and 2.070(2)A in [Zn2 (Ci3 H2 2 N 3 0 4 )2 ][ZnCl3 (py ) ] 2 . 7 0
The complex is held together in the crystal by very strong intermolecular hydrogen bonds 
and van der Waals’ interactions. The N(14)-H(14A)-”N(1A) hydrogen bond in the 
complex is associated with very short donor-acceptor distance o f 2.159(6)A and nearly 
linear donor-acceptor angle of 161.35(7)°, indicating the very strong interaction and the 
packing diagram o f the complex indicating the hydrogen bonds is shown in Figure 4.45.
Figure 4.45
Packing diagram o f  the complex [Zn(smz)2 (py)2]-2 py (15) where the hydrogen bonds are 
shown by dashed lines
Table 4.48: Possible hydrogen bonds and short interactions in [Zn(smz)2(py)2]»2py 
___________ (15) (distances and angles given in A and deg respectively)_______________
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N14 -H14A N14 ....N1A (1) H14A...N1A (1) N14 -H14A...N1A (1)
0.949(5) 3.073(2) 2.159(6) 161.35(7)
C4 -H4 C4 ....012(2) H4 ...012(2) C4 -H4 ...012(2)
0.950(3) 3.409(2) 2.483(4) 164.57(9)
Equivalent positions:
(1) x+1, +y, +z; (2) x, +y, + z - l
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4.9 Cadmium complexes
The crystal data and refinement details for the cadmium complexes [Cd(sdz)2 (dien)].DMF
(16), [Cd(smr)2(dien)].H20  (17), [Cd(sdz)2(bpy)] (18), [Cd(sdz)2(phen)] (19), 
[Cd(sdz)2(dmbpy)].DMF (20), [Cd(smr)2(phen)] (21), [Cd(smz)2(H20)].DMF}„ (22), 
[Cd(smz)2(H20)].2H 20}„ (23) and [Cd(smz)2(en)].DMF (24) are listed in Table 4.49.
4.9.1 Structures of the complexes (16) and (17)
The crystal structures of the complexes are shown in Figures 4.46 and 4.47 respectively for 
the complexes [Cd(sdz)2(dien)].DMF (16) and [Cd(smr)2(dien)].2H20  (17). Selected bond 
lengths and angles for the complexes are given in Table 4.50.
The Cd(II) ions in the complexes are seven coordinate with one tridentate dien molecule 
and two bidentate sulfa drug molecules. The Cd-N distances involving the 
diethylenetriamine ligand [2.362(2), 2.389(2) and 2.373(2)A for the complex (16) and 
2.343(2), 2.398(2) and 2.334(2) for the complex (17)] are comparable with the 
corresponding Cd-N(dien) bond distances in the structure [Cd3(dien)2(NCS)6]„.«H20 71 
with C d-N (l) = 2.287(6), Cd-N(2) = 2.453(8) and Cd-N(3) = 2.31(2)A, 2.340 -  2.425A in 
the polymeric cluster [Cd(dien)2]-[Cd(dien)2]-3(CN)-[Cd8(CN)i9]-3H20 72 and 2.327(5) -  
2.401(4)A in [Cd(dien)2]-2sac (where sacH = saccharin).73
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021C1
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C26 C27N2
S21C4 N1
C 19 lC cHN14 C 28C20 N24
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C18 N22
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C15 C12C17 S11 C11C16 C22
C24
N13 C13
C14011 C23
Figure 4.46
X-ray structure o f  the complex [Cd(sdz)2 (dien)].DMF (16) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms and DMF molecule are omitted fo r  clarity.
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Table 4.49: Crystal data and details of data collection and structure refinement [Cd(sdz)2 (dien)].DMF (16), (Cd(smr)2(dien)].H20 (17), 
[Cd(sdz)2(bpy)] (18), [Cd(sdz)2(phen)] (19), [Cd(sdz)2(dmbpy)].DMF (20), [Cd(smr)2(phen)] (21), ([Cd(smz)2(H20)].DM F}rt (22), 
{[Cd(smz)2(H20)].2H 20 } w (23) and [Cd(smz)2(en)].DMF (24)
(16) (17) (18) (19) (20) (21) (22) (23) (24)
Empirical Formula C27H38CdN,20 5S2 C26H37CdN i j 0 3S2 C3oH26CdN100 4S2C32H26CdN io04S2 C38H44CdN120 6S2C34H30CdN io04S2 C27H35CdN90 6S2 C24H32CdN80 7S2 C32H48CdN120 6S2
Formula Weight 787.21 760.19 767.13 791.15 941.37 819.20 758.16 721.10 873.34
Crystal System Triclinic Triclinic Orthorhombic Orthorhombic Monoclinic Monoclinic Monoclinic Monoclinic Orthorhombic
Space Group P\ P\ Pbcn Pbcn C2/c C2/c P2(l)/c P2x/c P2{1{2
«(A) 8.31170(10) 8.3269(2) 16.7889(5) 16.7230(4) 17.4428(4) 19.4025(7) 16.6200(4) 15.3580(4) 11.9126(5)
b( A) 14.2542(3) 10.8508(3) 15.5601(5) 16.0281(4) 16.2753(4) 15.6340(6) 14.6770(3) 15.0300(5) 22.7582(5)
c(A) 14.7348(3) 18.9660(5) 11.9429(4) 11.9127(3) 16.3873(4) 11.3864(4) 13.2500(2) 13.2270(5) 7.09670(10)
a<°) 88.8394(6) 106.4840(16) 90 90 90 90 90 90 90
PC) 76.4420(7) 90.8340(15) 90 90 118.3334(11) 97.699(2) 101.0440(8) 97.3810(14) 90
X°) 78.2833(11) 105.0620(9) 90 90 90 90 90 90 90
v/A3 2979.73 (18) 1579.53(7) 3119.93 (17) 3193.06(14) 4094.81(17) 3422.8(2) 3172.24(11) 3027.90(17) 1923.98(10)
z 2 4 4 4 4 4 4 4 2
TfK 150 150 150 150 150 150 150 150 150
Crystal Size/mm 0.15x0.12x0.08 0.15x0.12x0.08 0.25x0.22x0.18 0.20x0.18x0.18 0.20x0.18x0.18 0.20x0.18x0.18 0.18x0.15x0.12 0.20x0.18x0.15 0.20x0.18x0.16
Shape Block Block Block Block Block Block Block Block Block
Colour White White White White White White White White White
Grange for data collection 2 .92-27 .52 3 .14-27 .48 3 .12-27.47 3 .06-27 .47 3.43 -27 .48 3.17-27 .48 3.05 -27 .49 3.02-27.48 3.01-27.46
Reflection Collected 14955 23981 16696 32250 18995 14752 29768 20590 17156
Unique Reflections 3874 7103 3573 3653 4685 3910 7242 6895 4357
i^nt 0.0722 0.0559 0.0827 0.0810 0.0704 0.0585 0.0839 0.0964 0.1128
Index ranges -1 0<=h<=10 -10<=h<=10 -19<=h<=21 -2 1 <=h<=21 -22<=h<=22 -25<=h<=24 -21<=h<=21 -19<=h<=19 -15<=h<=13
-18<=k<=18 -14<=k<=14 -20<=k<=20 -20<=k<=20 -20<=k<=21 -20<=k<=20 -1 9<=k<=19 -16<=k<=19 -29<=k<=29
—19<=1<= 19 -23<=I<=24 — 15<=1<= 15 — 15<=1<= 14 -21 <=1<=21 -12<=1<=14 -1 7<=1<= 17 —17<=1<= 14 -9<=I<=9
Data/parameters 3874/231 7103/437 3573/213 3653/230 4685/277 3910/227 7242/436 6895/423 4357/252
Final R indices [I>2o(I)] 0.0360/0.0644 0.0388/0.0827 0.0490/0.1000 0.0358/0.0812 0.0397/0.0915 0.0420/0.0874 0.0466/0.1024 0.0545/0.1047 0.0462/0.1045
R indices (all data) 0.0508/0.0674 0.0548/0.0894 0.0781/0.1101 0.0548/0.0887 0.0531/0.0977 0.0591/0.0913 0.0784/0.1204 0.1053/0.1225 0.0575/0.1099
Largest diff. peak/hole(e.A-3) 0.527/-1.297 0.679/-0.961 0.668/ - l . 120 0.475/-0.681 0.897/-0.576 1.086/-0.806 0.654/-0.744 0.568/-0.780 1.714,/-0.674
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The Cd-N(sdz) bond distances are C d -N (ll)  = 2.495(2), Cd-N(12) = 2.403(2), Cd-N(21) 
= 2.738(2) and Cd-N(22) = 2.317(2)A in (16) and the corresponding Cd-N(smr) distances 
are C d -N (ll)  = 2.434(2), Cd-N(13) = 2.416(2), Cd-N(21) = 2.371(2) and Cd-N(23) = 
2.753(2)A in (17), which are longer than the C d-N  bond distance of 2.240(2)A in the 
complex [Cd(sdz)].2H2074 where Hsdz is sulfadiazine due to the formation o f a four 
membered ring and a high coordination number around the cadmium(II) ion. The pyrimido 
nitrogen N(22) in (16) and N(23) atom in (17) have a weak interaction with the cadmium 
ion in the complexes casing the Cd-N(pyrimido) bond distances to be longer than the 
others.
Table 4.50: Selected bond lengths [A] and angles [deg] in [Cd(sdz)2 (dien)2 ].DMF (16) 
and [Cd(smr)2(dien)].2H20 (17)
Bond (16) (17) Angle (16) (17)
C d(l)-N (ll) 2.495(2) 2.434(2) N(22)-Cd(l)-N(l) 109.68(8) 95.31(8)
Cd(l)-N(12) 2.403(2) 2.416(2) N(22)-Cd(l)-N(3) 84.49(8) 136.64(8)
Cd(l)-N(21) 2.317(2) 2.371(2) N(l)-Cd(l)-N(3) 128.00(8) 105.10(9)
Cd(l)-N(22) 2.738(2) 2.753(2) N(22)-Cd(l)-N(2) 154.95(8) 74.73(8)
Cd(l)-N (l) 2.362(2) 2.343(2) N (l)-Cd(l)-N(2) 74.81(8) 75.32(8)
Cd(l)-N(2) 2.389(2) 2.398(2) N(3)-Cd(l)-N(2) 74.38(8) 74.16(8)
Cd(l)-N(3) 2.373(2) 2.334(2) N(22)-Cd( 1 )-N( 12) 91.99(8) 74.51(8)
S (ll)-0 (11) 1.446(2) 1.449(2) N(l)-Cd(l)-N(12/13) 91.00(8) 91.90(8)
S(11)-0(12) 1.455(2) 1.450(2) N(3)-Cd(l)-N(12/13) 139.67(7) 140.52(8)
S ( ll) -N ( ll) 1.592(2) 1.593(2) N(2)-Cd(l)-N(12/13) 112.81(8) 145.28(7)
S(11)-C(15) 1.755(3) 1.774(3) N (22)-Cd(l)-N (ll) 97.31(8) 125.32(7)
N(11)-C(11) 1.367(3) 1.369(3) N (l)-C d(l)-N (l 1) 137.08(8) 105.91(8)
N(14)-C(18) 1.372(4) 1.376(4) N(3)-Cd(l)-N(l 1) 86.17(7) 85.47(8)
S(21)-0(21) 1.447(2) 1.445(2) N(2)-Cd(l)-N(l 1) 94.58(7) 159.00(8)
S(21)-0(22) 1.454(2) 1.450(2) N(12/13)-Cd(l)-N(l 1) 54.37(7) 55.40(7)
S(21)-N(21) 1.588(2) 1.596(2) N(3)-Cd(l)-N(21) 78.51(7) 96.87(9)
S(21)-C(25) 1.768(2) 1.770(3) N(l)-Cd(l)-N(21) 73.62(7) 145.75(8)
N(21)-C(21) 1.360(3) 1.368(3) N(13)-C(l 1)-N(12) 124.6(2) 125.1(2)
N(24)-C(28) 1.364(3) 1.378(4) N(23)-C(21 )-N(22) 123.8(2) 125.1(2)
N(21)-Cd(l)-N(13) 129.04(7) 87.28(8)
N(21)-Cd(l)-N(2) 109.36(7) 86.09(8)
N (21)-C d(l)-N (ll) 146.52(7) 101.67(8)
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Figure 4.47
X-ray structure o f  [Cd(smr)2 (dien)].H2 O (17) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms 
and water molecule are omitted fo r  clarity.
The geometry of the complex is highly distorted pentagonal pyramid94 and lies between 
monocapped trigonal prism and monocapped octahedron. Inspecting Figure 4.48, it is 
observed that for a monocapped trigonal prism when N (11) is the capped N, then the close 
distance between N (l) and N(22) causes the deviation from the ideality. However, if  we 
describe the coordination sphere as monocapped octahedron with N(21) as the capping N, 
then it is the longer distance between N (l) and N(3) which causes the deviation from 
ideality.
N3
N1 N13
Figure 4.48
Monocapped octahedron structure o f  the complex [Cd(smr)2 (dien)J.H2 0  (17) containing 
only the bonded nitrogen atom
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The sulfonyl (-SO 2- )  and amino (-NH 2 ) groups o f the drug molecules and amino groups of 
diethylenetriamine molecules appear to be hydrogen bonded with each other and also 
hydrogen bonded to the lattice DMF in (16) and water in (17) o f the complexes. The 
N (14)-H (14B )...0(11), N(14)-H(14A)...0(11), N (24)-H (24A )...0(1) and N(2)-H(2A) 
...N(21) hydrogen bonds shows very short donor-acceptor distances and nearly linear 
donor-acceptor angles, which indicate that these interactions are very strong. The packing 
diagram of the complexes (16) and (17) are shown in Figures 4.49 and 4.50 respectively, 
where the hydrogen bonds are shown by open bonds in (16) and dashed lines in (17).
Figure 4.49
Packing diagram o f  the complex [Cd(sdz)2 (dien)].DMF (16) showing the hydrogen bonds 
with open bonds
The several hydrogen bonds present in the complex Cd(sdz)2 (dien)].DMF (16) are listed in 
Table 4.51 and are shown in the packing diagram (Figure 4.50). The hydrogen bonds are 
strong with short donor-acceptor distances and linearity o f the bond angles.
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Table 4.51: The hydrogen bonds for Cd(sdz)2 (dien)].DMF (16) (distances and angles
given in (A) and (°) respectively)
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N2 -H2 N2 ....01 (0) H2 ...01 (0) N2 -H2 ...01 (0)
1.095(.003) 2.971(.005) 1.879(.004) 175.06(0.14)
N3 -H3B N3 ....012(0) H3B ...012 (0) N3 -H3B ...012(0)
0.920(.024) 3.014(.023) 2.151(.011) 155.84( 0.23)
N14 -H14A N 14....01 (1) H14A...01 (1) N14 -H14A...01 (1)
0.936(.025) 3.057(.035) 2.141(.021) 165.75(0.44)
N14 -H14B N14 ....022 (2) H14B...022 (2) N14 -H14B...022 (2)
0.893(.003) 3.076(.005) 2.281(.003) 147.96(0.21)
N1 -H1A N1 ....012(3) H1A ...012 (3) N1 -H1A ...012 (3)
0.920(.020) 3.119(.030) 2.225(.019) 163.91(0.32)
N24 -H24B N24 ....022 (3) H24B...022 (3) N24 -H24B...022 (3)
0.923(.024) 3.144(.027) 2.412(.015) 136.17( 0.29)
N24 -H24B N24 ....N23 (3) H24B...N23 (3) N24 -H24B...N23 (3)
0.923(.024) 3.179(.029) 2.379(.019) 144.77( 0.23)
N24 -H24A N24 ....O il (4) H 24A ...011 (4) N24 -H 24A ...011 (4)
0.891(.004) 2.988(.005) . 2.104(.003) 171.55( 0.23)
Equivalent positions:
(0) x, y, z; (1) -x -1 , -y+1, -z+1; (2) x -l,+ y ,+ z+ l; (3) x+l,+y,+z; (4) -x+1, -y , - z
Figure 4.50
Packing diagram o f  the complex [Cd(smr)2 (dien)].H 2 0  (17) showing the hydrogen bonds 
by dashed lines
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The other hydrogen bonds present in the complex Cd(smr)2(dien)].H20 (16) are listed in 
Table 4.51 and are shown in the packing diagram (Figure 4.51). These are strong with short 
donor-acceptor distances and linearity o f the bond angles.
Table 4.52: Possible hydrogen bonds in [Cd(smr)2(dien)].H20 (17) (distances and
angles given in A and deg respectively)
Donor-H Donor... Acceptor H...Acceptor Donor-H.....Acceptor
N2 -H2 N2 ....N21 (0) H2 ...N21 (0) N2 -H2 ...N21 (0)
0.880(1) 3.256(4) 2.399(2) 164.66(4)
N24 -H24B N 24....01  (1) H24B...01 (1) N24 -H24B...01 (1)
0.935(3) 3.142(3) 2.210(3) 174.48(6)
N14 -H14B N 14....011 (2) H14B...011 (2) N14 -H 14B ...011 (2)
0.933(4) 3.230(5) 2.360(3) 154.91(6)
N24 -H24A N 24....01  (3) H24A...01 (3) N24 -H24A...01 (3)
0.928(2) 3.145(3) 2.247(3) 162.75(5)
N1 -H1C N1 ....022(4) H 1C ...022 (4) N1 -H1C ...022 (4)
0.920(3) 3.045(5) 2.331(8) 134.21(5)
Ol -HIE O l ....N22 (5) H1E...N22 (5) Ol -HIE ...N22 (5)
0.926(3) 3.043(4) 2.154(4) 160.49(5)
N1 -HID N1 ....012(6) H ID  ...012 (6) N1 -HID ...012 (6)
0.920(8) 3.019(8) 2.197(4) 148.46(3)
N3 -H3C N3 ....011(6) H 3C...011 (6) N3 -H 3C ...011 (6)
0.920(3) 3.319(4) 2.501(4) 148.32(4)
Equivalent positions:
(0) x,y,z; (1) x,+y-l,+z; (2) x+l,+y,+z; (3) -x+l,-y,-z; (4) x-l,+y,+z; (5) -x+ l,-y+l,-z; (6) - 
x,-y,-z+l
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4.9.2 Description and discussion of the complex (18), (19), (20) and (21)
Single crystals suitable for X-ray determination were obtained for the complexes 
[Cd(sdz)2(bpy)] (18), [Cd(sdz)2(phen)] (19), [Cd(sdz)2(dmbpy)].DMF (20) and 
[Cd(smr)2(phen)] (21). The bond lengths and angles are listed in Table 4.53.
Table 4.53: Selected bond lengths [A] and angles [°] in the complexes (18) -  (21)
Bonds (18) A (19) A (20) A (21) A
Cd(l)-N(l 1) 2.283(3) 2.275(2) 2.253(2) 2.194(2)
Cd(l)-N(12) 2.501(3) 2.517(2) 2.504(2) 2.793(2)
C d(l-N (l) 2.313(3) 2.315(2) 2.313(2) 2.303(2)
S (ll)-0 (11) 1.442(3) 1.443(2) 1.444(2) 1.446(2)
S (ll)-0 (12) 1.443(3) 1.448(2) 1.450(2) 1.448(2)
S (ll)-N (l 1) 1.607(3) 1.603(2) 1.606(2) 1.616(2)
S(ll)-C(15) 1.759(4) 1.763(3) 1.757(3) 1.760(3)
N(11)-C(11) 1.371(5) 1.379(3) 1.371(3) 1.377(3)
N(14)-C(18) 1.358(5) 1.374(3) 1.362(4) 1.367(4)
Angle 0 (°) (°) (°)
N(11)-Cd(l)-N(12) 55.79(10) 55.69(7) 56.11(7) 52.25(9)
N(l)-Cd(l)-N(12) 88.18(11) 86.44(8) 91.24(8) 91.24(8)
N(1 T )-C d(l)-N (ll) 103.49(15) 105.45(11) 116.96(11) 108.74(11)
N(1 T)-Cd(l)-N(l) 110.47(11) 113.05(8) 102.86(8) 116.98(9)
N(11)-Cd(l)-N(l) 131.04(12) 125.92(8) 128.99(8) 119.31(9)
N (l)-C d(l)-N (l') 71.29(17) 72.28(12) 70.91(11) 72.35(13)
N(1 l')-Cd(l)-N(12) 92.14(11) 91.10(8) 95.55(7) 93.00(1)
, N(T)-Cd(l)-N(12) 136.12(12) 142.01(8) 134.16(8) 148.65(9)
N(12')-Cd(l)-N(12) 129.83(14) 126.57(10) 127.68(10) 122.54(9)
N(13)-C(l 1)-N(12) 125.4(4) 125.7(2) 125.6(2) 126.5(2)
Symmetry transformations used to generate equivalent atoms: (') -x , y ,  -Z+V 2
The geometry of the complexes [(18), (19) and (20)] is trigonal prismatic with the Cd atom 
lying on a two-fold axis which are very similar to that found in the cadmium complex 
[Cd(L)(NCS)2]75,95 (where L is bis-(l-pyridin-2-yl-ethylidene)-propane-1,3-diamine) which 
is also similar to the zinc complex [Zn(py)3 (ch)]% (where py = pyridine-2-carboxaldimino 
and ch = cyclohexane). In the complexes both the sulfa drug molecules are bonded to the 
Cd atom through the sulfonamidic nitrogen [N (ll)] and the pyrimido nitrogen 
[N(12)/N(13)] atoms and the secondary ligands are coordinated through the nitrogen N (l) 
atoms.
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Figure 4.51
X-ray structure o f  the complex [Cd(sdz)2 (bpy)] (18) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The ring 
hydrogen atoms are omitted fo r  clarity.
The C d-N (l) bond distances of 2.313(3)A in (18), 2.315(2)A in (19), 2.313(2)A in (20) 
and 2.303(2)A in (21) are very similar with each other and are comparable with the 
corresponding distances of the values of 2.314(9) and 2.32(1)A in the complex 
[Cd2(pda)(bpy)2Cl2]n76, 2.297(3) and 2.309(2)A in the complex
[Cd(bpy)2(0Ac)](C104)-«H20 77, 2.325(3) and 2.352(2)A in the complex
[Cd2(bpy)2( 0 Ac)4(H20 ) 2]11, 2.322(9)A in the complex [Cd(bpy){N(CN)2}2]78 and 2.322(3) 
and 2.342(2)A in the complex [Cd(phen){N(CN)2}2]78 and shorter than the corresponding 
values of 2.383(4) and 2.381(4)A in the complex [Cd(sac)2(bpy)]79, 2.391(6) and 
2.352(5)A in the complex [Cd(bipy)(tsgluO)]80, 2.340(8) and 2.385(8)A in the complex 
[Cd(L)(phen)]81 where L is 2-(2-mercaptophenyl)-iminophenoxy] and 2.371 (4)A in the 
complex [Cd(L)(phen)] where L is 2-[(2-methoxyphenyl)iminomethyl]-pyrrolato.
The Cd-N distances involving sulfonamidic nitrogen atoms, 2.283(3), 2.275(2), 2.253(2) 
and 2.194(2), are shorter than the corresponding bonds with values of 2.495(2)A in the 
complex [Cd(sdz)2(dien)].DMF (16) and 2.434(2)A in the complex [Cd(sdz)2(dien)].DMF
(17) and are very similar to that of 2.240(2)A in the complex [Cd(sdz)2].2H20 .74
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The N(14)-H(14A)—0(12) and N(14)-H(14B)*-N(13) hydrogen bonds in [Cd(sdz)2 (bpy)] 
complex have short donor-acceptor distances and nearly linear donor-acceptor angles, 
indicating the interactions are very strong.
Figure 4.52
Packing diagram o f  the complex [Cd(sdz)2 (bpy)] (18) showing the hydrogen bonds by 
dashed lines
Table 4.54: Possible hydrogen bonds and short interactions in [Cd(sdz)2 (bpy)] (18) 
(distances and angles given in A and deg respectively)
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N14 -H14A N14 ....012(1) H14A...012 (1) N14 -H14A...012 (1)
0.891(1) 2.925(1) 2.068(6) 161.09(4)
N14 -H14B N14 ....N13 (2) H14B...N13 (2) N14 -H14B...N13 (2)
0.930(4) 3.034(1) 2.203(7) 148.26(2)
C12 -H12 C12....011 (3) H12 ...O il (3) C12 -H12 ...O il (3)
0.950(1) 3.238(2) 2.528(7) 131.59(1)
C3 -H3 C3 ....011(4) H3 ...011(4) C3 -H3 ...011(4)
0.950(6) 3.218(5) 2.379(2) 147.09(3)
Equivalent positions:
(1) -X+V2 , +y+1/ 2 , +z; (2) x, -y+1, +Z-V2 ; (3) X-V2 , -y+'A, -z+ 1; (4) - x ,  -y ,  -z+1
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The crystal structure of [Cd(sdz)2 (phen)] (19) is shown in Figure 4.54 together with the 
crystallographic atom numbering scheme used.
C6 C6'
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Figure 4.54
X-ray structure o f  the complex [Cd(sdz)2 (phen)J (19) showing crystallographic atom 
numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms are omitted fo r  clarity.
In addition, it is found that the complex prefers the distribution o f the ligands and sulfa 
drug molecules in a way that the secondary ligand molecules remain on one side and two 
sulfa drug molecules remain on the other sides of the complexes.
The N (14)-H (14A )-0(11), N (14)-H (14B )-0(12) and N (14)-H (14A )-N (13) hydrogen 
bonds in [Cd(sdz)2 (phen)] (19) complex show strong interactions because o f the short 
donor-acceptor distances and linear angles.
132
Chapter 4
Figure 4.55
Packing diagram o f  the complex [Cd(sdz)2 (phen)] (19) showing the hydrogen bonds by 
dashed lines
Table 4.55: Possible hydrogen bonds and short interactions in [Cd(sdz)2 (phen)] (19) 
___________ (distances and angles given in A and deg respectively)___________________
Donor-H Donor... Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H14A N14 ....N13 (1) H14A...N13 (1) N14 -H14A...N13 (1)
0.946(4) 3.215(7) 2.353(7) 151.32(3)
N14 -H14A N 14....011 (1) H14A ...011 (1) N14 -H 14A ...011 (1)
0.946(4) 3.066(2) 2.418(3) 125.54(2)
N14 -H14B N14 ....012 (2) H14B...012 (2) N14 -H14B...012 (2)
0.947(2) 2.984(6) 2.041(2) 174.20(3)
Equivalent positions: 
(1) x, -y+ l,+ z-!4 ; (2)' -x+V^+y+V^+z; (3) x - !/ 2 , -y+Vz, -z+1; (4) -x , -y , -z+1
The crystal structure of the complex [Cd(sdz)2 (dmbpy)].DMF (20) is shown in Figure 4.56 
together with the crystallographic atom numbering scheme used.
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Figure 4.56
X-ray structure o f  the complex [Cd(sdz)2 (dmbpy)].2 DMF (20) showing crystallographic 
atom numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. The 
hydrogen atoms and DM F molecules are omitted fo r  clarity.
Figure 4.57
Packing diagram o f  the complex [Cd(sdz)2 (dmbpy)].2 DMF (20) showing the hydrogen 
bonds by dashed lines
The N (14)-H (14B )-0(11), N (14)-H (14A )-0(12) and N (14 )-H (14B )-0 (1 ) hydrogen 
bonds in [Cd(sdz)2(dmbpy)].2DMF (20) have very short donor-acceptor distances and 
nearly linear donor-acceptor angles showing the interactions are very strong.
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Table 4.56: Possible hydrogen bonds and short contracts in [Cd(sdz)2(dmbpy)].2DMF 
__________ (20) (distances and angles given in A and deg respectively)_________ ______
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N14 -H14A N14 ....012(1) H14A...012 (1) N14 -H14A...012 (1)
0.894(.078) 2.948(.088) 2.061 (.049) 171.66( 0.26)
N14 -H14B N 14....01 ' (2) H14B...01' (2) N14 -H14B...01' (2)
0.886(.093) 3.044(.350) 2.161 (.336) 175.19( 0.63)
N14 -H14B N 14....01 A(2) H14B...01 A(2) N14 -H14B...01 A(2)
0.886(.093) 2.859(.210) 2.026(.178) 156.13( 0.38)
Cl -HI Cl ....011(3) HI ...011(3) Cl -HI ...0 1 1 (3 )
0.950(.023) 3.283(.047) 2.494(.027) 140.53(0.21)
C12 -H I2 C12....011 (4) H 12...011 (4) C12 -H12 ...O il (4)
0.950(.089) 3.392(.088) 2.476(.043) 161.93(0.26)
Equivalent positions:
(1) -x+V2 ,+y+1/ 2 ,-z+ 1/ 2 ; (2) x, -y+lj+z+Vi; (3) -x , +y, -z+!/2; (4) x-V ^-y+V ^+z-1/^
The six coordinate cadmium complex is trigonal prismatic since the bpy molecule lies on 
the one part o f the molecule and the two larger sulfadiazine molecules lie on the other part. 
It is found that the N -C d-N  chelate angles within the complex are virtually identical.
N12
N11
N1
N i r
Cd1
N12'
Figure 4.53
Trigonal prismatic structure o f  the complex [Cd(sdz)2 (dmbpy)].2 DMF (20) containing only 
nitrogen atoms
The crystal structure o f [Cd(smr)2 (phen)] (21) is shown in Figure 4.58 together with the 
crystallographic atom numbering scheme used. The complex shows a bicapped tetrahedral 
arrangement around the cadmium centre which is similar in the zinc complex97 and 
hafnium complex.98
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Figure 4.58
X-ray structure o f  [Cd(smr)2 (phen)] (21) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms 
are omitted fo r clarity.
N12'
Figure 4.59
The bicapped tetrahedral structure fo r  the complex [Cd(smr)2 (phen)J (21) containing only 
the bonded nitrogen atoms
The N(14)-H(14A)*"0(11) and N (14)-H (14B)-N (13) hydrogen bonds in 
[Cd(smr)2 (phen)] show strong interactions having very short donor-acceptor distances and 
nearly linear donor-acceptor angles which are shown in the packing diagram (Figure 4.60). 
The other hydrogen bonds and short contacts of the complex [Cd(smr)2 (phen)] (21) are 
listed in Table 4.57.
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Figure 4.60
Packing diagram o f  the complex [Cd(smr)2 (phen)] (21) showing the hydrogen bonds by 
dashed lines
Table 4.57: Possible hydrogen bonds and short interactions in [Cd(smr)2 (phen)] (21) 
___________ (distances and angles given in A and deg respectively)___________________
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H14A N 14....011 (1) H14A ...011 (1) N14 -H 14A ...011 (1)
0.950(9) 2.994(1) 2.083(9) 160.24(3)
N14 -H14B N14 ....N13 (2) H14B...N13 (2) N14 -H14B...N13 (2)
0.949(7) 3.125(1) 2.381(7) 135.02(4)
N14 -H14B N 14....011 (2) H14B...011 (2) N14 -H 14B ...011 (2)
0.949(7) 3.173(2) 2.375(7) 141.55(2)
C16 -H16 C16 ....N12 (3) H16 ...N12 (3) C16 -H16 ...N12 (3)
0.950(9) 3.503(1) 2.556(6) 174.33(3)
C3 -H3 C3 ....011(4) H3 ...O il (4) C3 -H3 ...011(4)
0.950(7) 3.213(5) 2.375(2) 146.87(3)
Equivalent positions:
(1) -x+!/2 ,+y+!/2 ,-z+1/ 2 ; (2) x,-y+l,+z+/4; (3) -x,+y,-z+!/2 ; (4) x-y^+z+Vi
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4.9.3 Crystal structure of the polymeric cadmium complexes 
{[Cd(smz)2(H20)].DM F}n (22) and {[Cd(smz)2(H20)].2H 20 } n (23)
The complexes consist of a polymeric crystal structures held together in the crystals by 
very strong hydrogen bonds and Van der Waals’ interactions.
Table 4.58: Selected bond lengths [A] and angles [°] in (22) and (23)
Bond (2 2 )a (23)* Angle (22)° (23)*
Cd(l)-N(l 1) 2.307(3) 2.320(3) N(11)-Cd(l)-0(1) 86.38(11) 86.63(12)
Cd(l)-N(12) 2.407(3) 2.411(4) N(11)-Cd(l)-N(21) 177.50(11) 171.99(12)
Cd(l)-N(21) 2.355(3) 2.337(3) 0(1)-Cd(l)-N(21) 95.61(11) 95.82(12)
Cd(l)-N(22) 2.356(3) 2.322(3) N (ll)-C d(l)-N (22) 124.65(11) 114.80(13)
C d(l)-0(1) 2.325(3) 2.336(3) 0(1)-Cd(l)-N(22) 90.14(11) 98.54(12)
Cd(l)-N(14)#l 2.400(3) 2.372(4) N (21 )-Cd( 1 )-N (22) 56.97(10) 57.33(13)
S (ll)-0 (11) 1.444(3) 1.448(3) N( 11 )-Cd( 1 )-N( 14)# 1 91.24(11) 98.47(13)
S(11)-0(12) 1.454(3) 1.457(3) 0(1)-Cd(l)-N(14)#l 106.31(11) 95.57(13)
S(11)-N(11) 1.583(3) 1.586(4) N (21 )-Cd( 1 )-N( 14)# 1 86.75(11) 88.89(13)
S(11 )-C(l 5) 1.770(4) 1.761(4) N(22)-Cd(l)-N(14)#l 141.81(11) 144.40(13)
N(11)-C(11) 1.390(5) 1.382(6) N(11)-Cd(l)-N(12) 57.01(10) 56.65(12)
N(14)-C(18) 1.425(5) 1.411(6) 0(1)-Cd(l)-N(12) 140.23(10) 143.27(12)
S(21)-0(21) 1.445(3) 1.452(3) N(21)-Cd(l)-N(12) 121.48(11) 120.38(12)
S(21)-0(22) 1.459(3) 1.454(3) N(22)-Cd( 1 )-N( 12) 98.16(10) 96.29(12)
S(21)-N(21) 1.596(3) 1.597(4) N(14)#l-Cd(l)-N(12) 90.79(10) 91.48(13)
S(21)-C(25) 1.760(4) 1.750(4) N(13)-C(l 1)-N(12) 126.3(3) 126.6(4)
,N(21)-C(21) 1.385(5) 1.372(6) N(23)-C(21 )-N(22) 125.8(3) 125.9(4)
N(24)-C(28) 1.383(5) 1.369(6) C( 18)-N( 14)-Cd( 1 )#2 112.2(2) 113.9(3)
Symmetry transformations used to generate equivalent atoms:
O  #1 and (b) #2 -x+ l,y+1/ 2 ,-z+1/2; O  # 2  and (4) #1 -x+l.y-K.-z+'A
The cadmium ions lie on the centre o f symmetry in the complexes and exhibit highly 
distorted octahedral geometry, being coordinated to the sulfonamidic [N(l 1)/N(21)] and 
pyrimido N[(12)/(22)] nitrogen atoms of two bidentate sulfamethazine ligands generating 
four-membered rings. The nitrogen atom N(14) from the terminal amino group o f a third 
sulfamethazine, which is bonded to the adjacent Cd(II) ion, and the 0 (1 ) atom of water 
molecule complete the coordination sphere. Although both ligands are bound to cadmium, 
only one sulfamethazine presents two equivalent C d-N  bond distances [C d(l)-N (21) and 
Cd(l)-N (22) are 2.355(3) and 2.356(3)A respectively in the complex (22) and 2.337(3) 
and 2.322(3)A respectively in the complex (23)]. The other Cd-N bond distances
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C d (l)-N (ll)  and Cd(l)-N (12) are 2.307(3) and 2.407(3)A respectively in (22) and 
2.320(3) and 2.411(3)A respectively in (22).
The terminal N(24)-C(28) bond distance [1.383(5)A in (22) and 1.369(6)A in (23)] is 
shorter than the N(14)-C(18) bond distance [1.425(5)A in (22) and 1.411(6)A in (23)] 
which is comparable with the corresponding value of 1.413(9)A in the polymeric complex 
{[Cd(smz)2 (H2 0 )].2 H2 0 }„1 and 1.428(4)A in the previous polymeric cobalt complex 
{[Co(smz)2(H20)].DMF}„ (3) and is consistent with the coordination of the terminal amino 
group [N(14)] to the adjacent Cd(II) ion. The packing of the complex unit is governed by a 
long chain formed by the bridging sulfamethazine ligand which is bound to C d(l) via 
N(11)/N(12) and C d(l)# l via —NH2 of the N(14)-Cd distances of 2.400(2)A in (22) and 
2.372(4)A in (23) are comparable o f the bond distance of 2.379(7)A in the complex 
[Cd(smz)2(H20)].2H20.1 That is, one o f the sulfamethazine molecules attached to the 
cadmium ion acts as bridging ligand with the adjacent cadmium ion of the second molecule 
to form the polymer. The bond lengths and angles of the phenyl rings conform to those 
found in the free sulfamethazine molecule.9,10 Stacking interactions are present in the 
crystal structure involving phenyl and heterocyclic rings.
The asymmetric unit o f the complex (22) is shown in Figure 4.61 together with the 
crystallographic atom numbering used and polymeric form is shown in Figure 4.62.
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Figure 4.61
X-ray structure o f  [Cd(smz)2(H20)].DMF (22) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms 
and DMF molecule are omitted fo r  clarity.
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Figure 4.62
Structure o f  polymeric form  o f  [Cd(smz)2 (H2 0 )].DM F (22) where cobalt ion is bonded to 
the terminal N(14) atom o f  the adjacent cobalt ion.
In complex (22), there exist several hydrogen bonds between the electronegative elements 
and hydrogen atoms. The N (14)-H (14B )-0(11), N (14)-H (14A )-0(12) and N (14)- 
H(14B)—N(13) hydrogen bonds in the complex show very short donor-acceptor distances 
and nearly linear donor-acceptor angles indicating strong interactions. In the packing 
diagram the hydrogen bonds are shown by dashed lines (Figure 4.63).
Figure 4.63
Packing diagram o f  the complex [Cd(smz)2 (H2 0 )].D M F (22) showing the hydrogen bonds 
with open bonds
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Table 4.59: The hydrogen bonds in [Cd(smz)2(H20)].DMF (22) (distances and angles 
given in A and deg respectively)
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
01 -H1A 01 ...02 (0) H1A ...02 (0) 01 -H1A ...02  (0)
0.821(4) 2.733(5) 1.931(4) 165.58(4)
01 -H1B O l ...012 (0) H1B ...012 (0) 01 -H1B ...012(0 )
0.890(4) 2.767(4) 1.892(4) 167.28(4)
N14 -H14A N14 ...O il (1) H14A ...O il (1) N14 -H14A ...O il (1)
0.926(3) 2.978(4) 2.095(3) 159.18(3)
N14 -H14B N14 ...022 (2) H14B ...022 (2) N14 -H14B ...022 (2)
0.863(4) 2.933(4) 2.076(4) 172.49(3)
N24 -H24B N24 ...021 (3) H24B ...021 (3) N24 -H24B ...021 (3)
0.972(7) 3.011(5) 2.059(7) 165.95(5)
Equivalent positions:
(0) x,y,z; (1) Xj-y+V^+z-1/^; (2) -x+l,+y-1>4,-z+1/2; 0 ) x -y+ l/2+\,+z-V2
The asymmetric unit o f the complex (23) is shown in Figure 4.64 together with the 
crystallographic atom numbering used and the polymeric form is shown in Figure 4.65.
C 1 1 2
N 2 4 C 1 3
C 1 1 1C 2 9 C 1 4C 2 8 C 1 2C 3 0
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N1 1 0 1 50 2 2  C 2 1  
N 2 3  « r
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Figure 4.64
X-ray structure o f  [Cd(smz)2 (H2 0 )] .2 H2 O (23) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms 
and lattice water molecules are omitted fo r  clarity.
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Figure 4.65
Polymeric structure o f  [Cd(smz)2 (H2 0 )]. 2 H2 O (23) in the polymeric form  where cobalt ion 
is bonded to the terminal N(14) atom o f  sulfamethazine attached to the adjacent cobalt ion.
Figure 4.66
Packing diagram o f  the complex [Cd(smz)2 (H2 0 )] .2 H2 0  (23) showing the hydrogen bonds 
with open bonds
In the complex the cadmium species has a distorted octahedral stereochemistry with the 
equatorial plane defined by two sulfonamidic nitrogen atoms [N (ll)  and N(21)] in trans 
position, two pyrimido nitrogen atoms [N(12) and N(22)] in cis position, one terminal
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amino atom [N(24)] and one oxygen atom from the lattice water completing the 
coordination sphere. The N(14)-H(14B)""0(1), N(14)-H(14A)' 0(12) and N (24)- 
H(24A) 0(11) hydrogen bonds and short interactions in {[Cd(smz)2.H20].2H20}„ are 
very strong with almost linear bond angles and short distances. The hydrogen bonds and 
short contacts are shown in packing diagram (Figure 4.66).
Table 4.60: The hydrogen bonds in [Cd(smz)2(H20)].2H20 (23) (distances and angles 
given in A and deg respectively)
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
01 -H1B 
0.949(5)
01 ...022 
2.750(5)
(0) H1B ...022 
1.832(5)
(0) 01 -H1B ...022 
161.81(4)
(0)
N14 -H14A 
0.947(4)
N14 ...012 
3.076(5)
(1) H14A ...012 
2.210(4)
(1) N14 -H14A ...012 
151.62(3)
( 1)
N14 -H14B 
0.949(3)
N14 ...01 
3.098(5)
(2) H14B ...01 
2.151(2)
(2) N14 -H14B ...01 
175.05(2)
(2)
N24 -H24A 
0.948(3)
N24 ...O il 
2.946(5)
(3) H24A ...O il 
2.038(3)
(3) N24 -H24A ...O il 
159.70(2)
(3)
N24 -H24B 
0.947(3)
N24 ...021 
2.963(5)
(4) H24B ...021 
2.024(3)
(4) N24 -H24B ...021 
171.20(2)
(4)
01 -H1A 
0.948(2)
01 ...03
2.699(5)
(5) H1A ...03 
1.754(2)
(5) 01 -H1A ...03 
174.28(2)
(5)
0 2  -H2A 
0.948(4)
0 2  ...012 
3.062(4)
(6) H2A ...012 
2.118(4)
(6) 0 2  -H2A ...012 
173.35(3)
(6)
0 2  -H2B 
0.949(6)
0 2  ...N13 
3.131(5)
(7) H2B ...N13 
2.200(6)
(7) 0 2  -H2B ...N13 
166.69(5)
(7)
03  -H3A 
0.948(4)
03  ...021 
2.890(5)
(8) H3A ...021 
2.019(4)
(8) 03 -H3A ...021 
151.91(3)
(8)
03  -H3B 
0.949(6)
03  ...02 
2.774(5)
(8) H3B ...02 
1.835(5)
(8) 03  -H3B ...02  
169.45(5)
(8)
Equivalent positions:
(0) x, y, z; (1) x,-y-!/2,+z+!4; (2) -x+2,+y-1/2,-z+1/2; (3) -x+l,+y+1/2 ,-z+1/ 2; (4) Xj-y+V^+z+Vz; 
(5) x,+y,+z-l; (6) -x+l,-y,-z; (7) x-l,+y,+z; (8) -x+l,-y,-z+l
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4.9.4 Crystal structure of the complex [Cd(smz)2(en)].2DMF (24)
The crystal structure o f the complex [Cd(smz)2(en)].2DMF (24) is shown in Figure 4.67 
together with the crystallographic atom numbering scheme used. The bond lengths and 
angles are given in Table 4.61 and the hydrogen bond dimensions are listed in Table 4.62.
The geometry o f the complex is distorted octahedral with the Cd atom lying on a two-fold 
axis. Both the sulfamethazinato ligands are bonded to Cd by a sulfonamidic nitrogen 
[N (ll)] atom and a pyrimido nitrogen [N(12)] atom and two nitrogen atoms from the 
ethylenediamine molecules complete the coordination sphere on the cadmium ion.
011 01 2
C15 C16 C1?
S11
C20 C19 C18N12'
N14N11C1'
C11 N13
d r Cd1
N12 C14 C112
N1
C12 C13
c m
Figure 4.67
X-ray structure o f  [Cd(smz)2(en)].2DMF (24)  showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. Hydrogen atoms and 
DMF molecules are omitted fo r  clarity.
The ethylenediamine molecule is chelated to the Cd atom symmetrically in the octahedral 
structure. The C d-N (l)(en) distance o f 2.321(4)A is comparable with the values o f 2.39(2) 
and 2.26(2)A in the complex [Cd(en)][Ni(CN)4 ].2 C6 H 6 83 and 2.317(3)A in 
[Cd(en)(N0 3 )2(4,4'-bpy)]„84 and the C d -N (ll)  distance o f 2.311 (3)A is shorter than 
Cd-N(12) distance o f 2.471 (4)A which are comparable with the corresponding distance o f 
2.307(3)A in the complex {[Cd(smz)2 (H2 0 )].DMF}„ (22), 2.337(3) and 2.322(3)A in the 
complex {[Cd(smz)2 (H2 0 )].2 H2 0 }„ (23) and 2.426(6) and 2.326(6)A in the complex 
[Cd(smz)2(H20)].2H 20.1 The C d-N (l) bonds are similar in length to the C d-N (l 1) bonds 
and the difference between these two types o f C d-N  bonds, [A = (d[C d-N (l)] -  
d [C d-N (ll)]}  (A)], -0.010(4)A  suggesting that the C d -N (l) bonds have similar strengths 
as the C d-N (l 1) bonds in the complex.
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Table 4.61: Selected bond lengths |A] and angles [deg] in [Cd(smz)2(en)].2DMF (24)
Bond (A) Bond (A )
C d(l)-N (l 1) 2.311(3) C d(l)-N (l) 2.321(4)
Cd(l)-N(12) 2.471(4) S(11)-0(12) 1.448(3)
S(11)-0(11) 1.449(3) S(11)-N(11) 1.608(3)
S(ll)-C (15) 1.763(4) N(11)-C(11) 1.368(5)
N(14)-C(18) 1.382(6)
Angle (°) Angle (°)
N (11)-Cd(l)-N (l T) 144.99(18) N (11)-Cd(l)-N (l) 117.47(12)
N (ll ')-C d (l)-N (l) 90.46(12) N (l)-C d(l)-N (T ) 77.44(19)
N (ll)-C d(l)-N (12 ') 104.23(12) N (l)-C d(l)-N (12') 137.34(12)
N (11 )-Cd( 1 )-N( 12) 56.00(11) N (l)-C d(l)-N (12) 94.44(12)
N (l')-C d(l)-N (12) 137.34(12) N(12')-Cd(l)-N(12) 117.22(16)
0(12)-S(11)-0(11) 116.46(18) 0(12)-S(11)-N(11) 112.00(19)
0 ( 1 1)-S(11)-N(11) 104.99(17) 0(12)-S(11)-C(15) 107.42(18)
0(11 )-S( 11 )-C( 15) 107.32(19) N(11)-S(11)-C(15) 108.33(18)
C( 11 )-N( 11 )-S(l 1) 121.3(3) N(13)-C(l 1)-N(12) 125.7(4)
Symmetry transformations used to generate equivalent atoms: (') -x , -y , z
The N (1 4 )-H (1 4 B )-0 (1 1), N (14)-H (14A )-0 (12), N (l) -H (l A )-O (l)  and
N (1)-H (1B )--0(11) are very strong with almost linear bond angles and short distances. 
The several hydrogen bonds are shown in the packing diagram (Figure 4.68).
Figure 4.68
Packing diagram o f  the complex [Cd(smz)2 (en)].2DMF (22) showing the hydrogen bonds 
with open bonds
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Table 4.62: The hydrogen bonds in [Cd(smz)2(en)].2DMF (24) (distances and angles 
given in A and deg respectively)
Donor-H Donor... Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H14A N14 ....012(1) H 14A...012 (1) N14 -H14A...012 (1)
0.950(9) 3.111(7) 2.265(8) 148.07(2)
N14 -H14B N14 ....O il (2) H 14B ...011 (2) N14 -H 14B ...011 (2)
0.949(3) 3.134(4) 2.324(5) 142.97(2)
N1 -H1A N1 ....01 (3) H 1A ...01  (3) N1 -H 1A ...01 (3)
0.920(6) 2.958(9) 2.062(7) 164.15(9)
N1 -H1B N1 ....011(3 ) H1B ...O il (3) N1 -H 1B ...011 (3)
0.920(2) 3.088(1) 2.286(5) 145.48(2)
Equivalent positions:
(1) x-Vi, y  V2 , -z+ 1 ; (2) x - lA, -y - 'A , -z ; (3) -x , -y ,  +z
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4.10 Mercury complexes of triple sulfa drugs (TSD)
The diversity o f the coordination numbers for the mercury complexes can be found in the 
literature. In monoorganomercury(II) compounds, the primary bonds leave the Hg atom 
with enough residual acidity for it to be able to reach a coordination number of six when 
the donor atoms forming the secondary bonds are small. There are only a small number of
o r
Hg complexes with coordination number two. On the other hand, Hg(II), has an 
extremely high affinity for thiol-containing compounds, and forms 1:2 metahligand linear
o /
complexes with them.
The tetrahedral geometry was postulated in the mercury(II) complexes o f the type HgX2 L2  
(where L = l,3-imidazole-2-thione, 1-methyl-1,3-imidazole-2-thione; X = Cl~, Br”) on the
0 7
basis of IR and NM R data. In the Hg(II) complex with 2-(cr-hydroxybenzyl)thiamine, the 
metal coordination unit consists o f two distorted tetrahedra sharing two vertexes, and the
* • Q Ohigh basicity o f the N o f the pyrimidine ring allows the coordination with the metal. An 
example o f octahedral local geometry is the complex o f Hg(II) with the bidentate ligand
RQlactobionic acid (L): [HgL2].2H20. With respect to Hg(II)-sulfa drug complexes, both
1 'Jgeometries (linear arrangement and tetrahedral ) were founded by X-ray crystal structure.
In this section, we will discuss the mercury complexes o f sulfa drugs with two 
(sulfamerazine complex), four (sulfadiazine and sulfamethazine) and six (sulfamerazine 
with 2,2'-bipyridine) coordination geometry.
4.10.1 Crystal structure of the complexes (25), (26), (27) and (28)
Single crystals suitable for X-ray determination were obtained for the complexes and 
characterised by independent analytical and spectroscopic data. We also determined the 
modes o f coordination and molecular geometry and compared these with other related 
species. The crystal data and refinement details for the complexes are listed in Table 4.63.
The crystal structures o f the complexes [Hg(sdz)2 (DMF)2 ] (25), [Hg(smr)2 ] (26), 
[Hg(smr)2 (bpy)] (27) and [Hg(smz)2 (DMF)2 ] (28) are shown in Figures 4.69, 4.71, 4.73 
and 4.75 respectively together with the crystallographic atom numbering scheme used. The 
selected bond lengths and angles are collected together in Table 4.64.
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Table 4.63 Crystal data and details of data collection and structure refinement for the complexes [Hg(sdz)2 (DMF)2 ] (25), 
[Hg(smr)2] (26), [Hg(smr)2(bpy)] (27) and [Hg(smz)2(DMF)2] (28)
[Hg(sdz)2(DMF)2] (25) [Hg(smr)2] (26) [Hg(smr)2(bpy)] (27) [Hg(smz)2(DMF)2] (28)
Empirical Formula C26H32HgN i0O6S2 C22H22HgN804S2 C32H3oHgN,o04S2 C3oH4oHgNio06S2
Formula Weight 845.33 727.19 883.37 901.43
Crystal System Monoclinic Monoclinic Monoclinic Monoclinic
Space Group C2/c C 2/c C 2/c P2\!c
a{ A) 20.0760(5) 12.8834(5) 18.7483(8) 12.4196(2)
b( A) 8.3210(3) 14.5693(5) 15.0824(7) 8.8066(2)
c(A ) 19.8380(6) 12.7683(6) 12.1143(6) 17.0090(3)
A °) 108.659(2) 97.5505(14) 100.202(2) 107.9718(14)
v/Ar3 3139.8(2) 2375.86(17) 3139.8(2) 1769.58(6)
z 4 4 4 2
77K 150 150 150 150
Crystal Size/mm 0 .1 2x0 .10x0 .08 0 .15x0 .12x0 .08 0 .1 8x0 .15x0 .12 0 .16x0 .12x0 .10
Shape Block Block Block Block
Colour White White White White
Grange for data collection 3 .01-27 .46 3.19-27 .46 3.20-27.51 2.93 -  27.47
Reflection Collected 14863 16902 14955 19422
Unique Reflections 3570 2713 3874 4020
i^nt 0.0761 0.0866 0.0722 0.0842
Index ranges -26<=h<=25 -16<=h<=16 —24<=h<=19 -16<=h<=15
—10<=k<=10 -18<=k<=18 — 19<=k<=19 -11<=k<=11
—25<=1<=25 —16<=1<= 16 -14<=1<=15 -22<=1<=21
Data/parameters 3570/214 2713/177 3874/231 4020/235
Final R indices [7>2o(/)] 0.0373/0.0629 0.0386/0.0842 0.0360/0.0644 0.0357/0.0703
R indices (all data) 0.0523/0.0679 0.0465/0.0872 0.0508/0.0674 0.0624/0.0804
Largest diff. peak and hole A-3 1.248 and -0.895 1.125 and -2.001 1.142 and -0.710 0.509 and -0.983
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Table 4.64: Selected bond lengths [A] and angles [°] in the complexes
[Hg(sdz)2(DMF)2] (25), [Hg(smr)2] (26), [Hg(smr)2(bpy)] (27) and 
[Hg(smz)2(DMF)2] (28)
Bond (25) [A r (26)[A f (27) [A f (28) [ A f
H g -N (ll) 2.047(3) 2.017(4) 2.216(3) 2.048(4)
Hg-N(12) 2.881(3)
H g-O (l) 2.713(3) 2.727(4)
H g-N (l) 2.322(3)
S(1 l) -O (ll) 1.443(3) 1.433(4) 1.434(3) 1.441(3)
S (ll)-0 (1 2 ) 1.444(3) 1.444(2) 1.457(3) 1.445(3)
S(11)-N(11) 1.630(4) 1.648(4) 1.612(3) 1.636(4)
S( 11 )-C(l 5) 1.759(4) 1.749(5) 1.764(3) 1.754(4)
N(11)-C(11) 1.386(6) 1.397(6) 1.389(5) 1.400(6)
N(14)-C(18) 1.384(6) 1.369(7) 1.373(5) 1.372(6)
Angle (°) (°) (°) (°)
N (ll) -H g -N (1 T ) 179.4(2) 171.5(2) 107.55(15) 180.0
N (12)-H g-N (12) 132.13(11)
0 (1 )-H g -0 (T ) 162.7(2) 180.0
N (l)-H g -N (T ) 69.98(16)
N(1 l)-H g -O (T ) 88.0(1) 94.8(2)
0 (1 ) -H g -N ( ir ) 92.1(2) 85.2(2)
N (1T )-H g(l)-N (l) 123.41(11)
N (11)-H g(l)-N (l) 114.68(12)
N (12 ')-H g(l)-N (l) 86.04(11)
N (12)-H g(l)-N (ll) 51.12(12)
N (12')-H g(l)-N (l 1) 98.52(16)
N(13)-C(l 1)-N(12) 127.1(4) 128.0(5) 126.3(3) 127.9(4)
Symmetry transformations used to generate equivalent atoms: (fl) - x ,y ,  -z+V.■> 
Symmetry transformations used to generate equivalent atoms: (b) -x , -y+ 1, -z
The geometry o f the complexes [Hg(sdz)2(DMF)2] (25) and [Hg(smz)2(DMF)2 ] (28) are 
square planar with the Hg atom lying on the two-fold axis showing the Hg(II) atom is four 
coordinated with two oxygen [0(1)] atoms from two DMF molecules and two nitrogen 
[N( 11)] atoms from the sulfa drug molecules. The DMF molecules are coordinated to the 
Hg atom from the trans position in the structure. The complex [Hg(smr2] (26) is linear with 
two molecules o f sulfamerazine coordinated through the sulfonamidic nitrogen atoms and 
the complex [Hg(smr)2(bpy)] (27) is six coordinate with trigonal prismatic structure.
The oxygen atom of the DMF molecule makes longer bonds with mercury atoms in the 
complexes (25) and (28) and the H g -O (l) distances o f 2.713(3)A for (25) and 2.727(4)A 
for (28) are comparable with the corresponding bonds of the values of H g-O (l) = 
2.769(7)A in the complex [Hg(sdz)2(DMSO)2].3 The H g -N (ll)  bond distances of
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2.047(3)A for (25), 2.017(4)A for (26) and 2.084(4)A for (28) are also comparable with the 
values o f 2.071(4)A in the complex [Hg(smpz)2 ]1, 2.087(4)A in [Hg(sdz)2 (DMSO)2 ]3, 
2.041(6) and 2.031(6) A in [Hg(mq)2 ]90 and 2.14(2)A in [Hg(bpy)2 (N 0 2 psgly- 
7V,O)]0.5H2O91 where smpz,, sdzH, mq and N02psgly are sulfamethoxypiridazine, 
sulfadiazine, 4-m ehtyl-2(l//)-quinoline and N-2-nitrophenylsulfonylglycine respectively 
but the H g-N (l 1) distance o f 2.216(3)A for (27) is slightly longer than the others.
The C(18)-N(14) bond distances of 1.384(6)A in (25), 1.369(7)A in (26), 1.373(5)A in (27) 
and 1.372(6)A in (28) are in good agreement with the corresponding bond in the pure 
ligands suggesting the terminal amino group is not coordinated with the Hg atoms in the 
complexes and are also comparable with the corresponding bond found in the mercury- 
sulfadiazinato complex [Hg(sdz)2 (DMSO)2 ] and in the previous complexes.
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Figure 4.69
X-ray structure o f  [Hg(sdz)2 (DMF)2]  (25) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms 
are omitted fo r  clarity.
The square planar geometry around Hg atom in the complexes (25) and (28) is fairly 
regular showing only minor variations from ideal geometry o f the mutually cis 90° and 
trans 180° angles. This is evident from the values o f trans angles N(1 T )-H g (l)-N (l 1) and 
0 (T )-H g ( l) -0 (1 )  are 179.4(2)° for (25) and 162.7(2)° for (25) and 180.0° for (28)
respectively and the cis angles vary from 88.0(1) and 92.1(2)° in the complex (25) and 
85.2(2) and 94.8(2)° in the complex (28).
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The packing o f the complex units is governed by long chains formed by weak hydrogen 
bonds between the amino (-N H 2 ) group o f one complex unit and the sulfonyl oxygen and 
the pyrimido nitrogen atoms o f the next unit, N(14)-H(14A)—0(12) (other complex unit) = 
2.346(2)A with an angle o f 157.75(3)° and N(14)-H(14B)--N(13) (other complex unit) = 
2.452(1)A with an angle o f 136.74(3)° and the packing diagram of the complex 
[Hg(sdz)2 (DMF)2 ] (25) is shown in Figure 4.70.
Figure 4.70
Packing diagram o f  the complex (25) showing the hydrogen bonds by dashed lines
Table 4.65: Possible hydrogen bonds and short interactions in [Hg(sdz)2 (dmf)2 ] (25) 
____________(distances and angles given in A and deg respectively)___________________
Donor-H Donor... Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H14A N14 ....012(1) H14A...012 (1) N14 -H14A...0 1 2 (1 )
0.950(8) 3.244(4) 2.346(2) 157.75(3)
N14 -H14B N 14....N 13(2) H14B...N13 (2) N14 -H14B...N13 (2)
0.949(5) 3.210(2) 2.452(1) 136.74(3)
C13 -H13 C13 ....O il (3) H13 ...O il (3) C13 -H I3 ...O il (3)
0.950(2) 3.148(1) 2.429(1) 132.31(1)
C2 -H2B C2 ....O il (4) H 2B ...011 (4) C2 -H2B ...O il (4)
0.980(2) 3.476(1) 2.499(1) 174.74(1)
Equivalent positions:
(1) - x -  '/2 ,+y+ !/2 ,-z +  lA ; (2) x-'/^+y-'/^+z; (3) x,+y+l,+z; (4) - x - y  , - z
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The hydrogen bonds in the complex [Hg(sdz)2 (DMF)2 ] (25) are associated with very short 
donor-acceptor distances and nearly linear donor-acceptor angles, which indicate that these 
have weak interactions.
The complex (26) lies on a two-fold axis in which the sulfamerazinato ligands are bonded 
to Hg-atom through the sulfonamidic nitrogen [N (ll)] atom with an angle 
N (11)-H g-N (l T) o f 171.5(2)° indicating the linearity o f the complex.
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Figure 4.71
X-ray structure o f  [Hg(smr)2]  (26) showing crystallographic atom numbering scheme used. 
Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms are omitted 
fo r  clarity
Figure 4.72
Packing diagram o f  the complex [Hg(smr)2] (26) showing hydrogen bonds by dashed lines
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In the packing diagram of the complex (26) the amino group, sulfonyl oxygen and 
pyrimido nitrogen atoms are hydrogen bonded which is shown in Figure 4.72 by dashed 
lines.
Table 4.66: Possible hydrogen bonds and short interactions in [Hg(smr)2 ] (26) 
____________(distances and angles given in A and deg respectively)___________________
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H14A N14 ...N13 (1) H14A ...N13 (1) N14 -H14A...N13 (1)
0.931(3) 3.323(7) 2.583(4) 136.78(2)
N14 -H14B N14 ...012 (2) H14B ...0 1 2 (2 ) N14 -H14B...012 (2)
0.937(6) 3.173(7) 2.399(7) 139.93(5)
C l l l  -HI 1C C l l l  ...O il (3) H11C ...O il (3) C l l l  -HI 1C...011 (3)
0.960(6) 3.377(7) 2.455(4) 161.06(4)
Equivalent positions: (1) x+lA, +y-1A, +z; (2) x, -y, +z+lA; (3) x+!4, -y+!4, +z +lA
The Hg atom in the complex (27) is six coordinate bonding through the two sulfonamidic 
and pyrimido nitrogen atoms and two nitrogen atoms from the bpy molecules complete the 
coordination sphere.
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Figure 4.73
X-ray structure o f  [Hg(smr)2 (bpy)]  (27) showing crystallographic atom numbering scheme 
used. Thermal ellipsoids are drawn at 50% probability level. The hydrogen atoms are 
omitted fo r  clarity.
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The Hg-Nbpy bond distance o f 2.323(3)A  is longer than the corresponding bond lengths of 
2.140(3) and 2.124(3)A in [H g(l,3 -dimethyluracil-C 5 )(bpy)](C 1 0 4 ) 9 2  and 2.130A in 
[Hg(sac)(bpy)].93
The geometry o f the complex (27) is trigonal prismatic (Figure 4.74) like the previous 
cadmium complexes (18, 19 and 20) with the Hg atom lying on a two-fold axis. The 
geometry of the complex is trigonal prismatic since the bpy molecule lies on the one part 
and the two larger sulfamerazine molecules lie on the other part. The sulfamerazinato 
ligands are bonded to Hg through sulfonamidic nitrogen [N (ll)] atom and the pyrimido 
nitrogen [N(l 2)] atom o f the sulfamerazine molecules and the N (l)  atom of the bpy ligand.
N12'
NT N12
Figure 4.74
Trigonal prismatic structure o f  the complex [Hg(smr)2 (bpy)J (27) containing only the 
bonded nitrogen atoms
Figure 4.75
Packing diagram o f  the complex [Hg(sdz)2 (bpy)2]  (27) where hydrogen bonds are shown 
by dashed lines
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The N(14)-H(14A)**-0(11) hydrogen bond in (27) is associated with very short donor- 
acceptor distances and nearly linear donor-acceptor angles indicating strong interactions. 
The bipyridine molecule is chelated to the Hg atom symmetrically in the complex.
Table 4.67: Possible hydrogen bonds and short interactions in [Hg(smr)2 (bpy)] (27) 
____________(distances and angles given in A and deg respectively)___________________
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
N14 -H14A N 14....011  (1) H 14A ...011 (1) N14 -H 14A ...011 (1)
0.950(9) 2.994(1) 2.083(9) 160.24(3)
N14 -H14B N14 ....N13 (2) H14B...N13 (2) N14 -H14B...N13 (2)
0.949(7) 3.125(2) 2.381(7) 135.02(4)
N14 -H14B N 14....011  (2) H 14B ...011 (2) N14 -H 14B ...011 (2)
0.949(7) 3.173(2) 2.375(7) 141.55(2)
C3 -H3 C3 ....011(4) H3 ...O il (4) C3 -H3 ...011(4 )
0.950(7) 3.213(5) 2.375(2) 146.87(3)
Equivalent positions:
(1) -X+V2, +y+V:2, -Z+V2; (2) x, -y+\,+z+l/2; (3) jc, -y , +z+V2
In the complex (28) the Hg atom is four coordinate with two oxygen atoms from DMF 
molecules and two nitrogen atoms from sulfamethazine molecules.
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Figure 4.76
X-ray structure o f  [Hg(smz)2 (DMF)2]  (28) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level. Hydrogen atoms are 
omitted fo r  clarity.
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The sulfonyl oxygen and pyrimido nitrogen atoms are hydrogen bonded in the complex, 
are shown by dashed lines in the packing diagram (Figure 4.77).
#
Figure 4.77
Packing diagram o f  the complex [Hg(sdz)2 (DMF)2]  (28) showing the hydrogen by dashed 
lines
Table 4.68: The hydrogen bonds and short interactions in [Hg(smz)2 (DMF)2 ] (28) 
____________(distances and angles given in A and deg respectively)___________________
Donor-H Donor...Acceptor H...Acceptor Donor-H.....Acceptor
C16 -H16 C 16....01  (0) H 16...01  (0) C16 -H 16...01  (0)
0.950(9) 3.388(1) 2.482(8) 159.53(8)
N14 -H14A N 14....011 (1) H 14A ...011 (1) N14 -H 14A ...011 (1)
0.948(8) 3.031(1) 2.104(8) 165.47(3)
N14 -H14B N 14....011 (2) H 14B ...011 (2) N14 -H 14B ...011 (2)
0.949(8) 3.038(7) 2.223(4) 143.46(6)
Equivalent positions:
( 0 ) x, v,z; (1) -x + 1  , + y - l/ 2 - z + l/ 2; ( 2 ) x - y + '^ + z + 'A
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4.11 Summary
We synthesized the following new metal (Co, Ni, Cu, Zn, Cd and Hg) complexes o f triple 
sulfa drugs (TSD) with secondary ligands such as water, ammonia, pyridine (py), 
dimethylformamide (DMF), dimethylsulfoxide (DMSO), ethylenediamine (en), 2,2'- 
bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (dmbpy), 1,10-phenanthroline (phen), 
diethylenetriamine (dien) and ^^(S-am inopropy^-bis-ethylenediam ine (apen) and 
characterised them by elemental analysis, spectroscopic and X-ray crystallographic 
methods.
Cobalt complex
1. {[Co(smz)2 (H 2 0)].DM F}n (3)
Nickel complexes
2. [Ni(en)3 ][(sdz)2 .H2 0 ] (4) 3. [Ni(smr)2 (py)2 ].4 py (5)
Copper complexes
4. [Cu(en)2 (sdz)2] (6 )
6 . [Cu(en)2 (H2 0 ) 2 ][(smr)2] (8 )
8 . [Cu2 (smr)4 ].2DMF (10)
10. [Cu(smz)2 (apen)].3H 2 O.CH3OH (12)
5. [Cu(dien)(sdz)2] (7)
7. [Cu(en)2 (H2 0 ) 2 ][(smr)2 ].H20  (9)
9. [Cu2 (smr)4 ].2DMSO (11)
ll.{[C u(sm z)2(NH3)].2H20}„(13)
Zinc complexes
12. [Zn(smz)2 (NH3)2] (14) 13. [Zn(smz)2 (py)2 ].2py (15)
Cadmium complexes
14. [Cd(dien)(sdz)2].DMF (16)
16. [Cd(sdz)2 (bpy)] (18)
18. [Cd(sdz)2 (dmbpy)].2DMF (20)
20.{[Cd(smz)2 (H2 O)].DMF}„ (22)
22. [Cd(smz)2 (en)].2DMF (24)
15. [Cd(dien)(smr)2].DMF (17)
17. [Cd(sdz)2 (phen)] (19)
19. [Cd(smr)2 (phen)] (21)
21. {[Cd(smz)2 (H 2 0)] .2H20  }„ (23)
Mercury complexes
23. [Hg(sdz)2 (DMF)2] (25)
25. [Hg(smr)2 (bpy)] (27)
24. [Hg(smr)2] (26)
26. [Hg(smz)2 (DMF)2] (28)
We also synthesised the metal complexes o f sulfathiazole (Chapter 5) with 
ethylenediamine and sulfadimethoxine (Chapter 6 ) with ammonia as secondary ligands.
Chapter 4
Metal complexes o f sulfathiazole
1. [C 0 C I4] [(H2 Stz)2 ].CH 3 COOH (30); 2. [Cu(en)2 (H2 0 )2 ][stz)2 ].2 H 2 0  (31)
Zinc complex of sulfadimethoxine
1. [Zn(sdm)2 (NH3 )2 ].2 H 2 0  (33)
4.11.1 Type of coordination around the metal centres
The metal atoms in the complexes studied display different coordination numbers. The 
most common coordination number found is six with the metal having octahedral,
{[Co(smz)2 (H2 0)] .DMF} „ (3), [Ni(en)3 ][(sdz)2 .H2 0 ]  (4), [Ni(smr)2 (py)2 ].4py (5), 
[Cu(dien)(sdz)2] (7), [Cu(en)2 (H2 0 )2 ][(smr)2 ] (8 ), [Cu(en)2 (H2 0 )2 ][(smr)2 ].H 2 0  (9) 
[Cu(smz)2 (apen)].3H 2 O.CH3OH ( 1 2 ), {[Cu(smz)2 (NH 3 )].2H 2 0}„ (13), [Zn(smz)2 (NH3)2] 
(14), [Zn(smz)2 (py)2 ].2py (15), {[Cd(smz)2 (H 2 0)].DM F}„ (22), {[Cd(smz)2 (H2 0 )]H2 0 }„ 
(23), [Cd(smz)2 (en)].2 DMF (24) and [Cu(en)2 (H2 0 )2 ][stz)2 ].2 H 2 0  (31); trigonal prismatic, 
[Cd(sdz)2 (bpy)] (18), [Cd(sdz)2 (phen)] (19), [Cd(sdz)2 (dmbpy)].2DMF (20), 
[Hg(smr)2 (bpy)] (27) and [Zn(sdm)2 (NH 3 )2 ].2 H 2 0  (33); and bicapped tetrahedral 
geometry, [Cd(smr)2 (phen)] (21). The two copper complexes [Cu2 (smr)4 ].2 DMF (10) and 
[Cu2 (smr)4 ].2 DMSO (11) are five coordinate with one metal-metal bond. The complexes 
[Cu(en)2 (sdz)2] (6 ), [Hg(sdz)2 (DMF)2] (25), [Hg(smz)2 (DMF)2] (28), [CoCl4 ][(smz)2]- 
CH3COOH (30) show a coordination number o f four (square planar) and the only mercury 
complex o f sulfamerazine [Hg(smr)2 ] (26) shows a coordination number o f two with linear 
arrangement. The complexes [Cd(dien)(sdz)2 ].DMF (16) and [Cd(dien)(smr)2 ].DMF (17) 
have seven coordination number with distorted pentagonal bipyramidal geometry. The 
geometries are often associated with distortions from ideal geometries both in bond lengths 
and in angles. These aspects have already been discussed and explained when describing 
each individual structure in the previous chapters. However it needs to be emphasised here 
that the distortions are in most cases due to electronic effects, steric factors and also, in 
most cases, due to the intra- and/or inter-molecular hydrogen bonding effects.
4.11.2 Status of TSD anion as ligand
It has been mentioned earlier (Chapter 2) that TSD ions have six possible donor sites for 
potential binding with a metal ion. These six sites are the sulfonamidic nitrogen, two 
pyrimido nitrogen, two sulfonyl oxygen and amino nitrogen atoms. Since the neutral TSD 
molecules contain a hydrogen atom on the sulfonamidic nitrogen atom, after deprotonation
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the negative charge is located (entirely or at least most o f it) on the nitrogen atom of the 
TSD anion. Therefore, the N atom with a negative charge should be the most preferred site 
for bonding with a metal ion. In fact, this mode o f coordination o f the TSD anion has been 
found as the most common in the complexes where most o f the sulfa drug molecules are 
directly bonded with the metals. Thus N-coordinated complexes are listed in Table 4.68. In 
one unusual case, the sulfamethazinato ion is bonded to the metal centre, not through the 
sulfonamidic nitrogen atom, but through the sulfonyl oxygen atom ( 1 2 ).
Table 4.68: Comparison of the M -N (ll)  and M -N (12) bond lengths
Complexes
Bonds
M -N (ll) M -N(12)
{[Co(smz)2 (H 2 0)].D M F}„ (3) 2.142(2) 2.187(2)
[Ni(smr)2 (py)2 ].4py (5) 2.139(2) 2 . 1 0 0 (2 )
[Cu2 (smr)4] .2DMF (10) 2.057(3) 1.992(3)
[Cu2 (smr)4 ].2DMSO (11) 2.040(5) 1.998(5)
{[Cu(smz)2 (NH 3 )].2H2 0 } „ (13) 2.044(3) 2.035(3)
[Zn(smz)2 (NH3)2] (14) 2.040(3) 2.844(3)
[Zn(smz)2 (py)2] .2py (15) 2.223(3) 2.323(3)
[Cd(dien)(sdz)2] .DMF (16) 2.495(2) 2.403(2)
[Cd(dien)(smr)2].DMF (17) 2.434(2) 2.416(2)
fCd(sdz)2 (bpy)l (18) 2.283(3) 2.501(3)
[Cd(sdz)2 (phen)] (19) 2.275(2) 2.517(2)
[Cd(sdz)2 (dmbpy)].2DMF (20) 2.253(2) 2.504(2)
[Cd(smr)2 (phen)] (21) 2.193(2) 2.793(2)
{[Cd(smz)2 (H2 0)].DMF}„ (22) 2.307(3) 2.407(3)
{[Cd(smz)2 (H2 0)].H 2 0}„ (23) 2.337(3) 2.322(3)
[Cd(smz)2 (en)].2DMF (24) 2.311(3) 2.471(4)
[Hg(sdz)2 (DMF)2] (25) 2.047(3)
[Hg(smr)2] (26) 2.017(4)
fHg(smr)2 (bpy)] (27) 2.216(3) 2.881(3)
[Hg(smz)2 (DMF)2] (28) 2.048(4)
In some cases, the nickel and copper complexes [(4), (6 ), (7), (8 ), (9), (30) and (31) 
complexes], the sulfa drug molecules are not coordinated with the metal ions because a 
stronger ligand such as ethylenediamine and/or diethylenetriamine are attached to the 
metal centres, and they remain outside the coordination sphere and are attached to the 
cationic species through very strong hydrogen bonds. In complex (30), the cobalt atom is 
surrounded by four chloride ions forming the negatively charged anion and the two 
molecules o f positively charged sulfathiazole cations remain outside the coordination 
spheres. These complexes are typical examples for the formation of “cation-anion” pairs.
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Thus our studies clearly indicate that (i) the sulfa drug anions are not directly coordinated 
with the metals in some cases, and (ii) when it is coordinated to a metal, it commonly 
involves the sulfonamidic and pyrimido nitrogen atoms. Involvement o f the sulfonyl 
oxygen atom is also possible and in fact, it is observed in one case o f the copper complex 
of sulfamethazine (12), and in the polymeric complexes o f sulfamethazine, the terminal 
amino group takes part in the coordination to the metal centres.
Another aspect that was stated earlier but should also be pointed out here is that the sulfa 
drug anions may act as a monodentate, bidentate or tridentate chelating as well as bridging 
ligands, as observed in polymeric complex o f sulfadiazine [Zn(sdz)2 ]1 and 
[Cd(sdz)2].2H202 and in the complex o f sulfamethazine [Cd(smz)2(H20)].2H20.3 In our 
present complexes, however, the ligands are also monodentate, bidentate or tridentate in 
some cases.
The question that may arise in this context is: why do the sulfa drug molecules show 
different coordination modes in different complexes. The explanation is not simple, but it 
would obviously depend on the competition between different possible coordinating 
species in the reaction media as well as their relative basicities. Ligands such as H 2O, N H 3, 
pyridine, etc., are well known Lewis bases, and can bind with metal ions due to the ease 
with which these species can donate their electrons to the metal ions, which act as Lewis 
acids. Since in our complexes sulfa drug molecules are found to coordinate with the metal 
centres along with H 2 O, pyridine, ethylenediamine, bipyridine, phenanthroline, we believe 
that sulfa drug molecules are also relatively strong ligands and can compete with the above 
mentioned secondary ligands for bonding with the metal ions. The relative basicities at the 
sulfonyl oxygen atoms o f the sulfa drug molecules would be much less compared with that 
of the sulfonamidic and pyrimido nitrogen atoms. So coordination involving sulfonyl 
oxygen atoms is rather rare, and such modes o f coordination would be guided not by the 
electron donating capacity alone, but by other factors such as hydrogen bonding and/or 
steric reasons.
4.11.3 Role of hydrogen bonds in the formation of crystal architecture
Hydrogen bonds between a proton and corresponding donor and acceptor atoms are 
probably the most important non-covalent interactions in organic and metal complexes.
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Their roles in determining molecular geometry, conformations, and crystal architecture and 
the overall stability have long been emphasised and recognised.
In the complexes studied in this work, both intra- and inter-molecular/ionic hydrogen 
bonds and short van der Waals’ interactions have been noted and listed in selected Tables 
for the individual complexes. These hydrogen bonds are o f the O -H —O/N type and in the 
case of diamine/triamine complexes of the N -H —O type. They play important roles in the 
distribution of ligands around the metal centres and their relative orientations. The sulfa 
drug anions that remain outside the coordination sphere are held in the crystal due to the 
extensive hydrogen bonding network. This determines the overall packing arrangement in 
the unit cell. The truth o f this statement lies in the fact that for ALL the complex species 
containing water molecules either coordinated and/or in the lattice, hydrogen bonds are 
always present and their dimensions indicate that they are fairly strong hydrogen bonds 
based on normal criteria [0 (-H )—0/N  = 3.1, H---0/N = 2.0 A]. The complexes that do not 
contain any water molecules do not have such strong hydrogen bonds, but these complexes 
also contain weaker interactions of the type C -H —O and van der W aals’ interactions, and 
these are the forces that hold individual molecules together in the crystal.
4.11.4 Conclusion
The work in this thesis is not complete as far as the global aim is concerned, but 
nonetheless, it embraces the structural studies of the metal complexes o f sulfa drugs. The 
metal complexes o f sulfa drugs, which have been studied, are Co, Ni, Cu, Zn, Cd and Hg 
with sulfadiazine, sulfamerazine, sulfamethazine, sulfathiazole and sulfadimethoxine. It 
has been shown that when sulfa drugs are bonded to the metal atom, it is usually through 
the sulfonamidic and pyrimido nitrogen atoms. In most o f the complexes the bonds through 
the sulfonamidic nitrogen atom is shorter than that o f the pyrimido nitrogen atom.
4.11.5 Further works
As the sulfa drugs are active antibacterial compounds and some metal complexes are still 
used as topical medicine for bum treatment, the compounds, which we have synthesized in 
the laboratory, may also have some biological activity and antibacterial activity. In 
addition there may be more complexes of sulfa drugs with metal ions and secondary 
ligands. Their biological activity may be investigated in future.
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STUDIES OF METAL COMPLEXES 
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Chapter 5
COMPLEXES OF SULFATHIAZOLE
5.1 Introduction
Sulfathiazole (Figure 5.1) shows an extensive polymorphism, in fact highest among all the
1 9sulfa drugs. ’ It also has a remarkable solvate forming ability with interesting structural 
and conformational properties. Some 100 plus solvate containing sulfathiazoles are known 
and a lot o f them have been studied crystallographically. On the basis of these results, it 
has been suggested that different crystal structures in these systems can be explained in the 
presence o f similar hydrogen bonding association but different supramolecular assemblies.
Figure 5.1: Structure o f  sulfathiazole
Shirotani et a l 4 described three solvates o f sulfathiazole. Kruger et al. reported the crystal 
structures of polymorphs II5, I6 and III.6 Hughes et al.1 and Chan et al.8 reported the 
polymorph V o f sulfathiazole.
Caira et al.9 reported the crystal structure of the 1:1 complex o f sulfathiazole and 
cyclodextrin and these molecules are hydrogen bonded with each other making a layer and 
these layers are linked by hydrogen bonding with water molecules.
The deprotonated sulfonamidic nitrogen atom co-ordinates with a suitable metal(II) ion 
(Figure 5.2).
Figure 5.2
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In addition to this, the other potential donor sites are sulfonyl oxygen atoms, amino and 
thiazolato nitrogen and sulfur atoms. But in this chapter we will discuss the complexes 
where the sulfathiazole acts as a counter ion.
Casanova et a / . 1 0 - 1 3  reported some copper complexes of sulfathiazole with different 
secondary ligands such as the Cu(II) complex o f dichlorodisulfathiazole ethanol 
[Cu(stz)2 Cl2 ].EtOH 1 0 in which the Cu(II) ion is five coordinate with two nitrogen atoms 
from the amino (-N H 2 ) group of the two sulfathiazole molecules, two chloride ions and 
one oxygen atom from the ethanol molecule. The coordination polyhedron is intermediate 
between square pyramid and trigonal bipyramid and is very similar to the complex of 
dichlorodisulfathiazole methanol [C u^ tz^C y .M eO H . 11 Both the complexes are triclinic 
with a space group o f P 1 and are isostructural with the same arrangement o f ligands about 
the metal centre.
1 n #
The copper complex o f chlorodisulfathiazole tris-(pyridine) [Cu(stz)(py)3 Cl2 ] is 
orthorhombic with the space group of Pbca and is a distorted square pyramid consisting o f 
mononuclear units linked via hydrogen bonds to form the tridimensional pyramid.
The dimeric copper complex of sulfathiazole [Cu2 (stz)4 ] is orthorhombic with the space 
group o f P2\cn in which the copper atom is four coordinate and the chromophore is CUN4 . 
There exists a metallic C u-C u bond in the complex.
Henderson et al . 14 described the platinum and palladium complexes o f sulfathiazole. Again 
Casanova et a l} 5 reported the copper complex o f sulfathiazole with 1,2-dimethylimidazole 
ligand. Alzuet et a l} 6 synthesised the copper complex of sulfathiazole with dimethyl 
sulfoxide and more recently Anacona et a l} 1 reported the copper complex o f sulfathiazole 
where sulfathiazole acts as a counter ion.
5.2 Experimental
5.2.1 Preparation of sulfathiazole nitrate [(C9 HioN3 0 2 S2 ][N0 3 ].H 2 0  (29)
Solid sulfathiazole (0.255g; 1 mmol) was dissolved in 1M HNO 3  (50 mL) and stirred for 
30 minutes, filtered off and the clear solution was left at room temperature for 
crystallization. Pale yellow block crystals o f sulfathiazole nitrate were obtained by slow 
evaporation of the solution. Anal. Found: C, 32.11, H, 3.57; N, 16.65%. Calc, for
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C9 Hi2N 4 0 6 S2 : C, 32.16; H, 3.55; N, 16.63%. IR: (KBr disc): c m '1, 3510(b), 3410(s), 
3375(m), 1621 (s), 1535(vs), 1329(vs), 1269(vs), 1143(m), 933(m), 689(w), 627(vw).
5.2.2 Preparation of cobalt complex of sulfathiazole [CoCl4 ][(stz)2 ].CH 3 COOH (30)
Solid sulfathiazole (0.565g, 2 mmol) was dissolved in hot methanol and methanolic 
solution o f C0 CI2 .6 H2 O (0.23 8 g, 1 mmol) was added with constant stirring. The purple 
precipitate was filtered off and dried over silica gel. It was dissolved in water in presence 
of acetic acid. After three days green crystals were obtained. Anal. Found: C, 31.03, H, 
3.10; N, 10.86%. Calc, for C2 0 H 2 4 CI4 C0 N 6 O6 S4 : C, 31.10; H, 3.15; N, 10.75%. IR: (KBr 
disc): c m '1, 3513(b), 3426(s), 3383(m), 1625(s), 1537(vs), 1331(vs), 1267(vs), 1141(m), 
933(m), 689(w), 625(vw).
5.2.3 Preparation of the complex [Cu(en)2(H20)2][(stz)2].2H20 (31)
Sodium salt o f sulfathiazole (Nastz) (2 mmol) was dissolved in hot methanol and to this 
methanolic solution o f CUCI2 .2 H2 O (1 mmol) was added with constant stirring. The pale 
blue precipitate was filtered off and dried over silica gel. It was again dissolved in 1:10 
ethylenediamine:water solution and stirred for 30 min. The solution was filtered off and the 
filtrate was kept for crystallisation. After seven days purple crystals were obtained, filtered 
and dried over silica gel. The compound is soluble in water, DMF and DMSO. Anal. 
Found: C, 35.54, H, 5.23; N, 18.31%. Calc, for C2 2 H4 oCuN1 0 0 8 S4 : C, 35.48; H, 5.27; N, 
18.35%. IR: (KBr disc): cm-1, 3512(b), 3436(s), 3390(m), 1623(s), 1537(vs), 1328(vs), 
1270(vs), 1141(m), 931(m), 687(w), 625(vw).
5.3 Results and discussion for the complexes (29), (30) and (31)
5.3.1 IR Spectra
The bands at 3510, 3513 and 3512 cm - 1  are assigned to O -H  of water molecules in (29) 
and (30) and acetic acid in (31) respectively. The bands at 3410 and 3375 cm - 1  for (29), 
3426 and 3383 cm - 1  for (31) are assigned to as{N -H ) and 5 y(N-H) vibrations o f the -N H 2  
group which are shifted with respect to those o f the free sulfathiazole (3349 and 3319 
cm-1). The bands due to ay(S0 2 ) at 1328 -  1331 cm - 1  and 5 y(S0 2 ) at 1141 -  1137 cm - 1  
remain unchanged. There is no change o f the bands at 1537, 933 and 625 -  687 cm - 1  
assigned to the characteristic thiazole ring, (S-N ) and (C-S) vibrations respectively.
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5.3.2 Crystal structures of the complexes (29), (30) and (31)
The crystal data and refinement details for (29), (30) and (31) are summarized in Table 5.1. 
The compounds (29) and (30) are new complexes and have been characterised by X-ray 
diffraction methods and the complex (31) was published recently . 17
Table 5.1: Crystal data and details of data collection and structure refinement for the
complexes (29), (30) and (31)
(29) (30) (31)
Empirical Formula C9 H12N4 O6 S2 C2 0H2 4CI4 C0 N6O6 S4 C2 2H4 0 CUN10O8 S4
Formula Weight 336.35 773.42 764.42
Crystal System Monoclinic Triclinic Triclinic
Space Group P 2\lc P \ P \
a(A ) 12.1917(2) 8.07940(10) 7.3770(2)
b( A) 7.6348(2) 10.98430(10) 8.2760(2)
c(A ) 15.3895(2) 18.1087(2) 13.5565(4)
a (° ) 90 83.3332(4) 78.4912(8)
A 0) 107.4660(10) 83.5157(4) 86.0748(8)
K°) 90 72.5918(6) 82.0850(10)
v/ks 1366.43(5) 1517.91(3) 802.57(4)
z 4 2 1
77K 150 150 150
Crystal Size/mm 0.18x0.15x0.12 0.25x0.22x0.20 0.18x0.15x0.10
Shape Block Block Block
Color White Green Purple
(9-range for data collection 3.01 -2 7 .4 9 2 .9 7 -2 7 .3 8 3 .0 7 -2 7 .4 3
Reflection Collected 17799 24140 14729
Unique Reflections 3117 6716 3642
Rint 0.0813 0.0271 0.0743
Index ranges —15 <=h<=15 —1 0 <=h< = 1 0 -9<=h<=9
-9<=k<=9 —14<=k<=14 - 1 0 <=k< = 1 0
-19<=1<=18 —2 3 <=1<=2 3 —17<=1<=17
Data/parameters 3117/214 6716/411 3642/229
Final R indices [I>2a(I)] 0.0377/0.1003 0.0270/0.0800 0.0382/0.0891
R indices (all data) 0.0456/0.1055 0.0287/0.0810 0.0491/0.0947
Largest diff. peak and hole e.A - 3 0.465 and -0.605 0.588 and -0.497 0.588 and -0.748
5.3.2.1 Structure of the complex [(C9HioN3 0 2S2][N0 3 ].H20  (29)
An ORTEP drawing o f the sulfathiazole nitrate is shown in Figure 5.3 together with the 
crystallographic atom numbering scheme used. The sulfathiazole molecule is hydrogen 
bonded with nitrate ion which is also hydrogen bonded with a water molecule present in 
the complex. The sulfathiazole molecule is positively charged gaining one proton on its 
terminal amino group. The 0(1) atom of the nitrate ion is hydrogen bonded with the
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H(13A) atom of the amino group of sulfathiazole and 0(2) is hydrogen bonded with H(4A) 
atom o f the water molecule.
The planes o f the phenyl and thiazole rings are inclined in a Gauche conformation about 
S (1 2 )-N (ll) bond with a torsion angle o f 87.63(6)°. The crystal structure is stabilized by 
network hydrogen bonds and van der W aals’ interactions.
N12
N11 011 0 3C13 C19 01
C18 N1
C11
S12
C14
C12
0 4
02S11 0 1 7
N13C15
C16
Figure 5.3
X-ray structure o f  the complex sulfathiazole nitrate [(C 9H 1 qN3O2S2][NOz].H 2 0  (29) 
showing crystallographic atom numbering scheme used. Thermal ellipsoids are drawn at 
50% probability level. The hydrogen atoms are omitted fo r  clarity. Intermolecular 
hydrogen bonds are indicated by dashed lines.
The bond angles in the benzene ring differ slightly from the theoretical value o f 120°. The
C(17)-N(13) bond distance of 1.462(2)A is slightly longer than the corresponding bond in
6  18 sulfathiazole III and in good agreement with the distance proposed by Camerman for the
length of C(sp2)~N(sp2) single bond of 1.470(5)A.
The S(12)-C(14) bond distance of 1.774(2)A is slightly longer than the theoretical 
S-C(s/?2) value (1.75A) calculated from the atomic radii and electronegativities given by
10  • 9 0 — 9 ^Truter and with the experimental data obtained for sulfonamides.
The S (1 2 )-0  distances o f 1.444(2) and 1.457(2)A are slightly longer than the 
corresponding bonds with values o f 1.42(1) and 1.43(1)A in sulfaguanidine 
monohydrate , 2 4  1.41(2) and 1.42(2)A in sulfadiazine , 2 5  1.424(4) and 1.435(3)A and 
1.414(4) and 1.431 (3)A in sulfamerazine2 6  and 1.431(2) and 1.435(2)A and 1.426(8) and 
1.430(6)A in sulfamethazine . 2 7 , 2 8  This is due to the presence o f the negative nitrate ion in 
the complex.
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Table 5.2: Selected bond lengths [A] and angles |°1 in KC^ipNaC^lfNOal.EbO (29)
Bond (A) Bond (A )
S(11)-C(13) 1.732(2) S ( l l ) - C ( l l ) 1.736(2)
S(12)—0(12) 1.444(2) S (1 2 )-0 (l 1) 1.457(2)
S(12)-N (l 1) 1.582(2) S(12)-C(14) 1.774(2)
N (11)—C(11) 1.344(2) N (12)-C (l 1) 1.335(2)
N(12)-C(12) 1.384(2) N(13)-C(17) 1.462(2)
C(12)-C(13) 1.335(3) C(14)-C(15) 1.381(2)
C( 14)—C( 19) 1.398(2) C(15)-C(16) 1.392(2)
C(16)-C(17) 1.382(2) C(17)-C(18) 1.382(2)
C(18)-C(19) 1.384(3)
Angle (°) Angle (°)
C (13)-S(l 1)-C (11) 90.84(8) 0 (1 2 )-S (1 2 )-0 (1 1) 117.06(8)
0 ( 1 2 )—S(1 2 )—N ( 1 1 ) 114.68(8) 0 ( 1 1 )—S( 1 2 )—N( 1 1 ) 104.67(8)
0 (  12)-S ( 12)-C ( 14) 106.87(8) 0 (1 1)-S(12)-C(14) 106.67(8)
N( 11 )-S ( 12)-C ( 14) 106.17(8) C ( ll) -N ( ll) -S (1 2 ) 120.76(13)
C(11)—N (12)—C( 12) 115.14(15) N (12)-C (l 1)-N (11) 119.41(15)
N (12)-C (l 1 )-S (11) 109.85(12) N (11)-C (11)-S (11) 130.74(14)
C(13)-C(12)-N(12) 112.90(17) C (12)-C (13)-S(l 1) 111.26(14)
C(15)-C( 14)-C ( 19) 121.33(15) C(15)-C(14)-S(12) 120.22(13)
C(19)-C(14)-S(12) 118.45(13) C (14)-C (l 5 )-C (l 6 ) 119.52(15)
C( 17)-C ( 16)-C ( 15) 118.86(15) C( 18)-C ( 17)-C ( 16) 121.95(16)
C(18)-C(17)-N(13) 118.90(15) C( 16)-C ( 17)-N ( 13) 119.15(15)
C( 17)-C( 18)-C( 19) 119.43(16) C( 18)-C ( 19)-C ( 14) 118.90(16)
Figure 5.4
Packing diagram o f  the complex (29) where the hydrogen bonds are shown by dashed lines
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In this compound the sulfathiazole acquires a positive charge on its amino (-N H 2 ) group 
forming a [-NH 3 ]+ cation that is balanced by the negative nitrate ion. In the nitrate ion the 
bond distances o f 0 ( 1 )—N (l) = 1.261(2)A, 0 (2 ) -N ( l)  = 1.263(2)A and 0 (3 ) -N (l)  =
1.236(2)A and the O -N -O  angles o f 0 ( l ) - N ( l ) - 0 ( 2  = 119.04(15)°, 0 (3 ) -N ( l) -0 (2  ) = 
120.16(15)° and 0 ( 3 ) - N ( l ) - 0 ( l )  = 120.80(15)° are in agreement with the planar 
configuration. The H -O -H  angle of 103(2)° is very similar to the theoretical value o f the 
tetrahedral configuration o f a water molecule.
Table 6.3: The hydrogen bonds in [(C9 HioN3 C>2 S2 ][N 0 3 ].H 2 0  (29) (distances and
angles given in [A] and [°] respectively)
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N13 -H13A N13 ....01 (0) H13A...01 (0) N13 -H13A...01 (0)
0.948(5) 2.765(5) 1.818(5) 177.47(6)
N13 -H I3A N13 ....Nl (0) H13A...N1 (0) N13 -H13A...N1 (0)
0.948(5) 3.308(4) 2.467(3) 147.92(4)
0 4  -H4A 0 4  ....02  (0) H 4A ...02  (0) 0 4  -H 4A ...02  (0)
0.945(7) 2.803(1) 1.867(1) 170.21(5)
N12 -H12A N 1 2 ....0 4  (1) H12A...04 (1) N12 -H12A...04 (1)
0.945(5) 2.905(4) 2.002(5) 159.27(2)
0 4  -H4B 0 4  ....O il (1) H 4B ...011 (1) 0 4  -H4B ...O il (1)
0.945(2) 2.881(3) 1.966(6) 162.12(1)
N13 -H13C N13 ....O il (2) H 13C ...011 (2) N13 -H 13C ...011 (2)
0.883(3) 2.907(2) 2.026(3) 175.68(2)
N13 -H13B N13 ....04 (3) H13B...04 (3) N13 -H 13B...04 (3)
0.949(2) 2.857(2) 1.910(2) 174.89(1)
Equivalent positions:
(0 ) x, y, z; ( 1 ) —x+ 1 , +y+!/2, -z+'A; (2 ) x, -y+ lA, + z -lA; (3) - x + 1 , -y , - z
§.3.2.2 Structure of the complex [CoCl4][(stz)2].CH3COOH (30)
The crystal structure o f the complex [CoCl4 ][(H 2 Stz)2 ].CH 3 COOH (30) is shown in Figure
5.6. It is found that there is no direct bonding o f sulfathiazole with the cobalt atom and the 
solid state structure consists o f [C0 CI4 ]2- anions and the protonated sulfathiazole [stzH2 ]+ 
cation in the ratio o f 1:2. In addition there is, in the crystal lattice, one molecule o f acetic 
acid per metal centre. All these species are held together in the crystal by an extensive 
hydrogen bonding network which is shown in packing diagram (Figure 5.9).
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The structural determination shows that the sulfathiazole molecule (A) is protonated in the 
complex (30) and becomes a cation like (B).
H
\
H
O
/"A /HrK.
o  H
(A)
O
H O N 12"
(®) H
Figure 5.5: Neutral molecule (A) is protonated to form  a positive cation (B)
Moreover, the hydrogen atom shifted from N ( l l ) to N (1 2 )  and has brought some changes 
in bond lengths and angles in the neutral molecules.
CI4
CI2
Co1
N13C17C16
CI3C15 C18
02 20 1 2 C19 C28 C29C14
S12 S22C27i0 1 1 N21C24
N23
N11 021 C2 1C26 C25
S11 C 1 1 N22
N12 S21
C12
C23
C13 C22<
Figure 5 . 6
X-ray structure o f  the complex [C o C lf [ (stzFl2) 2]■ CH3 OH (30) showing crystallographic 
atom numbering scheme used. Thermal ellipsoids are drawn at 50% probability level. 
Hydrogen atoms and acetic acid molecule are omitted fo r  clarity.
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The cobalt atom in the [C0 CI4 ] anion is four coordinate with tetrahedral geometry with 
four chloride ligands. The bond distances in [CoCLJ2- anion are C o-C l(l) = 2.276(1)A, 
C o-C l(2 ) = 2.290(1 )A , Co-Cl(3) = 2.278(1)A and C o-C l(4) = 2.266(1)A which are 
comparable to the corresponding bonds in 1,3-diammonium tetrachlorocobaltate 
[C0 CI4 HC3 H 12N 2 ] 2 9  with the values o f C o -C l(l) = 2.273(2)A, C o-C l(2 ) = 2.282(2)A, 
Co-Cl(3) = 2.278(3)A and Co-Cl(4) = 2.258(2)A, in bis(4-dimethylaminopyridinium) 
tetrachlorocobaltate [4DMAP]-[CoCU ] 3 0  with the values o f C o -C l(l) = 2.2754(11)A, 
Co-Cl(2) = 2.2683(11)A , Co-Cl(3) = 2.2813(11)A and C o-C l(4) = 2.2668(11)A and in 
bis-[l,3-(diammonium-methyl)benzene] tetrachlorocobaltate [DAMB][CoCl4 ] with the 
values o f C o-C l(l) = 2.2664(7)A, Co-C l(2 ) = 2.2768(7)A, Co-Cl(3) = 2.2666(7)A and 
Co-Cl(4) = 2.2557(7)A.
Table 5.4: Selected bond lengths [A] and angles [°] in the complex (30)
Bond (A) Bond (A)
C o (l)-C l(l) 2.276(5) C o(l)-C l(2) 2.290(5)
Co(l)-C l(3) 2.278(5) C o(l)-C l(4) 2.266(5)
S ( l l ) - C ( l l ) 1.731(2) S(11)—C( 13) 1.733(2)
S(12)—0(11) 1.440(1) S(12)-0(12) 1.449(2)
S(12)-N (l 1) 1.596(2) S(12)-C(14) 1.771(2)
N (11)—C(11) 1.336(2) N (12)-C (l 1) 1.337(2)
N(12)-C(12) 1.380(2) N(13)-C(17) 1.471(2)
S(21)-C(23) 1.731(2) S(21)-C(21) 1.731(2)
S(22)-0(21) 1.437(2) S(22)-0(22) 1.451(2)
S(22)-N(21) 1.602(2) S(22)-C(24) 1.771(2)
Angle (°) Angle (°)
C l(4 )-C o(l)-C l(l) 113.05(2) C l(4)-C o(l)-C l(3) 106.89(2)
C l(l)-C o(l)-C l(3 ) 109.39(2) Cl(4)-Co( 1 )-C l(2) 115.65(2)
C l(l)-C o(l)-C l(2 ) 103.75(2) Cl(3)-Co( 1 )-C l(2) 107.93(2)
C(11)—S( 11)—C(13) 90.84(9) 0 (1 1)-S (12)-0(12) 117.37(8)
0 (1 1)-S(12)-N (11) 113.33(8) 0 (  12)-S ( 12)-N  (11) 104.70(8)
0 (1 1)-S(12)-C(14) 107.74(8) 0(12)-S (12)-C (14) 107.90(8)
C (23)-S(21 )-C (2 1) 91.22(9) 0(21 )-S (2 2 )-0 (2 2 ) 117.78(8)
0(21 )-S (22)-N (21) 112.99(8) 0 (22 )-S (22 )-N  (21) 103.66(7)
0(21 )-S(22)-C(24) 107.29(8) 0(22)-S (22)-C (24) 107.47(8)
N (22)-C (21 )-S (2 1) 109.66(12)
The acidic hydrogen atom in the acetic acid molecule is distributed to both o f the oxygen 
atoms in the ratio o f 40% and 60%. These two hydrogen atoms are in equatorial position 
with each other.
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Figure 5.7
X-ray structure o f  sulfathiazole cation (30A) in the complex (30) showing crystallographic 
atom numbering scheme used. Thermal ellipsoids are drawn at 50% probability level.
0 2 2
N21
kC29
,S22
C28N2;
C21 C24lC23. 021
C27
C25 N23
S21 C26
C22
Figure 5.8
X-ray structure o f  sulfathiazole cation (30B) in the complex (30) showing crystallographic 
atom numbering scheme used. Thermal ellipsoids are drawn at 50% probability level.
The two sulfathiazole cations in the complex (30) have a different conformation. The 
torsion angles Cl 1 -N 1 1 —S 11-C14 for molecule (30A) is 76.00(10)° whereas that for the 
molecule (30B) it is 80.90(10)°. The dihedral angles between the planes o f the phenyl ring 
and thiazole ring is 88.30(6)° for (30A) and 79.65(5)° for (30B). The dihedral angles o f the 
previous one is larger than the later one because the previous is very close to the acetic 
acid molecule present in the complex.
Several hydrogen bonds and van der Waals’ interactions exist in the crystal to hold them 
together. These are shown in the packing diagram (Figure 5.9) by dashed lines.
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Figure 5.9
Packing diagram o f  the complex (30) where the hydrogen bonds are shown by dashed lines 
Table 6.5: Possible hydrogen bonds (distances and angles given in [A] and [°]
respectively) for [CoCl4 |[(H 2 Stz)2 l.CH 3 COOH (30)
Donor-H Donor... Acceptor H...Acceptor Donor-H.....Acceptor
N13 -H13B N13 ....022 (0) H13B...022 (0) N13 -H13B...0 2 2 (0 )
0.946(1) 2.766(1) 1.843(6) 164.57(3)
N13 -H13C N13 ....Cll (0) H13C...C11 (0) N13 -H13C...C11 (0)
0.946(7) 3.194(1) 2.254(8) 171.82(4)
N12 -H12A N12....N11 (1) H12A...N11 (1) N12 -H12A...N11 (1)
0.947(7) 2.847(1) 1.920(5) 165.46(4)
01 -HI 0 1  . . . . 0 2  (2 ) HI ...02 (2) 01 -HI ...02 (2)
0.953(2) 2.623(2) 1.755(1) 149.74(6)
N13 -H13A N13 ....012(3) H13A...012 (3) N13 -H13A...012 (3)
0.945(2) 2.792(2) 1.847(2) 178.67(4)
N23 -H23C N23 ....N21 (4) H23C...N21 (4) N23 -H23C...N21 (4)
0.949(2) 3.024(2) 2.087(2) 169.12(2)
N23 -H23A N23 ....C12 (4) H23A...C12 (4) N23 -H23A...C12 (4)
0.949(1) 3.226(3) 2.309(3) 162.34(3)
Equivalent positions:
(0) x, y, z; (1) -x+2,-y-l,-z; (2) -x+l,-y-l,-z; (3) -x+l,-y,-z; (4) x+l,+y,+z
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5.3.2.3 Structure of [Cu(en)2(H20)2][(stz)2].2H20  (31)
The crystal structure o f the complex [Cu(en)2 (H 2 0 )2 ][(stz)2 ].2 H2 0  (31) is shown in Figure 
5.10 together with the crystallographic atom numbering scheme used. Selected bond 
lengths and angles and the hydrogen bond dimensions are given in Tables 5.6 and 5.7.
2+
Complex (31) is the formation of a “cation-anion pair” involving the [Cu(en)2 (H2 0 )2 ] 
cation and the [stz]~ anion which are held together in the crystal by very strong 
intermolecular hydrogen bonds and van der W aals’ interactions.
The structure has a Jahn-Teller distorted octahedral geometry around the Cu(II) with four 
equatorially TV-coordinated ethylenediamine molecules forming the base and two axial O- 
atoms from two molecules o f water.
02
N13
C18 C17C2
C1 011 C19
C16N2
N1 S12
0 1 2
Cu1 N110 1
.011
o r S11
N12
c r C13 C12C2‘
Figure 5.10
X-ray structure o f  the complex [Cu(en)2(H20)2][(stz)2].2H20 (31) showing
crystallographic atom numbering scheme used. Thermal ellipsoids are drawn at 50% 
probability level. The hydrogen atoms are omitted fo r  clarity.
The elements o f the structure are joined to each other in the crystal packing by means of 
extended systems of hydrogen bonds where the protons belonging to the water molecules 
or NH 2 groups o f ethylenediamine molecules act as donors.
The cation contains two ethylenediamine molecules that coordinate the Cu atom in the 
equatorial plane in chelate mode and two water molecules occupying the apical positions 
o f the elongated octahedral structure.
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The C u-N  bond distances of 2.029(2) and 2.030(2)A involving ethylenediamine molecules 
are similar to the values o f 2.042(3) and 2.033(3)A found in the same complex reported by 
Anacona et a l} 1 and are also comparable with the corresponding bonds in the previous 
complexes (6 ), (8 ) and (9) and 1.997(3) and 2.00 1 (3)A in bis(en)copper(II) 
tetrachloronickelate [Cu(en)2 ][Ni(CN ) 4 ] , 31 2.007(3) -  2.024(3)A in diaquabis(en)copper(II) 
A-carboxyglycinate [Cu(en)2 (H 2 0 )2 ][0 0 CCH 2NHC 0 0 ].H 2 0 3 2  and 1.996(2) and 
2 .0 2 2 (2 ) A in diaquabis(en)copper(II) ethylenediaminebicarboxylate
[Cu(en)2 (H2 0 ) 2] [OOCNHCH2 CH2 NHCOO] .2H2 0 . 3 2
The Cu-0 bond distances o f 2.466(2)A are elongated due to the Jahn-Teller effect. These 
bonds are comparable with the corresponding bonds in the previous complexes (8 ) and (9) 
and shorter than the corresponding bonds with the values o f 2.591(3)A and 2.741(3)A in 
the complex [Cu(en)2 (H 2 0 )2 ][0 0 CCH2 NHC 0 0 ].H2 0 3 2  and 2.556(2)A in the complex 
[Cu(en)2 (H2 0 )2] [OOCNH2 CH2 NHCOO] .2H2 0 . 3 2
Table 5.6: Selected bond lengths [A] and angles [°] in complex (31)
Bond (A) Bond (A)
C u (l)-N (l) 2.029(2) C u(l)-N (2) 2.030(2)
C u (l)-0 (1 ) 2.466(2) S(11)-C(12) 1.724(2)
S (12 )-0 (l 1) 1.455(2) S(12)-0(12) 1.456(2)
S(12)-N (l 1) 1.580(2) S(12)-C(14) 1.762(2)
N (11)-C(11) 1.368(3) N(13)-C(17) 1.382(3)
Angle (°) Angle (°)
N (l)-C u (l)-N (T ) 180.00(1) N (l)-C u (l)-N (2 ) 84.24(8)
N(T) -C u (l)  -N (2) 95.76(8) N (2')-Cu( 1 )-N(2) 180.00(1)
C(12)-S(l 1)-C (11) 89.58(11) 0 ( 1 1)-S(12)-0(12) 114.74(10)
0 (1 1)-S(12)-N (11) 105.23(10) 0 (12)-S (12)-N (11) 113.88(10)
0 (1 1)-S(12)-C(14) 108.38(10) 0 (1 2)-S (l 2 )-C (l 4) 106.06(10)
Symmetry transformations used to generate equivalent atoms: (') -x+1, -y + 1, -z+2
The N -C u -N  trans angles are 180° and the cis angles have values ranging from 84.87(12) 
to 95.13(12)° which shows the regular octahedral arrangement in the complex.
In the sulfathiazole anions, the C ( 1 1 )—N ( 1 1 ) bond distance o f 1.368(3)A is increased from 
that o f the free ligand due to the formation o f hydrogen bonds with the cationic species in 
the complex.
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Table 6.7: Possible hydrogen bonds (distances and angles given in A and deg
respectively) for [Cu(en)2(H2Q)2lf(stz)2l.2H2Q (31)
Donor-H Donor... Acceptor H... Acceptor Donor-H.... Acceptor
N1 -H1B N1 ....N il (0) H1B ...N il (0) N1 -H1B ...N il (0)
0.920(1) 3.096(2) 2.198(2) 164.95(2)
0 2  -H2E 0 2  ....O il (0) H 2E ...011 (0) 0 2  -H 2E...011 (0)
0.946(2) 2.779(3) 1.957(3) 144.12(7)
N13 -H13A N13 ....02 (1) H13A...02 (1) N13 -H13A...02 (1)
0.947(5) 3.305(2) 2.488(2) 144.58(3)
N13 -H I3A N13 ....O il (1) H 13A ...011 (1) N13 -H 13A ...011 (1)
0.947(5) 3.241(1) 2.424(1) 144.31(2)
N1 -H1A N1 ....N13 (2) H1A ...N13 (2) N1 -H1A...N13 (2)
0.920(4) 3.222(1) 2.456(1) 140.78(2)
N13 -H13B N13 ....N12 (2) H13B...N12 (2) N13 -H13B...N12 (2)
0.947(2) 3.118(3) 2.175(2) 173.56(3)
01 -H1F 01 ....02 (3) H 1F ...02  (3) 01 -H1F ...02 (3)
0.948(4) 2.756(4) 1.831(4) 164.49(4)
01 -HIE 01 ....N il (4) H IE  ...N il (4) 01 -H IE ...N il (4)
0.947(7) 2.928(7) 2.070(9) 149.95(5)
N2 -H2B N2 ....N12 (4) H2B ...N12 (4) N2 -H2B ...N12 (4)
0.920(1) 3.150(1) 2.308(6) 152.14(2)
N2 -H2A N2 ....O il (5) H 2A ...011 (5) N2 -H 2A ...O H  (5)
0.920(1) 3.160(4) 2.390(2) 141.29(2)
0 2  -H2F 0 2  ....0 1 2 (6 ) H2F ...012 (6 ) 0 2  -H2F ...012 (6 )
0.948(3) 2.777(3) 1.876(3) 157.87(9)
Equivalent positions:
(0) x,y,z; (1) -x+ l,-y ,-z+ l; (2) -x+ l,-y+ l,-z+ l; (3) x,+y+l,+z; (4) -x+l,-y+l,-z+2; (5) - 
x+l,-y,-z+ 2 ; (6 ) x-l,+y,+z
The ethylenediamine molecules in the cation [Cu(en)2 (H2 0 )2 ] are hydrogen bonded with 
[stz]~ anions through N (1)-H (1B )...N (11) and N (2)-H (2B)...N (12) and the water 
molecule through 0(1)-H (1E )—N (ll) . The lattice water molecule is also hydrogen 
bonded with the sulfonyl oxygen atom of sulfathiazole through 0(2)-H (2E )—0(11). 
These hydrogen bonds are shown by dashed lines in the packing diagram (Figure 5.11).
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Figure 5.11
Packing diagram o f  the complex (31) where the hydrogen bonds are shown by dashed lines 
5.4 Summary
9 —
The complexes (30) and (31) consist o f discrete molecules o f [C0 CI4 ] anion and 
[Cu(en)2 (H2 0 )]2+ cation with [H2 Stz]+ cation and [stz]~ anion respectively, held together by
9—hydrogen bonds and van der Waals’ interactions. The [C0 CI4 ] anion has a four coordinate
94-tetrahedral geometry and the [Cu(en)2 (H2 0 )2 ] cation has a six coordinate octahedral 
geometry.
The octahedral geometry in (31) is distorted slightly with the cis and trans angle lying, 
respectively, in the ranges 84.24(8)°-95.76(8)° and 180.00°. The tetrahedral geometry 
around the Co(II) atom in (30) shows variance from the ideal angles, with values in the 
range of 103.75(2)°-! 15.65(2)°.
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SYNTHESIS AND STRUCTURAL 
STUDIES OF ZINC COMPLEX OF 
SULFADIMETHOXINE WITH
AMMONIA
Chapter 6
COMPLEX OF SULFADIMETHOXINE
6.1 Introduction
The crystal structure o f sulfadimethoxine (Figure 6.1) has been reported in the literature1 , 2  
and a few o f its metal complexes have been published earlier . 3 , 4
.o — c h 3
o — c h 3
Figure 6.1: Structure o f  sulfadimethoxine
Removal o f the acidic hydrogen from the sulfadimethoxine molecule produces a negative 
centre on the sulfonamidic nitrogen atom, which can then coordinate with a suitable 
metal(II) ion (Figure 7.2).
But in our complex, the short bond is through the pyrimido nitrogen atom. In addition, the 
amino nitrogen and sulfonyl oxygen atoms may coordinate with the metal ion.
6.2 Experimental
Solid sulfadimethoxine (0.520g; 2 mmol) was dissolved in methanol (50 mL) and to this 
solution (CH3 C 0 0 )2 Zn.2 H 2 0  (0.220g, 1 mmol) was added. This was stirred for six hours, 
a white precipitate was formed, filtered and dried over silica gel in a dessicator. This was 
dissolved in a solution of ammonia and water mixture ( 1 : 1 ) and stirred for 30 min., filtered
Figure 6.2
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and the filtrate was kept for crystallisation. After a week, two types o f crystals were 
obtained, one was block and the other was needle like crystals. The block type crystal was 
the ligand molecule sulfadimethoxine (32) and the needle like crystal was the zinc complex 
[Zn(sdm)2 (NH 3 )2 ].2H20  (33). IR for (32): (KBr disc), cm-1, 3456(s), 3125(s), 2956(sh), 
1625(vs), 1598, 1570, 1507(vs), 1465(sh), 1408, 1351, 1306(m), 1259(vs), 1190(sh),
1155(vs), 1125(s), 1093(s), 1005(s), 968(vs), 881(vw), 834, 805, 589, 535(vs). 'H  NMR 
(DMSO-<4): 6  11.18s [1H, N (11),] 6.11 [2H, NH2], 5.97 [1H, C(14)], 6.63d [2H, 
C(17)/C(19), J = 8 .6 ], 7.60d [2H, C(16)/C(20), J =  8 .6 ], 3.79s [C(l 11)] and 3.78s [C(l 12)], 
13C NMR (DMSO-^k): 5 160.1 [C (ll)], 164.3 [C(12)], 171.6 [C(13)], 84.2 [C(14)], 124.1 
[C (l5)], 129.3 [C(16)/C(20)], 112.4 [C(17)/C(19)], 153.3 [C(18)], 54.4 [C ( ll l) ]  and 53.6 
[C(l 12)]. IR fo r (33): (KBr disc), cm-1, 3461(s), 1629(vs), 1599, 1582, 1501(vs), 1460(sh), 
1404, 1373, 1224(vs), 1152(vs), 1122(s), 1096(s), 1014(s), 876(vw), 830, 805, 702(vs), 
574, 554(vs). lU NM R (DMSO-</6): 5 5.78 [2 H, NH2], 5.71 [1H, C(14)], 6.57d [2 H, 
C(17)/C(19), J  = 10.6], 7.45d [2H, C(16)/C(20), J  = 8 .6 ], 3.71s [C ( ll l) ]  and 3.54 
[C(l 12)], 13C NMR (DMSO-^6): 6  163.6 [C(l 1)], 166.4 [C(12)], 171.6 [C(13)], 84.6 
[C(14)], 128.3 [C (l5)], 128.9 [C(16)/C(20)], 112.3 [C (l7 )/C (l9)], 151.4 [C(18)], 53.8 
[C ( ll l) ]  and 53.3 [C(l 12)].
6.3 Results and discussion for the compounds (32) and (33)
6.3.1 IR Spectra
The absorption bands at 3461 cm - 1  suggest the presence o f water molecules and NH 2  
groups in the complex. This peak is very broad and split because o f the involvement o f 
water molecules and NH 2  group in hydrogen bonding to various extents.
The peak at 3125 cm - 1  for N -H  of the sulfonamidic group is not present in the IR spectra 
o f the complex, and this confirms the deprotonation o f the - S 0 2 N H - moiety. The 
characteristic v(C -C ) (ring) and v(C -N ) absorptions in the IR spectra appear at 1570 cm ' 1 
and 1351 cm ' 1 respectively in the sulfadimethoxine molecule. These peaks are observed at 
1582 cm ' 1 and 1373 cm"1, respectively, in the complex.
The scissoring vibrations for the -N H 2  group appear at 1629 and the peaks at 1570-1598 
cm ' 1 are due to the phenyl rings. The peaks at 1306 and 1259 cm ' 1 are assigned to c«(S02), 
and that at 1125 cm ' 1 to 5,y(S 0 2). The (CC) absorption band overlaps with the tfs(S02)
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peak at 1259 cm l. The band at 968 cm 1 in the sulfadimethoxine assigned to (S -N ) is 
changed to the higher frequency 1005 cm - 1  as a consequence o f coordination to zinc ion.
6.3.2 *H NMR and l3C NMR spectra
1 13H and C NMR spectra for the compounds (32) and (33) were obtained from a solution o f 
DMSO-^6 - The !H spectra of the complex (33) are consistent with the X-ray structure 
obtained. It consists o f two doublets for the para substituted phenyl ring and two singlets 
for the methyl substituents as methoxy groups at two different positions and one singlet for 
hydrogen on the pyrimidine ring and a broad singlet for the amino group on the phenyl 
ring. All integrals are consistent with this assignment. Small shifts in resonances are 
observed for complex compared to the parent ligand.
Table 6.1: NMR and 13C NMR shift assignment of sulfadimethoxine (32) and its
zinc complex (33) in DMSO-dk*
Assignment *H (32) *H(33) 13C(32) ljC(33) A8  (H)b A5 (C)b
N(11)-H 11.18
C (ll) 160.1 163.6 +3.5
C(12) 164.4 166.4 + 2 . 0
C(13) 171.0 171.6 + 0 . 6
C(14)-H 5.97 5.71 84.2 84.6 -0 .26 +0.4
C(15) 124.1 128.3 +4.2
C( 16)-H /C (20)-H 7.60 7.45 129.4 128.9 -0.15 -0 .5
C(17)-H/C(19)-H 6.63 6.57 112.4 112.3 -0 .06 - 0 . 1
C(18) 153.3 151.4 -1 .9
c m 3.79 3.54 54.4 53.8 -0.25 - 0 . 6
Cl 12 3.78 3.71 53.6 53.3 -0 .07 -0 .3
n h 2 6 . 1 1 5.78 -0.33
a Relative to TMS with D M SO -^ peak as reference ( H, 2.60 ppm, C, 43.5 ppm)
A 8  8 ( Complex) ^ (su lfa d im e th o x in e )
The N ( l l ) -H  peak has disappeared upon complexation with zinc(II) ion and a shift was 
observed for the C ( l l )  resonance of sulfadimethoxine and from this observation it is 
probable that the zinc(II) ion is bonded to N ( l l )  atom as also suggested by the X-ray 
structure. Another shift was observed for the C(12) atom confirming the bonding o f N(12) 
with the zinc ion. In addition the amino protons, in the complex, are shifted down field 
from the “free” ligand value upon coordination.
The 13C spectra (</-DM SO) of the complex are relatively simple to interpret and are 
similar to that observed for the free ligand, with ten peaks for sulfadimethoxine.
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7.3.3 Crystal structures of sulfadimethoxine (32) and its zinc complex (33)
The crystals were characterised by X-ray analysis and compared with other related species.
Table 6.2: Crystal data and details o f data collection and structure refinement for
sulfadimethoxine (32) and its zinc complex [Zn(sdm)2(NH3)2].2H20  (33)
(32) (33)
Empirical Formula C 1 2H 1 4N 4 O4 S C2 4H3 6N1oZnOi2S2
Formula Weight 310.33 786.12
Crystal System Triclinic Orthorhombic
Space Group P \ Pbcn
a( A) 7.9123(2) 12.288(3)
6(A) 9.2293(2) 21.078(2)
c (k ) 10.3055(3) 13.328(4)
« (°) 93.8300(9) 90
A °) 94.4410(10) 90
X°) 113.6202(13) 90
VI k 3 683.49(3) 3452.1(14)
z 2 4
77K 150 150
Crystal Size/mm 0 .1 0 x 0 .1 0 x 0 .0 8 0 .1 5 x 0 .1 2 x 0 .1 2
Shape Block Needlelike
Colour White White
Grange for data collection 2.97 to 27.48 3.98 to 26.04
Reflection Collected 12647 6266
Unique Reflections 3122 3370
Goodness-of-fit on F2 1.063 1.036
Rint 0.0729 0.0496
Index ranges - 1 0 < = £ < = 1 0 —15 <=/?<= 15
- 1 1 < = £ < = 1 1 -25<=£<=26
—13<=/<=l 3 —16<=/<=l 6
Data/parameters in the refinement 3122/192 3370/245
Final R indices I>2o(I) 0.0385/0.0938 0.0591/0.1449
R indices (all data) 0.0460/0.0987 0.0934/0.1652
Largest diff. peak and hole e.A -3 0.382 and -0.527 1.085 and -0 .627
6.3.3.1 Structure of the sulfadimethoxine molecule (32)
The structure o f sulfadimethoxine (32) is shown in Figure 6.3 together with the 
crystallographic atom numbering scheme used. The planes o f the phenyl and pyrimidine 
rings are inclined to Gauche conformation about S (11)-N (11) bond with a torsion angle of 
91.29(9)°. The crystal structure is stabilized by the network hydrogen bonding and van der 
Waals’ interactions. The dihedral angle between the planes o f phenyl and pyrimidine rings 
is 76.10(5)° which is smaller than the value o f 77.6(8)° proposed by Patel et al.2
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Figure 6.3
X-ray structure o f  sulfadimethoxine (32) showing crystallographic atom numbering 
scheme used. Thermal ellipsoids are drawn at 50% probability level.
The sulfadimethoxine forms a dimer through the hydrogen bonding N (11)-H (11)...0 (12) 
which is shown in Figure 6.4. The bond length and angle are 1.988(8)A and 158.68(2)° 
respectively confirming the strong hydrogen bonding.
Table 6.3: Selected bond lengths [A] and angles [deg] in sulfadimethoxine (32)
Bond (A) Bond (A)
S (ll)-0 (1 1 ) 1.429(2) S(11)-0(12) 1.442(2)
S(11)-N(11) 1.647(2) S(11 )-C( 15) 1.743(2)
0(13)-C(12) 1.337(2) 0(14)-C(13) 1.342(2)
N(11)-C(11) 1.399(2) N(12)-C(12) 1.334(2)
N(12)-C(l 1) 1.343(2) N(13)-C(12) 1.328(2)
N(13)-C(13) 1.328(2) N(14)-C(18) 1.367(2)
C(11)-C(14) 1.383(2) C(13)-C(14) 1.390(2)
C(15)-C(16) 1.395(2) C(15)-C(20) 1.397(2)
C(16)-C(17) 1.379(2) C(17)-C(18) 1.407(2)
C(18)-C(19) 1.401(2) C(19)-C(20) 1.380(2)
Angle (°) Angle (°)
0 (1 1)-S(11 )-0 ( 12) 117.73(7) 0 ( 1 1)-S(11)-N(11) 109.47(7)
0(12)-S(11)-N(11) 102.69(7) 0 ( 1 1)-S(11)-C(15) 108.58(7)
0(12)-S(11)-C(15) 110.94(7) N(11)-S(11)-C(15) 106.81(7)
C(11)-N(11)-S(11) 125.15(10) C(12)-N(12)-C(l 1) 114.84(13)
C(12)-N(13)-C(13) 114.88(13) N(12)-C(l 1)-C(14) 123.48(14)
N(12)-C(l 1)-N(11) 112.87(13) C(14)-C(l 1)-N(11) 123.64(14)
N(13)-C(12)-N(12) 127.87(14) N (13)-C(12)-0(13) 118.88(14)
N(12)-C(12)-0(13) 113.23(13) N(13)-C(13)-0(14) 118.75(14)
N(13)-C(13)-C(14) 124.13(14) 0(14)-C(13)-C(14) 117.11(14)
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The bond angles in the benzene ring differ slightly from the theoretical value o f 120°. The 
C(18)-N(14) bond distance of 1.367(2)A is very similar to the corresponding bond in
sulfamerazine with the values 1.367(2)A (2), 1.357(7) and 1.354(72)A7 and shorter than
8 2 2 the bond lengths proposed by Camerman for the length o f C(sp ) -N (sp ) single bond
1.470(5)A.
N 14
,C19
C1
C 2 0
C1
C 15
C16* 0 1 2S11
011I N11'
C 1 4 N1 o i r
0 1 4
H11 0 1 2 1 S 1 1 'C13
C11
N12C112
N1 C12
0 1 3
C111|
Figure 6.4
Dimeric form  o f  the structure o f  sulfadimethoxine (32) through the N ( l l ) - H ( l l )  0(12) 
hydrogen bond. Thermal ellipsoids are drawn at 50% probability level. The hydrogen 
atoms are omitted fo r  clarity
The S( 11)—C(15) bond distance of 1.743(2)A is also comparable with the theoretical 
S-C (sp 2) value (1.75A) calculated from the atomic radii and electronegativities given by 
Truter11 and with the experimental data obtained for sulfonamides . 1 0 - 1 3
Figure 6.5
Packing diagram o f  sulfadimethoxine (32) where the hydrogen bonds are shown by dashed 
lines
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The S ( l l ) - 0  distances, 1.429(2)A and 1.443 (2)A, are slightly longer than the 
corresponding bonds in the following structures: sulfaguanidine monohydrate [1.42(1) and
1.43(1 )A ]14, sulfadiazine [1.41(2) and 1.42(2)A]15, sulfamerazine [1.424(4) and 1.435(3)A, 
• and 1.414(4) and 1.431(3)A]7 and are in good agreement with the corresponding bonds 
with values o f 1.431(2) and 1.435(2)A16 and 1.426(8) and 1.430(6)A17 in sulfamethazine.
The several hydrogen bonds are shown in the packing diagram by dashed lines which is 
shown in Figure 6.5.
Table 6.4: Possible hydrogen bonds in sulfadimethoxine (32) (distances and angles
____________given in A  and deg respectively)________________________________________
Donor-H Donor... Acceptor H... Acceptor Donor-H.....Acceptor
N i l  -HI 1 N i l  ....012(1) H ll  ...012 (1 ) N i l  -H ll ...0 1 2 (1 )
0.946(3) 2.890(8) 1.988(8) 158.68(2)
N14 -H14A N14 ....N12 (2) H14A...N12 (2) N14 -H14A...N12 (2)
0.948(3) 3.182(5) 2.244(3) 170.44(2)
Equivalent positions:
( 1 ) -x,-y+l,-z; (2 ) x+ l,+ y+ l,+ z
6.3.3.2 Structure of the complex [Zn(sdm)2(NH3)2].2H20 (33)
The structure o f the zinc complex [Zn(sdm)2 (NH 3 )2 ].2 H2 0  (33) is shown in Figure 6 . 6  
together with the crystallographic atom numbering scheme used. The bond lengths and 
angles are given in Table 6.5 and the possible hydrogen bonds are summarized in Table
6 .6 . The Zn(II) ion lies on the two fold axis and is coordinated to two sulfonamidic and 
two pyrimidino nitrogen atoms from two sulfadimethoxine anions and two other nitrogen 
atoms from the coordinated ammonia ligands. This structure shows that Zn(II) has a six 
coordinate bicapped tetrahedral geometry like the previous cadmium complex (21) in 
which two nitrogen [N (l)] atoms from ammonia and two from pyrimido [N(12)] atoms 
form the tetrahedron and two sulfonamidic nitrogen [N( 11)] atoms complete the 
coordination sphere around the zinc ion. The core geometry is shown in Figure 6 .8 .
The N ( l l )  atom has a longer interaction with the bond distance o f 2.834(3)A  than the 
N (1 2 ) atom with the Z n -N ( 1 2 ) bond distance of 2.015(3)A which is comparable with the 
corresponding bonds in [Zn(smz)2(NH 3 )2] (14) with the values o f  2.045(3) and 2.036(3)A 
and in [Zn(sdz)2(NH 3 )2 ] 18 2.166(4) and 2.078(4)A  but shorter than the values o f 2.122(3)A
189
Chapter 6
and 2.324(3)A in [Zn(smz)2 (py)2 ].2 py (15). The Z n -N (l) (ammonia) distance o f 
2.032(4)A is also comparable with the values o f 2.019(5) and 2.045(5)A in 
[Zn(smz)2 (NH 3 )2] (14) and 2.036(4) and 2.050(4)A in [Zn(sdz)2 (NH 3 )2 ] . 18
N1
Figure 6 . 6
X-ray structure o f  the complex [Zn(sdm)2 (N 1^ 3) 2]. 2 H 2 O (33) showing crystallographic 
atom numbering scheme used. Thermal ellipsoids are drawn at 35% probability level. The 
hydrogen atoms and water molecules are omitted fo r  clarity.
Table 6.5: Selected bond lengths [A] and angles [deg] in [Zn(sdm)2 (NH 3 )2 ].2 H 2 0  (33)
Bond (A) Bond (A)
Zn(l)-N (l 1) 2.834(3) Zn(l)-N(12) 2.015(3)
Z n(l)-N (l) 2.032(4) S(11)-0(12) 1.449(4)
S (ll)-0 (1 1 ) 1.453(4) S(1 1 )-N(1 1 ) 1.599(4)
S(ll)-C (15) 1.742(6) N(11)-C(11) 1.350(5)
N(14)-C(18) 1.360(9)
Angle (°) Angle (°)
N(12')-Zn(l)-N(12) 112.9(2) N (12 ')-Z n(l)-N (l) 113.8(2)
N (12)-Zn(l)-N (l) 107.8(2) N (11)-Zn(l)-N (l T) 96.2(2)
N (12)-Zn(l)-N(T) 113.8(2) N (l)-Z n(l)-N (T ) 1 0 0 .2 (2 )
0 (1 2)-S(l 1 )-0 ( l 1) 114.7(2) 0(12)-S(11)-N (11) 104.4(2)
0 (1 1)-S(11)-N(11) 113.6(2) 0(12)-S(11)-C(15) 107.6(3)
0 (1 1)-S(11 )-C(l 5) 107.7(3) N(11)-S(11 )-C(l 5) 108.6(2)
C(11)-N(11)-S(11) 121.4(3) N(13)-C(13)-C(14) 124.6(4)
Symmetry transformations used to generate equivalent atoms: (') -x , y, —z+ / 2
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The Z n -N (l) bonds are very similar to the Zn-N(12) bonds and the difference between 
these two types o f Z n-N  bonds, V = d[Z n-N (l)] -  d[Zn-N(12)] (A), +0.017 suggests that 
the Z n -N (l)  bond has similar strength as the Zn-N(12) bond in the complex.
The planes o f the phenyl and pyrimidine rings are inclined to Gauche conformation about 
S(11)—N (11) bond with a torsion angle o f 71.11(5)° which is larger than that of the free 
ligand which has a value of 58.16(2)°. The dihedral angle between the planes of phenyl and 
pyrimidine rings in the complex is 83.28(15)° which is larger than the value o f 76.10(5)° of 
the free ligand due to the coordination of the sulfadimethoxine with the zinc atom.
The lattice water molecules and coordinated ammonia form several hydrogen bonds with 
sulfonyl oxygen atoms, pyrimido nitrogen and amino nitrogen atoms in the complexes and 
these are shown in the packing diagram (Figure 6.7).
Figure 6.7
Packing diagram o f  the complex (33) where the hydrogen bonds are shown by dashed lines
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Figure 6.8
The bicapped tetrahedral structure o f  the complex [Zn(sdm)2 (NH3) 2] .2 H 2 O (33) containing 
only bonded nitrogen atoms with the zinc ion
Table 6.6: The possible hydrogen bonds in [Zn(sdm)2(NH3)2].2H20 (33) (distances
and angles given in A and deg respectively)
Donor-H Donor... Acceptor H... Acceptor Donor-H.....Acceptor
N1 -H1C 
0.949(5)
N1 ....01 (0) 
3.007(2)
H 1C ...01  (0) 
2.112(7)
N1 -H 1C ...01 (0) 
156.46(2)
01 -H IE 
0.836(7)
01 ....03 (0) 
2.574(2)
H IE  ...03 (0) 
1.776(1)
01 -H IE ...03 (0) 
159.13(4)
0 2  -H2A 
1.086(3)
0 2  ....03 (0) 
2.689(6)
H 2A ...03  (0) 
1.801(5)
0 2  -H 2A ...03  (0) 
135.94(7)
0 2  -H2B 
1.144(9)
0 2  ....O il (0) 
2.732(1)
H2B ...O il (0) 
1.618(8)
0 2  -H2B ...O il (0) 
162.75(7)
N14 -H14A 
0.880(5)
N 1 4 ....0 2  (1) 
3.047(8)
H14A...02 (1) 
2.172(5)
N14 -H14A...02 (1) 
172.47(3)
N14 -H14B 
0.880(1)
N 14....01  (2) 
2.842(6)
H14B...01 (2) 
1.999(6)
N14 -H14B...01 (2) 
159.85(5)
N1 -H1A 
0.949(6)
N1 ....N13 (3) 
3.096(2)
H1A ...N13 (3) 
2.189(3)
N1 -H1A...N13 (3) 
159.57(3)
01 -HID 
0.913(4)
01 ....N14 (4) 
2.842(6)
H ID  ...N14 (4) 
2.016(4)
01 -HID ...N14 (4) 
149.67(5)
03  -H3D 
1.153(7)
0 3  ....03 (5) 
2.305(1)
H 3D ...03  (5) 
1.153(8)
03  -H 3D ...03  (5) 
179.98(6)
Equivalent positions:
(0) x, y, z; ( 1 ) -x+V2, -y-'/2, +z-1/2; (2) -x+Yi, +y-1/ 2 , +z; (3) -x, -y, -z+2; (4) -x+'/2, +y+!/2, +z; 
(5) -x+1, -y, -z+2.
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